10-Q

Large accelerated filer

Accelerated filer

Non-accelerated
filer

Smaller reporting company

Emerging growth company

0001193125-21-239469.txt : 20210809 0001193125-21-239469.hdr.sgml : 20210809 20210806181612 ACCESSION NUMBER: 0001193125-21-239469 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 50 CONFORMED PERIOD OF REPORT: 20210630 FILED AS OF DATE: 20210809 DATE AS OF CHANGE: 20210806 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Consonance-HFW Acquisition Corp. CENTRAL INDEX KEY: 0001824893 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 981556622 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-39635 FILM NUMBER: 211154097 BUSINESS ADDRESS: STREET 1: 1 PALMER SQUARE STREET 2: SUITE 305 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: (609) 921-2333 MAIL ADDRESS: STREET 1: 1 PALMER SQUARE STREET 2: SUITE 305 CITY: PRINCETON STATE: NJ ZIP: 08540 10-Q 1 d188183d10q.htm 10-Q 10-Q

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM

10-Q

(MARK ONE)

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarter ended June 30, 2021

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from

Commission file number:

001-39635

Consonance-HFW

Acquisition Corp.

(Exact Name of Registrant as Specified in Its Charter)


Cayman Islands		98-15556622
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)


1 Palmer Square, Suite 305 Princeton, NJ		08540
(Address of principal executive offices)		(Zip Code)

(609)

921-2333

Not Applicable (Issuer’s telephone number)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
units, each consisting of one Class A ordinary share and one-third of a warrant to acquire one Class A ordinary share	CHFW.U	NYSE American LLC
Class A ordinary shares, par value $0.0001 per share	CHFW	NYSE American LLC
Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50	CHFW.W	NYSE American LLC

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation

S-T

(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a

non-accelerated

filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerging growth company” in

Rule 12b-2

of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule

12b-2

of the Exchange Act). Yes ☒ No ☐

As of August

, 2021, there were 9,634,000 Class A ordinary shares, par value $0.0001 per share, and 2,300,000 Class B ordinary shares, par value $0.0001 per share, issued and outstanding.

Table of Contents

CONSONANCE-HFW

ACQUISITION CORP.

FORM

10-Q

FOR THE QUARTER ENDED JUNE 30, 2021

TABLE OF CONTENTS


	Page
Part I. Financial Information
Item 1. Financial Statements
Condensed Balance Sheets as of June 30, 2021(Unaudited) and December 31, 2020		1
Condensed Statements of Operations for the three and six months ended June 30, 2021 (Unaudited)		2
Condensed Statement of Changes in Shareholders’ Equity for the three and six months ended June 30, 2021 (Unaudited)		3
Condensed Statement of Cash Flows for the six months ended June 30, 2021 (Unaudited)		4
Notes to Condensed Financial Statements (Unaudited)		5
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations		14
Item 3. Quantitative and Qualitative Disclosures Regarding Market Risk		16
Item 4. Controls and Procedures		16
Part II. Other Information
Item 1. Legal Proceedings		17
Item 1A. Risk Factors		17
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds		17
Item 3. Defaults Upon Senior Securities		18
Item 4. Mine Safety Disclosures		18
Item 5. Other Information		18
Item 6. Exhibits		18
Part III. Signatures		19

Table of Contents

PART I - FINANCIAL INFORMATION

Item 1.

Interim Financial Statements.

CONSONANCE-HFW

ACQUISITION CORP.

CONDENSED BALANCE SHEETS


	June 30, 2021			December 31, 2020
	(unaudited)
ASSETS
Current assets
Cash	$	390,673		$	987,187
Prepaid expenses		526,805			790,341

Total Current Assets		917,478			1,777,528

Cash and marketable securities held in Trust Account		92,029,147			91,997,501

TOTAL ASSETS	$	92,946,625		$	93,775,029

LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities
Accrued expenses	$	1,544,646		$	290,148

Total Current Liabilities		1,544,646			290,148

Warrant liability		5,138,148			3,404,014
Deferred underwriting fee payable		3,220,000			3,220,000

Total Liabilities		9,902,794			6,914,162

Commitments

Class A ordinary shares subject to possible redemption 7,804,383 and 8,186,086 shares at redemption value at June 30, 2021 and December 31, 2020		78,043,830			81,860,860

Shareholders’ Equity
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding		—			—
Class A ordinary shares, $0.0001 par value; 350,000,000 shares authorized; 1,829,617 and 1,447,914 shares issued and outstanding (excluding 7,804,383 and 8,186,086 shares subject to possible redemption) at June 30, 2021 and December 31, 2020, respectively		183			145
Class B ordinary shares, $0.0001 par value; 150,000,000 shares authorized; 2,300,000 shares issued and outstanding		230			230
Additional paid-in capital		10,938,952			7,121,960
Accumulated deficit		(5,939,364	)		(2,122,328	)

Total Shareholders’ Equity		5,000,001			5,000,007

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$	92,946,625		$	93,775,029

The accompanying notes are an integral part of the unaudited condensed financial statements.

Table of Contents

CONSONANCE-HFW

ACQUISITION CORP.

CONDENSED STATEMENTS OF OPERATIONS

(UNAUDITED)


	Three Months Ended June 30, 2021			Six Months Ended June 30, 2021

Operating and formation costs	$	1,049,339		$	2,114,548

Loss from operations		(1,049,339	)		(2,114,548	)

Other expense:
Interest earned on marketable securities held in Trust Account		8,534			31,646
Unrealized loss on marketable securities held in Trust Account		(6,299	)		—
Changes in fair value of warrant liability		(2,536,968	)		(1,734,134	)

Other expense, net		(2,534,733	)		(1,702,488	)

Net loss	$	(3,584,072	)	$	(3,817,036	)

Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to redemption		8,162,790			8,174,309

Basic and diluted net income per share, Class A ordinary shares subject to redemption	$	—		$	—

Basic and diluted weighted average shares outstanding, Non-redeemable ordinary shares		3,771,210			3,759,691

Basic and diluted net loss per share, Non-redeemable ordinary shares	$	(0.95	)	$	(1.02	)

The accompanying notes are an integral part of the unaudited condensed financial statements.

Table of Contents

CONSONANCE-HFW

ACQUISITION CORP.

CONDENSED STATEMENT OF CHANGES IN SHAREHOLDERS’ EQUITY

THREE AND SIX MONTHS ENDED JUNE 30, 2021

(UNAUDITED)


	Class A Ordinary Shares				Class B Ordinary Shares				Additional Paid-in		Accumulated			Total Shareholders’
	Shares		Amount		Shares		Amount		Capital		Deficit			Equity
Balance — January 1, 2021		1,447,914	$	145		2,300,000	$	230	$	7,121,960	$	(2,122,328	)	$	5,000,007
Change in value of Class A ordinary shares subject to redemption		23,296		2		—		—		232,958		—			232,960
Net loss		—		—		—		—		—		(232,964	)		(232,964	)

Balance – March 31, 2021		1,471,210	$	147		2,300,000	$	230	$	7,354,918	$	(2,355,292	)	$	5,000,003
Change in value of Class A ordinary shares subject to redemption		358,407		36		—		—		3,584,034		—			3,584,070
Net loss		—		—		—		—		—		(3,584,072	)		(3,584,072	)

Balance – June 30, 2021		1,829,617	$	183		2,300,000	$	230	$	10,938,952	$	(5,939,364	)	$	5,000,001

The accompanying notes are an integral part of the unaudited condensed financial statements.

Table of Contents

CONSONANCE-HFW

ACQUISITION CORP.

CONDENSED STATEMENT OF CASH FLOWS

SIX MONTHS ENDED JUNE 30, 2021

(UNAUDITED)


Cash Flows from Operating Activities:
Net loss	$	(3,817,036	)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account		(31,646	)
Changes in fair value of warrant liability		1,734,134
Unrealized gain on marketable securities held in Trust Account		—
Changes in operating assets and liabilities:
Prepaid expenses and other current assets		263,536
Accrued expenses		1,254,498

Net cash used in operating activities		(596,514	)

Net Change in Cash		(596,514	)
Cash – Beginning of period		987,187

Cash – End of period	$	390,673

Non-Cash investing and financing activities:
Change in value of Class A ordinary shares subject to possible redemption	$	(3,817,030	)

The accompanying notes are an integral part of the unaudited condensed financial statements.

Table of Contents

CONSONANCE-HFW

ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

JUNE 30, 2021

(Unaudited)

NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

Consonance-HFW

Acquisition Corp. (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on August 21, 2020. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (“Business Combination”).

The Company is not limited to a particular industry or geographic region for purposes of completing a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

As of June 30, 2021, the Company had not commenced any operations. All activity through June 30, 2021 relates to the Company’s formation, the initial public offering (“Initial Public Offering”), which is described below, and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate

non-operating

income in the form of interest income from the proceeds derived from the Initial Public Offering.

The registration statement for the Company’s Initial Public Offering became effective on November 18, 2020. On November 23, 2020, the Company consummated the Initial Public Offering of 8,000,000

units (the “Units” and individually a “Unit” and, with respect to the Class A ordinary shares included in the Units sold, the “Public Shares”), at

$10.00 per Unit, generating gross proceeds of $80,000,000 which is described in Note 3.

Simultaneously with the consummation of the Initial Public Offering, the Company consummated the sale of 410,000

units (the “Private Placement Units” and individually a “Private Placement Unit”) at a price of

$10.00 per Private Placement Unit in a private placement to Consonance Life Sciences (the “Sponsor”), generating gross proceeds of $4,100,000, which is described in Note 4.

Following the consummation of the Initial Public Offering on November 23, 2020, an amount of $80,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Units was placed in a trust account (the “Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting certain conditions of

Rule 2a-7

of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below.

On December 1, 2020, the underwriters fully exercised their over-allotment option, resulting in an additional 1,200,000 Units issued for an aggregate amount of $12,000,000. In connection with the underwriters’ full exercise of their over-allotment option, the Company also consummated the sale of an additional 24,000 Private Placement Units at $10.00 per Private Placement Unit, generating total proceeds of $12,240,000. A total of $12,000,000 was deposited into the Trust Account, bringing the aggregate proceeds held in the Trust Account to $92,000,000.

Transaction costs amounted to $5,658,864, consisting of $1,840,000 of underwriting fees, $3,220,000 of deferred underwriting fees and $598,864 of other offering costs.

he Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward completing a Business Combination. The Company must complete its initial Business Combination with one or more target businesses that together have a fair market value equal to at least 80% of the net assets held in the Trust Account (excluding any deferred underwriting commissions held in the Trust Account and taxes payable on the interest earned on the Trust Account) at the time of the agreement to enter into a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50%

or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act. On April 15, 2021, the Company has entered into a Business Combination agreement with Surrozen, Inc., see Note 10. Subsequent Events — Business Combination Agreement, PIPE Financing and Proxy Statement, however, There is no assurance that the Company will be able to successfully effect a Business Combination.

The Company will provide its shareholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The shareholders will be entitled to redeem their shares for a pro rata portion of the amount held in the Trust Account (initially $10.00 per share), calculated as of two business days prior to the completion of a Business Combination, including any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations. There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. On June 24, 2021, the Company filed a Proxy Statement on Schedule 14A with the Securities and Exchange Commission (the “SEC”), see Note 10. Subsequent Events — Business Combination Agreement, PIPE Financing and Proxy Statement.

usiness Combination Agreement, PIPE Financing and Proxy Statement

$200,000,000 and a $10.00

per share value of the Company’s common stock. In connection with the foregoing and concurrently with the execution of the Business Combination Agreement, the Company entered into subscription agreements with certain investors (the “Subscription Agreement(s)” and such investors, the “PIPE Investors”), pursuant to which the PIPE Investors have agreed to subscribe for and purchase, and the Company has agreed to issue and sell to the PIPE Investors, an aggregate of

12,020,000 units, each consisting of one share of the Company’s common stock and

one-third

per share, subject to adjustment as described in the form of warrant agreement attached to the form of Subscription Agreement, and only whole PIPE Warrants will be exercisable. The PIPE Warrants have substantially the same provisions as the warrants issued in connection with the Company’s Initial Public Offering. The securities to be issued pursuant to the Subscription Agreements have not been registered under the Securities Act of 1933, as amended (the “Securities Act”) in reliance upon the exemption provided in Section 4(a)(2) of the Securities Act. On June 24, 2021, the Company filed a Proxy Statement on Schedule 14A with the Securities and Exchange Commission (the “SEC”), announcing an extraordinary general meeting of the Company submitting the Business Combination and its Condition Precedent Proposals (as defined in the Proxy Statement) for shareholder approval.

isks and Uncertainties

anagement continues to evaluate the impact of the

COVID-19

pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position and/or effecting our Business Combination, the specific impact is not readily determinable as of the date of the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Table of Contents

CONSONANCE-HFW ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

JUNE 30, 2021

(Unaudited)

OTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form

10-Q

and Article 8 of Regulation

S-X

of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form

10-K/A

for the year ended December 31, 2020 as filed with the SEC on May 14, 2021. The interim results for the three and six months ended June 30, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future periods.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to

non-emerging

growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of the condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2021 and December 31, 2020.

Marketable Securities Held in Trust Account

At June 30, 2021 and December 31, 2020, substantially all of the assets held in the Trust Account were held in U.S. Treasury Bills.

Warrant Liability

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, “Distinguishing Liabilities from Equity” (“ASC 480”) and ASC 815, “Derivatives and Hedging” (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification.

Table of Contents

CONSONANCE-HFW ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

JUNE 30, 2021

(Unaudited)

This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional

paid-in

capital at the time of issuance or modification. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a

non-cash

gain or loss on the statements of operations.

Class A Ordinary Shares Subject to Possible Redemption

The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480. Class A ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet.

Income Taxes

The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the condensed financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s condensed financial statements and prescribes a recognition threshold and measurement process for condensed financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be

more-likely-than-not

to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2021 and December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

The Company is considered an exempted Cayman Islands company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the period presented.

Net Loss Per Ordinary Share

Net loss per share is computed by dividing net loss by the weighted-average number of ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture. The Company has not considered the effect of the warrants sold in the Initial Public Offering and private placement to purchase an aggregate of 3,211,334 shares in the calculation of diluted loss per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive.

The Company’s statements of operations includes a presentation of loss per share for ordinary shares subject to possible redemption in a manner similar to the

two-class

method of loss per share. Net loss per ordinary share, basic and diluted, for Class A ordinary shares subject to possible redemption is calculated by dividing the proportionate share of income or loss on marketable securities held by the Trust Account by the weighted average number of Class A ordinary shares subject to possible redemption outstanding since original issuance.

Net loss per share, basic and diluted, for

non-redeemable

ordinary shares is calculated by dividing the net income (loss), adjusted for income or loss on marketable securities attributable to Class A ordinary shares subject to possible redemption, by the weighted average number of

non-redeemable

ordinary shares outstanding for the period.

on-redeemable

common stock includes Founder Shares (as defined in Note 5) and

non-redeemable

ordinary shares as these shares do not have any redemption features.

Non-redeemable

ordinary shares participate in the income or loss on marketable securities based on

non-redeemable

shares’ proportionate interest.

Table of Contents

CONSONANCE-HFW

ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

JUNE 30, 2021

(Unaudited)

he following table reflects the calculation of basic and diluted net loss per ordinary share (in dollars, except per share amounts):


	Three Months Ended June 30, 2021			Six Months Ended June 30, 2021
Class A ordinary Shares subject to possible redemption
Numerator: Earnings allocable to Class A ordinary shares subject to possible redemption
Interest earned on marketable securities held in Trust Account	$	7,239		$	26,845
Unrealized loss on marketable securities held in Trust Account
Less: interest available to be withdrawn for working capital		(5,343	)		—

Net income attributable	$	1,896		$	26,845

Denominator: Weighted Average Class A ordinary shares subject to possible redemption
Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption		8,162,790			8,174,309

Basic and diluted net income per share, Class A ordinary shares subject to possible redemption	$	—		$	—

Non-Redeemable Ordinary Shares
Numerator: Net Loss minus Net Earnings
Net loss	$	(3,584,072	)	$	(3,817,036	)
Less: Net income allocable to Class A ordinary shares subject to possible redemption		(1,896	)		(26,845	)

Non-Redeemable Net Loss	$	(3,585,968	)	$	(3,843,881	)

Denominator: Weighted Average Non-redeemable ordinary shares
Basic and diluted weighted average shares outstanding, Non-redeemable ordinary shares		3,771,210			3,759,691

Basic and diluted net loss per share, Non-redeemable ordinary shares	$	(0.95	)	$	(1.02	)

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts.

air Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature.

air Value Measurements

air value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

•

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

•

Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

•

Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

Derivative Financial Instruments

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then

re-valued

at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or

non-current

based on whether or not

net-cash

settlement or conversion of the instrument could be required within 12 months of the balance sheet date.

Table of Contents

CONSONANCE-HFW ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

JUNE 30, 2021

(Unaudited)

Recent Accounting Standards

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements.

In August 2020, the FASB issued Accounting Standards Update (“ASU”)

2020-06,

Debt — Debt with Conversion and Other Options

(Subtopic

470-20)

and

Derivatives and Hedging — Contracts in Entity’s Own Equity

(Subtopic

815-40)

(“ASU

2020-06”)

to simplify accounting for certain financial instruments. ASU

2020-06

eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU

2020-06

amends the diluted earnings per share guidance, including the requirement to use the

if-converted

method for all instruments. ASU

2020-06

is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU

2020-06

would have on its financial position, results of operations or cash flows.

NOTE 3. INITIAL PUBLIC OFFERING

Pursuant to the Initial Public Offering, the Company sold 9,200,000 Units, inclusive of 1,200,000 Units sold to the underwriters on December 1, 2020 upon the underwriters’ election to fully exercise their over-allotment option, at a purchase price of $10.00 per Unit. Each Unit consists of one Class A ordinary share and

one-third

of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at an exercise price of $11.50 per share, subject to adjustment (see Note 8).

NOTE 4. PRIVATE PLACEMENT

Simultaneously with the consummation of the Initial Public Offering, the Sponsor purchased an aggregate of 410,000 Private Placement Units at a price of $10.00 per Private Placement Unit, for an aggregate purchase price of $4,100,000. On December 1, 2020, as a result of the underwriters’ election to fully exercise their over-allotment option, the Sponsor purchased an additional 24,000 Private Placement Units, at a price of $10.00 per Private Placement Unit, or $240,000 in the aggregate (see Note 8). Each Private Placement Unit consists of one

Class A ordinary

and

one-third

of one redeemable warrant

Each whole Private Placement Warrant is exercisable for one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 8). The proceeds from the sale of the Private Placement Units were added to the net proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Units held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Units and all underlying securities will expire worthless.

NOTE 5. RELATED PARTY TRANSACTIONS

Founder Shares

On September 4, 2020, the Sponsor paid $25,000 to cover certain offering and formation costs of the Company in consideration for 3,593,750 Class B ordinary shares. On October 8, 2020 and November 10, 2020, 718,750 and 575,000 Class B ordinary shares were contributed back to the Company for no consideration, respectively, resulting in there being 2,300,000 Class B ordinary shares (the “Founder Shares”) being issued and outstanding. The Founder Shares include an aggregate of up to 300,000 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment is not exercised in full or in part, so that the number of Founder Shares will collectively represent 20% of the Company’s issued and outstanding shares upon the completion of the Initial Public Offering (not including the Private Placement Shares). On December 1, 2020, the underwriters fully exercised their over-allotment option, therefore there are no Founder Shares subject to forfeiture.

The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination; and (B) subsequent to a Business Combination, (x) if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for

share sub-divisions, share

capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within

any 30-trading day

period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, amalgamation, share exchange, reorganization or other similar transaction that results in all of the Company’s shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property.

Table of Contents

CONSONANCE-HFW ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

JUNE 30, 2021

(Unaudited)

Administrative Services Agreement

The Company entered into an agreement, commencing on November 18, 2020 through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay the Sponsor a total of up to $55,000 per month for office space and administrative support services. For the period three and six months ended June 30, 2021, the Company incurred and paid $165,000 and $330,000, respectively, of such fees.

Related Party Loans

In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s directors and officers may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into Private Placement Units of the post-Business Combination entity at a price of $10.00 per Private Placement Unit. The Private Placement Units would be identical to the Units. As of June 30, 2021 and December 31, 2020, the Company had no outstanding borrowings under the Working Capital Loans.

NOTE 6. COMMITMENTS

Registration and Shareholder Rights

Pursuant to a registration rights agreement entered into on November 18, 2020, the holders of the Founder Shares, Private Placement Units (including securities contained therein) and warrants that may be issued upon conversion of the Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Units and warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) will be entitled to registration rights. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. However, the registration and shareholder rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable

lock-up

period. The registration rights agreement does not contain liquidating damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

The underwriters are entitled to a deferred fee of $0.35 per Unit, or $3,220,000 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

NOTE 7. S

HARE

HOLDERS’ EQUITY

Preference Shares

—

The Company is authorized to issue 1,000,000 preference shares with a par value of $0.0001 per share, with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At June 30, 2021 and December 31, 2020, there were no preference shares issued or outstanding.

Class

A ordinary shares

—

The Company is authorized to issue 350,000,000 Class A ordinary shares, with a par value of $0.0001 per share. Holders of Class A ordinary shares are entitled to one vote for each share. At June 30, 2021 and December 31, 2020, there were 1,829,617 and 1,447,914 (excluding 7,804,383 and 8,186,086 shares subject to possible redemption) Class A ordinary shares issued and outstanding, respectively.

Class

B ordinary shares

—

The Company is authorized to issue 150,000,000 Class B ordinary shares, with a par value of $0.0001 per share. Holders of the Class B ordinary shares are entitled to one vote for each share. At June 30, 2021 and December 31, 2020, there were 2,300,000 Class B ordinary shares issued and outstanding.

Only holders of the Class B ordinary shares will have the right to vote on the election of directors prior to the Business Combination. Holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all other matters submitted to a vote of the Company’s shareholders except as otherwise required by law.

The Class B ordinary shares will automatically convert into Class A ordinary shares on the first business day following the consummation of a Business Combination at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an

as-converted

basis, 20% of the sum of (i) the total number of ordinary shares issued and outstanding (excluding the Private Placement Shares underlying the Private

Table of Contents

CONSONANCE-HFW ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

JUNE 30, 2021

(Unaudited)

Placement Units) upon completion of the Initial Public Offering, plus (ii) the sum of the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of a Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in a Business Combination and any Private Placement Warrants issued to the Sponsor, members of the Company’s founding team or any of their affiliates upon conversion of Working Capital Loans. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than one to one.

NOTE 8. WARRANT LIABILITY

Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) one year from the closing of the Initial Public Offering. The Public Warrants will expire five years from the completion of a Business Combination or earlier upon redemption or liquidation.

The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating thereto is available, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption is available.

The Company has agreed that as soon as practicable, but in no event later than 20 business days, after the closing of a Business Combination, it will use its commercially reasonable efforts to file with the SEC a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants, and the Company will use its commercially reasonable efforts to cause the same to become effective within 60 business days after the closing of a Business Combination, and to maintain the effectiveness of such registration statement and a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement; if the Class A ordinary shares are, at the time of any exercise of a warrant, not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th day after the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption, but will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.

Redemption of warrants when the price per Class

A ordinary share equals or exceeds $18.00

—Once the warrants become exercisable, the Company may redeem the outstanding Public Warrants (except with respect to the Private Placement Warrants):

•

in whole and not in part;

•

at a price of $0.01 per Public Warrant;

•

upon not less than 30 days’ prior written notice of redemption to each warrant holder; and

•

if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share

sub-divisions,

share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a

30-trading

day period ending on the third trading day prior to the date on which notice of the redemption is given to the warrant holders (the “Reference Value”).

If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws.

Redemption of Warrants When the Price per Class

A Ordinary Share Equals or Exceeds $10.00

—Once the warrants become exercisable, the Company may redeem the outstanding warrants:

•

in whole and not in part;

•

at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption; provided that during such 30 day period holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares, based on the redemption date and the fair market value of the Class A ordinary shares, that if the warrants are not exercised on a cashless basis or otherwise during such 30 day period, the Company shall redeem such warrants for $0.10 per share;

•

if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted for share subdivisions, share dividends, reorganizations, recapitalizations and the like) on the trading day before the Company sends the notice of redemption to the warrant holders; and

Table of Contents

CONSONANCE-HFW ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

JUNE 30, 2021

(Unaudited)

•

if the Reference Value is less than $18.00 per share (as adjusted for share splits, share dividends, reorganizations, recapitalizations and the like), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above.

The exercise price and number of ordinary shares issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as described below, the Public Warrants will not be adjusted for issuances of ordinary shares at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless.

In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of its Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00 and $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively.

The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A ordinary shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and be

non-redeemable,

except as described above, so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

NOTE 9. FAIR VALUE MEASUREMENTS

The Company follows the guidance in ASC Topic 820, “Fair Value Measurements” for its financial assets and liabilities that are

re-measured

and reported at fair value at each reporting period, and

non-financial

assets and liabilities that are

re-measured

and reported at fair value at least annually.

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:


		Level 1:		Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

		Level 2:		Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.

		Level 3:		Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.

The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at June 30, 2021 and December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:


Description	Level		June 30, 2021		December 31, 2020
Assets:
Marketable securities held in Trust Account		1	$	92,029,147	$	91,997,501

Liabilities:
Warrant liability – Public Warrants		1	$	4,753,334	$	3,250,667
Warrant liability – Private Placement Warrants		3		384,814		153,347

Table of Contents

CONSONANCE-HFW ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

JUNE 30, 2021

(Unaudited)

The Warrants were accounted for as liabilities in accordance with ASC

815-40

and are presented within warrant liabilities on our balance sheet. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the consolidated statements of operations.

oth the Private Placement Warrants and the Public Warrants were initially valued using a binomial lattice model, which is considered to be a Level 3 fair value measurement. As of June 30, 2021, the Public Warrants were valued using the instrument’s publicly listed trading notice as of the balance sheet date, which is considered to be a Level 1 measurement due to the use of an observable market quote in an active market. The Private Warrants were valued using a binomial lattice model, which is considered to be a Level 3 fair value measurement. The binomial lattice model’s primary unobservable input utilized in determining the fair value of the Private Placement Warrants is the expected volatility of the common stock. The expected volatility as of the Initial Public Offering date was derived from observable public warrant pricing on comparable ‘blank-check’ companies without an identified target. The expected volatility as of subsequent valuation dates will be implied from the Company’s own public warrant pricing. A binomial lattice model methodology was also used in estimating the fair value of the Public Warrants for periods where no observable traded price was available, using the same expected volatility as was used in measuring the fair value of the Private Placement Warrants. For periods subsequent to the detachment of the Warrants from the Units, the close price of the Public Warrant price will be used as the fair value as of each relevant date.

The following table presents the changes in the fair value of warrant liabilities:


	Private Placement			Public			Warrant Liabilities
Fair value as of January 1, 2021	$	153,347		$	3,250,667		$	3,404,014
Change in valuation inputs or other assumptions		(36,167	)		(766,667	)		(802,834	)

Fair value as of March 31, 2021	$	117,180		$	2,484,000		$	2,601,180

Change in valuation inputs or other assumptions		267,634			2,269,334			2,536,968

Fair value as of June 30, 2021	$	384,814		$	4,753,334		$	5,138,148

There were no transfers in or out of Level 3 from other levels in the fair value hierarchy.

NOTE 10. SUBSEQUENT EVENTS

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements.

Table of Contents

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

References in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to

Consonance-HFW

Acquisition Corp. References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to Consonance Life Sciences. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the condensed financial statements and the notes thereto contained elsewhere in this Quarterly Report on Form

10-Q.

Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Special Note Regarding Forward-Looking Statements

This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Exchange Act of 1934 (the “Exchange Act”) that are not historical facts, and involves risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Form

10-Q

including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s final prospectus for its Initial Public Offering filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

Overview

We are a blank check company incorporated in the Cayman Islands on August 21, 2020 formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or other similar business combination with one or more businesses (the “Business Combination”). We intend to effectuate our Business Combination using cash derived from the proceeds of the Company’s initial public offering (the “Initial Public Offering”) and the sale of private placement units, our shares, debt or a combination of cash, shares and debt.

We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.

Recent Development

Business Combination Agreement, PIPE Financing and Proxy Statement

On April 15, 2021, the Company entered into a business combination agreement (the “Business Combination Agreement”) with Surrozen, Inc. (“Surrozen”), pursuant to which a wholly-owned subsidiary of the Company will merge with and into Surrozen, with Surrozen surviving as a wholly-owned subsidiary of the Company and the Company will redomicile as a Delaware corporation. In accordance with the terms and subject to the conditions of the Business Combination Agreement, each share and equity award (whether vested or unvested) of Surrozen outstanding as of closing will be exchanged for shares of the Company’s common stock or comparable equity awards that are settled or are exercisable for shares of the Company’s common stock, as applicable, based on an implied Surrozen equity value of $200,000,000 and a $10.00 per share value of the Company’s common stock. In connection with the foregoing and concurrently with the execution of the Business Combination Agreement, the Company entered into subscription agreements with certain investors (the “Subscription Agreement(s)” and such investors, the “PIPE Investors”), pursuant to which the PIPE Investors have agreed to subscribe for and purchase, and the Company has agreed to issue and sell to the PIPE Investors, an aggregate of 12,020,000 units, each consisting of one share of the Company’s common stock and

one-third

of one redeemable warrant for one share of the Company’s common stock (the “PIPE Warrants”), for a purchase price of $10.00 per unit (the “PIPE Units”), for aggregate gross proceeds of $120,200,000 (the “PIPE Financing”). Each whole PIPE Warrant entitles the holder thereof to purchase one share of the Company’s common stock at a price of $11.50 per share, subject to adjustment as described in the form of warrant agreement attached to the form of Subscription Agreement, and only whole PIPE Warrants will be exercisable. The PIPE Warrants have substantially the same provisions as the warrants issued in connection with the Initial Public Offering. The securities to be issued pursuant to the Subscription Agreements have not been registered under the Securities Act in reliance upon the exemption provided in Section 4(a)(2) of the Securities Act. On June 24, 2021, the Company filed a Proxy Statement on Schedule 14A with the SEC, announcing an extraordinary general meeting of the Company submitting the Business Combination and its Condition Precedent Proposals (as defined in the Proxy Statement) for shareholder approval.

Results of Operations

We have neither engaged in any operations nor generated any operating revenues to date. Our only activities from inception through June 30, 2021 were organizational activities and those necessary to prepare for the Initial Public Offering, described below and, subsequent to the Initial Public Offering, the search for a target company for a Business Combination. We do not expect to generate any operating revenues until after the completion of our initial Business Combination. We expect to generate

non-operating

income in the form of interest income on marketable securities held after the Initial Public Offering. We expect that we will incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with searching for, and completing, a Business Combination.

Table of Contents

For the three months ended June 30, 2021, we had a net loss of $3,584,072, which consists of operating and formation costs of $1,049,339 and the change in fair value of warrant liability loss of $2,536,968, offset by interest income of $8,534, and an unrealized loss on marketable securities held in a trust account (“Trust Account”) of $6,299.

For the six months ended June 30, 2021, we had a net loss of $3,817,036, which consists of operating and formation costs of $2,114,458, and the change in fair value of warrant liability loss of $1,734,134, and offset by interest income of $31,646.

Liquidity and Capital Resources

On November 23, 2020, we consummated the Initial Public Offering of 8,000,000 units, at a price of $10.00 per unit (each a “Unit” and collectively, the “Units”), generating gross proceeds of $80,000,000. Simultaneously with the closing of the Initial Public Offering, we consummated the sale of 410,000 private placement units (each, a “Private Placement Unit” and collectively, the “Private Placement Units”) to the Sponsor at a price of $10.00 per Private Placement Unit generating gross proceeds of $4,100,000.

Additionally, on December 1, 2020, the underwriters fully exercised their over-allotment option, resulting in an additional 1,200,000 units issued for an aggregate amount of $12,000,000. In connection with the underwriters’ full exercise of their over-allotment option, the company also consummated the sale of an additional 24,000 Private Placement Units at $10.00 per Private Placement Unit, generating total proceeds of $12,240,000. A total of $12,000,000 was deposited into the Trust Account, bringing the aggregate proceeds held in the Trust Account to $92,000,000.

For the six months ended June 30, 2021, cash used in operating activities was $596,514. Net loss of $3,817,036 was affected by interest earned on marketable securities held in the Trust Account of $31,646, and the change in fair value of warrants of $1,734,134. Changes in operating assets and liabilities provided $1,518,034 of cash for operating activities.

Following the Initial Public Offering, the sale of the Private Placement Units, and the full exercise of the underwriter’s over-allotment option, a total of $92,000,000 was placed in the Trust Account. We incurred $5,658,864 in transaction costs, including $1,840,000 of underwriting fees, $3,220,000 of deferred underwriting fees and $598,864 of other costs.

At June 30, 2021, we had marketable securities held in the Trust Account of $92,029,147. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account, which interest shall be net of taxes payable and excluding deferred underwriting commissions, to complete our business combination. We may withdraw interest from the Trust Account to pay taxes, if any. To the extent that our share capital or debt is used, in whole or in part, as consideration to complete a business combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

At June 30, 2021, we had cash of $390,673. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, structure, negotiate and complete a Business Combination.

In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete a Business Combination, we may repay such loaned amounts out of the proceeds of the Trust Account released to us. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts, but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into Private Placement Units of the post-Business Combination entity, at a price of $10.00 per Unit, at the option of the lender. The Units would be identical to the Private Placement Units.

We do not believe we will need to raise additional funds in order to meet the expenditures required for operating our business. However, if our estimate of the costs of identifying a target business, undertaking

in-depth

due diligence and negotiating a Business Combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our initial Business Combination. Moreover, we may need to obtain additional financing either to complete our Business Combination or because we become obligated to redeem a significant number of our public shares upon completion of our Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination.

Off-Balance

Sheet Arrangements

We have no obligations, assets or liabilities, which would be considered

off-balance

sheet arrangements as of June 30, 2021. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating

off-balance

sheet arrangements. We have not entered into any

off-balance

sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any

non-financial

assets.

Contractual obligations

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to pay the Sponsor a monthly fee of $55,000 for office space and administrative support services provided to the Company. We began incurring these fees on November 18, 2020 and will continue to incur these fees monthly until the earlier of the completion of a Business Combination and the Company’s liquidation.

The underwriters are entitled to a deferred fee of $0.35 per Unit or $3,220,000. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that we complete a Business Combination, subject to the terms of the underwriting agreement.

Table of Contents

Critical Accounting Policies

The preparation of condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies:

Warrant Liability

We account for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, “Distinguishing Liabilities from Equity” (“ASC 480”) and ASC 815, “Derivatives and Hedging” (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to our own ordinary shares, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional

paid-in

capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a

non-cash

gain or loss on the statements of operations.

Class A Ordinary Shares Subject to Redemption

We apply the

two-class

method in calculating earnings per share. Net income (loss) per common share, basic and diluted for Class A ordinary shares subject to possible redemption is calculated by dividing the interest income earned on the Trust Account, net of applicable taxes, if any, by the weighted average number of shares of Class A ordinary shares subject to possible redemption outstanding for the period. Net income (loss) per ordinary share, basic and diluted for and

non-redeemable

common stock is calculated by dividing net loss less income attributable to Class A ordinary shares subject to possible redemption, by the weighted average number of shares of

non-redeemable

ordinary shares outstanding for the period presented.

Net Loss Per Ordinary Share

We apply the

two-class

method in calculating earnings per share. Net loss per ordinary share, basic and diluted for Class A ordinary shares subject to possible redemption is calculated by dividing the interest income earned on the Trust Account, net of applicable taxes, if any, by the weighted average number of shares of Class A ordinary shares subject to possible redemption outstanding for the period. Net loss per ordinary share, basic and diluted for and

non-redeemable

common stock is calculated by dividing net loss less income attributable to Class A ordinary shares subject to possible redemption, by the weighted average number of shares of

non-redeemable

ordinary shares outstanding for the period presented.

Recent Accounting Standards

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our condensed financial statements.

In August 2020, the FASB issued Accounting Standards Update (“ASU”)

2020-06,

Debt —

Debt with Conversion and Other Options

(Subtopic

470-20)

and

Derivatives and Hedging — Contracts in Entity’s Own Equity

(Subtopic

815-40)

(“ASU

2020-06”)

to simplify accounting for certain financial instruments. ASU

2020-06

amends the diluted earnings per share guidance, including the requirement to use the

if-converted

method for all convertible instruments. ASU

2020-06

is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. We are currently assessing the impact, if any, that ASU

2020-06

would have on its financial position, results of operations or cash flows.

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Not required for smaller reporting companies.

Item 4.

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Under the supervision and with the participation of our management, including our principal executive officer and principal financial and accounting officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended June 30, 2021, as such term is defined in Rules

13a-15(e)

and

15d-15(e)

under the Exchange Act. Based on this evaluation, our principal executive officer and principal financial and accounting

Table of Contents

officer have concluded that during the period covered by this report, our disclosure controls and procedures were not effective at a reasonable assurance level

due to the material weakness related to the initial classification of the warrant accounting which resulted in the restatement of the December 31, 2020 Form 10-K

and, accordingly, provided reasonable assurance that the information required to be disclosed by us in reports filed under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms as a result of restatement of the warrants to be presented as liabilities rather than equity instruments.

Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting that occurred during the fiscal quarter of 2021 covered by this Quarterly Report on Form

10-Q

that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

Item 1.

Legal Proceedings

None

Item 1A.

Risk Factors

Except as set forth below, as of the date of this Quarterly Report on Form

10-Q,

there have been no material changes with respect to those risk factors previously disclosed in our Amendment No. 1 to our Annual Report on Form

10-K

filed with the SEC on May 14, 2021. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations.

The securities in which we invest the funds held in the Trust Account could bear a negative rate of interest, which could reduce the value of the assets held in trust such that the

per-share

redemption amount received by public shareholders may be less than $10.00 per share.

The proceeds held in the Trust Account are invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule

2a-7

under the Investment Company Act, which invest only in direct U.S. government treasury obligations. While short-term U.S. government treasury obligations currently yield a positive rate of interest, they have briefly yielded negative interest rates in recent years. Central banks in Europe and Japan pursued interest rates below zero in recent years, and the Open Market Committee of the Federal Reserve has not ruled out the possibility that it may in the future adopt similar policies in the United States. In the event that we are unable to complete our initial business combination or make certain amendments to our Amended and Restated Certificate of Incorporation, our public shareholders are entitled to receive their

pro-rata

share of the proceeds held in the Trust Account, plus any interest income not released to us, net of taxes payable. Negative interest rates could impact the

per-share

redemption amount that may be received by public shareholders.

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds.

non-employee

directors. As a result of the underwriters’ election to fully exercise their over-allotment option, the Founder Shares are no longer subject to forfeiture. The foregoing issuance was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act. Pursuant to a sponsor letter agreement entered into in connection the Business Combination (Note 10. Subsequent Events — Business Combination Agreement, PIPE Financing and Proxy Statement), the Sponsor will forfeit 759,000 of Founder Shares at the closing of the Business Combination.

On November 23, 2020, we consummated our Initial Public Offering of 8,000,000 Units, at a price of $10.00 per Unit, generating total gross proceeds of $80,000,000. The securities sold in the offering were registered under the Securities Act on registration statements on

Form S-1

(No. 333-249394).

The registration statements became effective on November 18, 2020.

Simultaneously with the consummation of the Initial Public Offering, we consummated a private placement of 410,000 Private Placement Units to our Sponsor at a price of $10.00 per Private Placement Unit, generating total proceeds of $4,100,000. Such securities were issued pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.

The Private Placement Units are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Units are not transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions.

Of the gross proceeds received from the Initial Public Offering and the sale of the Private Placement Units, $92,000,000 was placed in the Trust Account.

We paid a total of $1,840,000 in underwriting discounts and commissions and $598,864 for other costs and expenses related to the Initial Public Offering. In addition, the underwriter agreed to defer $3,220,000 in underwriting discounts and commissions.

For a description of the use of the proceeds generated in our Initial Public Offering, see Part I, Item 2 of this Quarterly Report on

Form 10-Q.

Table of Contents

Item 3.

Defaults Upon Senior Securities

None

Item 4.

Mine Safety Disclosures

Not applicable.

Item 5.

Other Information

None.

Item 6.

Exhibits

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form

10-Q.


No.		Description of Exhibit

31.1*		Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2*		Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1**		Certification of Principal Executive Officer Pursuant and Principal Financial Officer to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2**		Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS*		Inline XBRL Instance Document

101.CAL*		Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.SCH*		Inline XBRL Taxonomy Extension Schema Document

101.DEF*		Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB*		Inline XBRL Taxonomy Extension Labels Linkbase Document

101.PRE*		Inline XBRL Taxonomy Extension Presentation Linkbase Document

104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)


*		Filed herewith.
**		Furnished.

Table of Contents

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


	CONSONANCE-HFW ACQUISITION CORP.

Date: August 6, 2021		/s/ Gad Soffer
	Name:	Gad Soffer
	Title:	Chief Executive Officer
		(Principal Executive Officer)

Date: August 6, 2021		/s/ Kevin Livingston
	Name:	Kevin Livingston
	Title:	Chief Financial Officer
		(Principal Financial and Accounting Officer)

EX-31.1 2 d188183dex311.htm EX-31.1 EX-31.1

EXHIBIT 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Gad Soffer, certify that:

I have reviewed this Quarterly Report on Form 10-Q of Consonance-HFW Acquisition Corp.;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313);

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

EX-31.2 3 d188183dex312.htm EX-31.2 EX-31.2

EXHIBIT 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Kevin Livingston, certify that:

I have reviewed this Quarterly Report on Form 10-Q of Consonance-HFW Acquisition Corp.;

(Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313);

(a)

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

EX-32.1 4 d188183dex321.htm EX-32.1 EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Consonance-HFW Acquisition Corp. (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2021, as filed with the Securities and Exchange Commission (the “Report”), I, Gad Soffer, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as added by §906 of the Sarbanes-Oxley Act of 2002, that:

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

EX-32.2 5 d188183dex322.htm EX-32.2 EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Consonance-HFW Acquisition Corp. (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2021, as filed with the Securities and Exchange Commission (the “Report”), I, Kevin Livingston, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as added by §906 of the Sarbanes-Oxley Act of 2002, that:

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

EX-101.SCH 6 chfw-20210630.xsd XBRL TAXONOMY EXTENSION SCHEMA 1001 - Document - Cover Page link:presentationLink link:definitionLink link:calculationLink 1002 - Statement - CONDENSED BALANCE SHEETS link:presentationLink link:definitionLink link:calculationLink 1003 - Statement - CONDENSED BALANCE SHEETS (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1004 - Statement - CONDENSED STATEMENTS OF OPERATIONS link:presentationLink link:definitionLink link:calculationLink 1005 - Statement - CONDENSED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY link:presentationLink link:definitionLink link:calculationLink 1006 - Statement - CONDENSED STATEMENT OF CASH FLOWS link:presentationLink link:definitionLink link:calculationLink 1007 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS link:presentationLink link:definitionLink link:calculationLink 1008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:definitionLink link:calculationLink 1009 - Disclosure - INITIAL PUBLIC OFFERING link:presentationLink link:definitionLink link:calculationLink 1010 - Disclosure - PRIVATE PLACEMENT link:presentationLink link:definitionLink link:calculationLink 1011 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:definitionLink link:calculationLink 1012 - Disclosure - COMMITMENTS link:presentationLink link:definitionLink link:calculationLink 1013 - Disclosure - SHAREHOLDERS' EQUITY link:presentationLink link:definitionLink link:calculationLink 1014 - Disclosure - WARRANT LIABILITY link:presentationLink link:definitionLink link:calculationLink 1015 - Disclosure - FAIR VALUE MEASUREMENTS link:presentationLink link:definitionLink link:calculationLink 1016 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:definitionLink link:calculationLink 1017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:definitionLink link:calculationLink 1018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:definitionLink link:calculationLink 1019 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) link:presentationLink link:definitionLink link:calculationLink 1020 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details) link:presentationLink link:definitionLink link:calculationLink 1021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:definitionLink link:calculationLink 1022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Basic and diluted net income (loss) per ordinary share (Details) link:presentationLink link:definitionLink link:calculationLink 1023 - Disclosure - INITIAL PUBLIC OFFERING (Details) link:presentationLink link:definitionLink link:calculationLink 1024 - Disclosure - PRIVATE PLACEMENT (Details) link:presentationLink link:definitionLink link:calculationLink 1025 - Disclosure - RELATED PARTY TRANSACTIONS - Founder Shares (Details) link:presentationLink link:definitionLink link:calculationLink 1026 - Disclosure - RELATED PARTY TRANSACTIONS - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 1027 - Disclosure - COMMITMENTS (Details) link:presentationLink link:definitionLink link:calculationLink 1028 - Disclosure - SHAREHOLDERS' EQUITY - Preferred Stock Shares (Details) link:presentationLink link:definitionLink link:calculationLink 1029 - Disclosure - SHAREHOLDERS' EQUITY - Common Stock Shares (Details) link:presentationLink link:definitionLink link:calculationLink 1030 - Disclosure - WARRANT LIABILITY (Details) link:presentationLink link:definitionLink link:calculationLink 1031 - Disclosure - FAIR VALUE MEASUREMENTS (Details) link:presentationLink link:definitionLink link:calculationLink 1032 - Disclosure - FAIR VALUE MEASUREMENTS - Summary of fair value of the warrant liabilities (Details) link:presentationLink link:definitionLink link:calculationLink 1033 - Disclosure - FAIR VALUE MEASUREMENTS - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 chfw-20210630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 chfw-20210630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 chfw-20210630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Information [Table] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Units Each Consisting Of One Share Of Class Ordinary Shares And One Third Of Redeemable Warrant To Acquire One Class Ordinary Share [Member] Units, each consisting of one share of Class A ordinary shares, and one-third of a redeemable Warrant to acquire one Class A ordinary share Information pertaining to Unit each consisting of one class common stock. Warrants Each Whole Warrant Exercisable For One Class Ordinary Share At Exercise Price Of 1150 [Member] Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price. Common Class A [Member] Class A ordinary Common Class B [Member] Class B ordinary Document Information [Line Items] Cover Page Document Type Document Period End Date Entity Registrant Name Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Ex Transition Period Entity Shell Company Entity Address, State or Province Entity Central Index Key Current Fiscal Year End Date Amendment Flag Document Transition Report Title of 12(b) Security Trading Symbol Security Exchange Name Entity Common Stock, Shares Outstanding Document Fiscal Year Focus Document Fiscal Period Focus Document Quarterly Report Entity File Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two City Area Code Local Phone Number Entity Tax Identification Number Entity Address, City or Town Entity Address, Postal Zip Code Statement of Financial Position [Abstract] Statement [Table] Statement [Line Items] Liabilities and Equity [Abstract] LIABILITIES AND STOCKHOLDERS' EQUITY Deferred underwriting fee payable Deferred underwriting fee payable The carrying value as of balance sheet date of underwriting fees payable or deferred, classified as noncurrent. Liabilities Total Liabilities Commitments and Contingencies Commitments Temporary Equity, Carrying Amount, Attributable to Parent Class A ordinary shares subject to possible redemption 7,804,383 and 8,186,086 shares at redemption value at June 30, 2021 and December 31, 2020 Stockholders' Equity Attributable to Parent [Abstract] Stockholder's Equity Preferred Stock, Value, Issued Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding Common Stock, Value, Issued Common stock Additional Paid in Capital Additional paid-in capital Retained Earnings (Accumulated Deficit) Accumulated deficit Stockholders' Equity Attributable to Parent Total Stockholder's Equity Balance at the beginning Balance at the end Liabilities and Equity TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY Warrant liability Warrant Liability Warrant liability. Liabilities, Current [Abstract] Current liabilities Accrued Liabilities, Current Accrued expenses Liabilities, Current Total Current Liabilities Assets [Abstract] ASSETS Assets Held-in-trust, Noncurrent Cash and marketable securities held in Trust Account Marketable securities held in Trust Account Assets TOTAL ASSETS Assets, Current [Abstract] Current assets Assets, Current Total Current Assets Prepaid Expense, Current Prepaid expenses Cash and Cash Equivalents, at Carrying Value Cash Temporary Equity, Shares Outstanding Temporary equity, shares outstanding Preferred Stock, Par or Stated Value Per Share Preferred stock, par value, (per share) Preferred stock, par value, (per share) Preferred Stock, Shares Authorized Preferred stock, shares authorized Preferred shares, shares authorized Preferred Stock, Shares Issued Preferred stock, shares issued Preferred shares, shares issued Preferred Stock, Shares Outstanding Preferred stock, shares outstanding Preferred shares, shares outstanding Common Stock, Par or Stated Value Per Share Common shares, par value, (per share) Common shares, par value (in dollars per share) Common Stock, Shares Authorized Common shares, shares authorized Common shares, shares authorized (in shares) Common Stock, Shares, Issued Common shares, shares issued Common shares, shares issued (in shares) Common Stock, Shares, Outstanding Common shares, shares outstanding Common shares, shares outstanding (in shares) Income Statement [Abstract] Class A Ordinary Shares Subject For Redemption [Member] Class A ordinary shares subject to redemption Class A ordinary Shares subject to possible redemption Represents about Class A ordinary shares subject for redemption. Nonredeemable Preferred Stock [Member] Non-redeemable ordinary shares Net Income (Loss) Attributable to Parent Net loss Net loss Operating Costs and Expenses Operating and formation costs Operating Income (Loss) Loss from operations Nonoperating Income (Expense) [Abstract] Other expense: Nonoperating Income (Expense) Other expense, net Unrealized Gain (Loss) on Investments Unrealized gain on marketable securities held in Trust Account Unrealized gain on marketable securities held in Trust Account Investment Income, Interest Interest earned on marketable securities held in Trust Account Interest earned on marketable securities held in Trust Account Fair Value Adjustment of Warrants Changes in fair value of warrant liability Changes in fair value of warrant liability Weighted Average Number of Shares Outstanding, Basic and Diluted Basic and diluted weighted average shares outstanding Earnings Per Share, Basic and Diluted Basic and diluted net income (Loss) per share Basic and diluted net loss per share STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY Increase (Decrease) in Stockholders' Equity [Roll Forward] Shares, Issued Balance at the beginning (in shares) Balance at the end (in shares) Stock Issued During Period Value Change In Value Of Class A Ordinary Shares Subject To Redemption Change in value of Class A ordinary shares subject to redemption Stock issued during period value change in value of class a ordinary shares subject to redemption. Stock Issued During Period Shares Change In Value Of Class A Ordinary Shares Subject To Redemption Change in value of Class A ordinary shares subject to redemption (in shares) Stock issued during period value change in value of class a ordinary shares subject to redemption. Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Retained Earnings [Member] Accumulated Deficit Common Stock [Member] Common Stock Additional Paid-in Capital [Member] Additional Paid-in Capital Statement of Cash Flows [Abstract] Net Cash Provided by (Used in) Operating Activities [Abstract] Cash Flows from Operating Activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other current assets Increase (Decrease) in Accrued Liabilities Accrued expenses Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Net Change in Cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash – Beginning of period Cash – End of period Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Non-Cash investing and financing activities: Change In Value Of Common Stock Subject To Possible Redemption Change in value of Class A ordinary shares subject to possible redemption Amount of change in value of common stock subject to possible redemption, classified as non-cash investing and financing activity. Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Accounting Policies [Abstract] Basis of Presentation and Significant Accounting Policies [Text Block] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES INITIAL PUBLIC OFFERING No definition available. Initial Public Offering [Text Block] INITIAL PUBLIC OFFERING The entire disclosure on information about initial public offering. PRIVATE PLACEMENT No definition available. Private Placement [Text Block] PRIVATE PLACEMENT The entire disclosure on information about private placement. Related Party Transactions [Abstract] Related Party Transactions Disclosure [Text Block] RELATED PARTY TRANSACTIONS COMMITMENTS Commitments and Contingencies Disclosure [Text Block] COMMITMENTS Stockholders' Equity Note [Abstract] Stockholders' Equity Note Disclosure [Text Block] SHAREHOLDERS' EQUITY Warrants [Text Block] WARRANT LIABILITY Warrants [Text Block]. Fair Value Disclosures [Abstract] Fair Value Disclosures [Text Block] FAIR VALUE MEASUREMENTS SUBSEQUENT EVENTS Subsequent Events [Text Block] SUBSEQUENT EVENTS Warrant Liability [Policy Text Block] Warrant Liability warrant liability[Policy text block]. Earnings Per Share, Policy [Policy Text Block] Net Loss Per Ordinary Share Concentration Risk, Credit Risk, Policy [Policy Text Block] Concentration of Credit Risk Fair Value of Financial Instruments, Policy [Policy Text Block] Fair Value of Financial Instruments New Accounting Pronouncements, Policy [Policy Text Block] Recent Accounting Standards Use of Estimates, Policy [Policy Text Block] Use of Estimates Cash and Cash Equivalents, Policy [Policy Text Block] Cash and Cash Equivalents Assets Held In Trust Account, Policy [Policy Text Block] Marketable Securities Held in Trust Account The disclosure of accounting policy for assets held in trust. Temporary Equity, Policy [Policy Text Block] Class A Ordinary Shares Subject to Possible Redemption The disclosure of accounting policy for temporary equity. Income Tax, Policy [Policy Text Block] Income Taxes Basis of Accounting, Policy [Policy Text Block] Basis of Presentation Emerging Growth Company [Policy Text Block] Emerging Growth Company Represents the accounting policy on Emerging Growth Company. Fair Value Measurement, Policy [Policy Text Block] Fair Value Measurements Derivatives, Reporting of Derivative Activity [Policy Text Block] Derivative Financial Instruments Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of basic and diluted net income (loss) per ordinary share Fair Value, Assets Measured on Recurring Basis [Table Text Block] Schedule of company's assets that are measured at fair value on a recurring basis Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Summary of fair value of the warrant liabilities Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Sale of Stock [Axis] Sale of Stock [Domain] Sale of Stock [Domain] IPO [Member] Initial Public Offering Private Placement [Member] Private Placement Over-Allotment Option [Member] Over-allotment option Subsidiary, Sale of Stock [Line Items] Share Price Share price Units Issued During Period, Shares, New Issues Sale of Units, net of underwriting discounts Sale of Units (in shares) Number of new units issued during the period. Threshold Minimum Aggregate Fair Market Value As Percentage Of Assets Held In Trust Account Threshold minimum aggregate fair market value as a percentage of the assets held in the Trust Account Represents the threshold minimum aggregate fair market value as a percentage of the assets held in the Trust Account. Transaction Costs Transaction Costs Represents the amount of transaction costs incurred. Sale of Stock, Other Offering Costs Other offering costs Represents the amount of other offering costs incurred. Sale of Stock, Underwriting fees Underwriting fees Represents the amount of offering fees incurred and paid for underwriters. Additions To Assets Held In Trust Additions to assets held in trust Amount of significant additions in the period in assets held in trust (current, noncurrent, or unclassified). Assets Held-in-trust Assets Held-in-trust Units Issued During Period, Value, New Issues Proceeds from issuance of units Equity impact of the value of new unit issued during the period. Condition for future business combination number of businesses minimum The minimum number of businesses which the reporting entity must acquire with the net proceeds of the offering. Threshold Percentage Of Outstanding Voting Securities Of Target To Be Acquired By Post Transaction Company To Complete Business Combination Threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination Represents the threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination. Stock Issued During Period, Shares, New Issues Stock issued during period shares new shares Number of shares issued Sale of Stock, Price Per Share Sale of stock price per share Proceeds from Issuance of Warrants Proceeds from issuance of warrants Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Warrant voting right per share Shares per warrant Class of Warrant or Right, Exercise Price of Warrants or Rights Class of warrant or right exercise price of warrants or rights Exercise price of warrants Exercise price of warrant Business Acquisition, Equity Interest Issued or Issuable, Value Assigned Business Acquisition equity interest issued or issuable value assigned Business Acquisition, Share Price Business acquisition share price Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Pipe Warrant [Member] Pipe warrant [Member]. Investor [Axis] Investor Axis Investor [Domain] Investor Domain PIPE Investors [Member] PIPE Investors Member Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Business Combination Agreement [Member] Business Combination Agreement Member Subscription Agreement [Member] Subscription Agreement Member Unrecognized Tax Benefits Unrecognized tax benefits Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Amounts accrued for the payment of interest and penalties Cash, FDIC Insured Amount Federal Depository Insurance Coverage Class of Warrant or Right, Number of Securities Called by Warrants or Rights Number of warrants to purchase shares issued Initial Public Offering And Private Placement [Member] Initial Public Offering and private placement Represents the information about Initial Public Offering and private placement. Undistributed Earnings (Loss) Allocated to Participating Securities, Basic Less: Net income allocable to Class A ordinary shares subject to possible redemption Net Income (Loss) Available to Common Stockholders, Basic Net income (loss) Interest Working Capital Less: interest available to be withdrawn for working capital Interest working capital. Public Warrants [Member] Public Warrants Represents a redeemable warrant (Public Warrant) that entitles the holder to purchase shares of common stock subject to adjustment. Number of Shares Issued Per Unit Shares per unit Represents the number of shares in a unit. EX-101.PRE 10 chfw-20210630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 d188183d10q_htm.xml IDEA: XBRL DOCUMENT 0001824893 2020-12-31 0001824893 2021-06-30 0001824893 2021-01-01 2021-06-30 0001824893 2021-04-01 2021-06-30 0001824893 2020-08-21 2020-12-31 0001824893 2020-12-01 2020-12-01 0001824893 2020-12-01 0001824893 2021-01-01 2021-03-31 0001824893 2021-03-31 0001824893 us-gaap:CommonClassAMember 2021-06-30 0001824893 us-gaap:CommonClassBMember 2021-06-30 0001824893 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-06-30 0001824893 us-gaap:IPOMember 2021-06-30 0001824893 chfw:PublicWarrantsMember 2021-06-30 0001824893 chfw:InitialPublicOfferingAndPrivatePlacementMember 2021-06-30 0001824893 chfw:WorkingCapitalLoansWarrantMember chfw:RelatedPartyLoansMember 2021-06-30 0001824893 chfw:FounderSharesMember chfw:SponsorMember 2021-06-30 0001824893 chfw:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-06-30 0001824893 chfw:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-06-30 0001824893 us-gaap:CommonClassAMember 2020-12-31 0001824893 us-gaap:CommonClassBMember 2020-12-31 0001824893 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001824893 chfw:WorkingCapitalLoansWarrantMember chfw:RelatedPartyLoansMember 2020-12-31 0001824893 chfw:PrivatePlacementWarrantsMember 2020-12-31 0001824893 chfw:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001824893 chfw:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001824893 us-gaap:NonredeemablePreferredStockMember 2021-04-01 2021-06-30 0001824893 chfw:ClassAOrdinarySharesSubjectForRedemptionMember 2021-04-01 2021-06-30 0001824893 chfw:AdministrativeSupportAgreementMember 2021-04-01 2021-06-30 0001824893 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001824893 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001824893 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001824893 chfw:PrivatePlacementWarrantsMember 2021-04-01 2021-06-30 0001824893 chfw:PublicWarrantsMember 2021-04-01 2021-06-30 0001824893 chfw:WarrantsLiabilitiesMember 2021-04-01 2021-06-30 0001824893 us-gaap:NonredeemablePreferredStockMember 2021-01-01 2021-06-30 0001824893 chfw:PublicWarrantsMember 2021-01-01 2021-06-30 0001824893 chfw:ClassAOrdinarySharesSubjectForRedemptionMember 2021-01-01 2021-06-30 0001824893 us-gaap:WarrantMember 2021-01-01 2021-06-30 0001824893 chfw:AdministrativeSupportAgreementMember 2021-01-01 2021-06-30 0001824893 chfw:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member chfw:PublicWarrantsMember 2021-01-01 2021-06-30 0001824893 chfw:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member chfw:PublicWarrantsMember 2021-01-01 2021-06-30 0001824893 chfw:FounderSharesMember us-gaap:CommonClassBMember 2021-01-01 2021-06-30 0001824893 chfw:PrivatePlacementWarrantsMember 2021-01-01 2021-06-30 0001824893 chfw:WarrantsLiabilitiesMember 2021-01-01 2021-06-30 0001824893 us-gaap:CommonClassAMember 2021-01-01 2021-06-30 0001824893 chfw:UnitsEachConsistingOfOneShareOfClassOrdinarySharesAndOneThirdOfRedeemableWarrantToAcquireOneClassOrdinaryShareMember 2021-01-01 2021-06-30 0001824893 chfw:WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf1150Member 2021-01-01 2021-06-30 0001824893 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001824893 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001824893 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001824893 chfw:PrivatePlacementWarrantsMember 2021-01-01 2021-03-31 0001824893 chfw:PublicWarrantsMember 2021-01-01 2021-03-31 0001824893 chfw:WarrantsLiabilitiesMember 2021-01-01 2021-03-31 0001824893 us-gaap:PrivatePlacementMember 2020-11-23 2020-11-23 0001824893 us-gaap:IPOMember 2020-11-23 2020-11-23 0001824893 chfw:PublicWarrantsMember us-gaap:IPOMember 2020-11-23 2020-11-23 0001824893 us-gaap:PrivatePlacementMember 2020-11-23 0001824893 us-gaap:IPOMember 2020-11-23 0001824893 chfw:PublicWarrantsMember us-gaap:IPOMember 2020-11-23 0001824893 us-gaap:OverAllotmentOptionMember 2020-12-01 2020-12-01 0001824893 us-gaap:PrivatePlacementMember 2020-12-01 2020-12-01 0001824893 us-gaap:IPOMember 2020-12-01 2020-12-01 0001824893 chfw:PrivatePlacementWarrantsMember us-gaap:PrivatePlacementMember 2020-12-01 2020-12-01 0001824893 us-gaap:PrivatePlacementMember 2020-12-01 0001824893 chfw:FounderSharesMember chfw:SponsorMember us-gaap:CommonClassBMember 2020-09-04 2020-09-04 0001824893 chfw:FounderSharesMember chfw:SponsorMember us-gaap:CommonClassAMember 2020-09-04 2020-09-04 0001824893 chfw:FounderSharesMember us-gaap:CommonClassBMember 2020-09-04 0001824893 chfw:FounderSharesMember us-gaap:CommonClassBMember 2020-10-08 2020-10-08 0001824893 chfw:FounderSharesMember us-gaap:CommonClassBMember 2020-11-10 2020-11-10 0001824893 chfw:AdministrativeSupportAgreementMember 2020-11-18 2020-11-18 0001824893 chfw:PipeInvestorsMember chfw:SubscriptionAgreementMember 2021-04-15 2021-04-15 0001824893 chfw:PipeInvestorsMember chfw:PipeWarrantMember chfw:SubscriptionAgreementMember 2021-04-15 2021-04-15 0001824893 chfw:PipeInvestorsMember chfw:SubscriptionAgreementMember 2021-04-15 0001824893 chfw:PipeInvestorsMember us-gaap:CommonStockMember chfw:SubscriptionAgreementMember 2021-04-15 0001824893 chfw:BusinessCombinationAgreementMember 2021-04-15 0001824893 us-gaap:CommonStockMember chfw:BusinessCombinationAgreementMember 2021-04-15 0001824893 us-gaap:CommonClassAMember 2021-08-06 0001824893 us-gaap:CommonClassBMember 2021-08-06 0001824893 chfw:PrivatePlacementWarrantsMember 2021-06-30 0001824893 chfw:WarrantsLiabilitiesMember 2021-06-30 0001824893 us-gaap:RetainedEarningsMember 2021-06-30 0001824893 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001824893 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-06-30 0001824893 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-06-30 0001824893 us-gaap:RetainedEarningsMember 2020-12-31 0001824893 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001824893 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2020-12-31 0001824893 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-12-31 0001824893 chfw:PublicWarrantsMember 2020-12-31 0001824893 chfw:WarrantsLiabilitiesMember 2020-12-31 0001824893 chfw:PrivatePlacementWarrantsMember 2021-03-31 0001824893 chfw:PublicWarrantsMember 2021-03-31 0001824893 chfw:WarrantsLiabilitiesMember 2021-03-31 0001824893 us-gaap:RetainedEarningsMember 2021-03-31 0001824893 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001824893 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-03-31 0001824893 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-03-31 iso4217:USD shares utr:Day utr:Year pure iso4217:USD shares chfw:item utr:D 0.33 0.33 false 0001824893 --12-31 Q2 false 98-1556622 NJ 10-Q true 2021-06-30 2021 false 001-39635 Consonance-HFW Acquisition Corp. E9 1 Palmer Square Suite 305 Princeton 08540 609 921-2333 units, each consisting of one Class A ordinary share and one-third of a warrant to acquire one Class A ordinary share CHFW.U NYSE Class A ordinary shares, par value $0.0001 per share CHFW NYSE Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 CHFW.W NYSE Yes Yes Non-accelerated Filer true true true 9634000 2300000

390673

987187

526805

790341

917478

1777528

92029147

91997501

92946625

93775029

1544646

290148

1544646

290148

5138148 3404014 3220000 3220000

9902794

6914162

7804383

8186086

78043830

81860860

0.0001

1000000

0.0001

350000000

1829617

1447914

7804383

8186086

183

145

0.0001

150000000

2300000

230

10938952

7121960

-5939364

-2122328

5000001

5000007

92946625

93775029

1049339

2114548

-1049339

-2114548

8534

31646

-6299

2536968

1734134

-2534733

-1702488

-3584072

-3817036

8162790

8174309

3771210

3759691

-0.95

-1.02

1447914

145

2300000

230

7121960

-2122328

5000007

23296 2 232958 232960

-232964

1471210

147

2300000

230

7354918

-2355292

5000003

358407 36 3584034 3584070

-3584072

1829617

183

2300000

230

10938952

-5939364

5000001

-3817036

31646

1734134

-263536

1254498

-596514

987187

390673

-3817030

<div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS </div></div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Consonance-HFW</div> Acquisition Corp. (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on August 21, 2020. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (“Business Combination”). </div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company is not limited to a particular industry or geographic region for purposes of completing a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. </div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">As of June 30, 2021, the Company had not commenced any operations. All activity through June 30, 2021 relates to the Company’s formation, the initial public offering (“Initial Public Offering”), which is described below, and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-operating</div> income in the form of interest income from the proceeds derived from the Initial Public Offering. </div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;">The registration statement for the Company’s Initial Public Offering became effective on November 18, 2020. On November 23, 2020, the Company consummated the Initial Public Offering of 8,000,000 <div style="letter-spacing: 0px; top: 0px;;display:inline;">units (the “Units” and individually a “Unit” and, with respect to the Class A ordinary shares included in the Units sold, the “Public Shares”), at </div>$10.00 per Unit, generating gross proceeds of $80,000,000 which is described in Note 3. </div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Simultaneously with the consummation of the Initial Public Offering, the Company consummated the sale of 410,000 </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">units (the “Private Placement Units” and individually a “Private Placement Unit”) at a price of</div></div><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> $10.00 per Private Placement Unit in a private placement to Consonance Life Sciences (the “Sponsor”), generating gross proceeds of $4,100,000, which is described in Note 4. </div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Following the consummation of the Initial Public Offering on November 23, 2020, an amount of $80,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Units was placed in a trust account (the “Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting certain conditions of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Rule 2a-7</div> of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below. </div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On December 1, 2020, the underwriters fully exercised their over-allotment option, resulting in an additional 1,200,000 Units issued for an aggregate amount of $12,000,000. In connection with the underwriters’ full exercise of their over-allotment option, the Company also consummated the sale of an additional 24,000 Private Placement Units at $10.00 per Private Placement Unit, generating total proceeds of $12,240,000. A total of $12,000,000 was deposited into the Trust Account, bringing the aggregate proceeds held in the Trust Account to $92,000,000. </div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transaction costs amounted to $5,658,864, consisting of $1,840,000 of underwriting fees, $3,220,000 of deferred underwriting fees and $598,864 of other offering costs. </div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">T</div>he Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward completing a Business Combination. The Company must complete its initial Business Combination with one or more target businesses that together have a fair market value equal to at least 80% of the net assets held in the Trust Account (excluding any deferred underwriting commissions held in the Trust Account and taxes payable on the interest earned on the Trust Account) at the time of the agreement to enter into a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act. On April 15, 2021, the Company has entered into a Business Combination agreement with Surrozen, Inc., see Note 10. Subsequent Events — Business Combination Agreement, PIPE Financing and Proxy Statement, however, There is no assurance that the Company will be able to successfully effect a Business Combination. </div></div></div> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company will provide its shareholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The shareholders will be entitled to redeem their shares for a pro rata portion of the amount held in the Trust Account (initially $10.00 per share), calculated as of two business days prior to the completion of a Business Combination, including any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations. There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. On June 24, 2021, the Company filed a Proxy Statement on Schedule 14A with the Securities and Exchange Commission (the “SEC”), see Note 10. Subsequent Events — Business Combination Agreement, PIPE Financing and Proxy Statement. </div></div></div> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">B</div>usiness Combination Agreement, PIPE Financing and Proxy Statement </div></div></div></div></div> <div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> </div></div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On April 15, 2021, the Company entered into a business combination agreement (the “Business Combination Agreement”) with Surrozen, Inc. (“Surrozen”), pursuant to which a wholly-owned subsidiary of the Company will merge with and into Surrozen, with Surrozen surviving as a wholly-owned subsidiary of the Company and the Company will redomicile as a Delaware corporation. In accordance with the terms and subject to the conditions of the Business Combination Agreement, each share and equity award (whether vested or unvested) of Surrozen outstanding as of closing will be exchanged for shares of the Company’s common stock or comparable equity awards that are settled or are exercisable for shares of the Company’s common stock, as applicable, based on an implied Surrozen equity value of </div></div>$200,000,000 and a $10.00 <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">per share value of the Company’s common stock. In connection with the foregoing and concurrently with the execution of the Business Combination Agreement, the Company entered into subscription agreements with certain investors (the “Subscription Agreement(s)” and such investors, the “PIPE Investors”), pursuant to which the PIPE Investors have agreed to subscribe for and purchase, and the Company has agreed to issue and sell to the PIPE Investors, an aggregate of </div></div> 12,020,000 units, each consisting of one share of the Company’s common stock and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-third</div> of one redeemable warrant for one share of the Company’s common stock (the “PIPE Warrants”), for a purchase price of $10.00 per unit (the “PIPE Units”), for aggregate gross proceeds of $120,200,000 (the “PIPE Financing”). Each whole PIPE Warrant entitles the holder thereof to purchase one share of the Company’s common stock at a price of $11.50 <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;">per share, subject to adjustment as described in the form of warrant agreement attached to the form of Subscription Agreement, and only whole PIPE Warrants will be exercisable. The PIPE Warrants have substantially the same provisions as the warrants issued in connection with the Company’s Initial Public Offering. The securities to be issued pursuant to the Subscription Agreements have not been registered under the Securities Act of 1933, as amended (the “Securities Act”) in reliance upon the exemption provided in Section 4(a)(2) of the Securities Act. On June 24, 2021, the Company filed a Proxy Statement on Schedule 14A with the Securities and Exchange Commission (the “SEC”), announcing an extraordinary general meeting of the Company submitting the Business Combination and its Condition Precedent Proposals (as defined in the Proxy Statement) for shareholder approval.</div></div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">R</div>isks and Uncertainties </div></div></div></div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">M</div>anagement continues to evaluate the impact of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position and/or effecting our Business Combination, the specific impact is not readily determinable as of the date of the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. </div></div>

1 8000000

10.00

80000000 410000

10.00

4100000 80000000

10.00

1200000 12000000 24000

10.00

12240000 12000000

92000000

5658864 1840000 3220000 598864 0.80 0.50

200000000

10.00

12020000

10.00

120200000

11.50

<div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">N</div>OTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES </div></div></div></div> <div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Basis of Presentation </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-Q</div> and Article 8 of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-X</div> of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K/A</div> for the year ended December 31, 2020 as filed with the SEC on May 14, 2021. The interim results for the three and six months ended June 30, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future periods. </div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Emerging Growth Company </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-emerging</div> growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. </div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of the condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. </div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Cash and Cash Equivalents </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2021 and December 31, 2020. </div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Marketable Securities Held in Trust Account </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">At June 30, 2021 and December 31, 2020, substantially all of the assets held in the Trust Account were held in U.S. Treasury Bills. </div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Warrant Liability </div></div></div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, “Distinguishing Liabilities from Equity” (“ASC 480”) and ASC 815, “Derivatives and Hedging” (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. </div></div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital at the time of issuance or modification. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> gain or loss on the statements of operations. </div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class A Ordinary Shares Subject to Possible Redemption </div></div></div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480. Class A ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. </div></div></div> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Taxes </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the condensed financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s condensed financial statements and prescribes a recognition threshold and measurement process for condensed financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">more-likely-than-not</div> to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2021 and December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company is considered an exempted Cayman Islands company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the period presented. </div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Net Loss Per Ordinary Share </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net loss per share is computed by dividing net loss by the weighted-average number of ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture. The Company has not considered the effect of the warrants sold in the Initial Public Offering and private placement to purchase an aggregate of 3,211,334 shares in the calculation of diluted loss per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Company’s statements of operations includes a presentation of loss per share for ordinary shares subject to possible redemption in a manner similar to the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-class</div> method of loss per share. Net loss per ordinary share, basic and diluted, for Class A ordinary shares subject to possible redemption is calculated by dividing the proportionate share of income or loss on marketable securities held by the Trust Account by the weighted average number of Class A ordinary shares subject to possible redemption outstanding since original issuance. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Net loss per share, basic and diluted, for <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-redeemable</div> ordinary shares is calculated by dividing the net income (loss), adjusted for income or loss on marketable securities attributable to Class A ordinary shares subject to possible redemption, by the weighted average number of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-redeemable</div> ordinary shares outstanding for the period. </div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">N</div>on-redeemable</div> common stock includes Founder Shares (as defined in Note 5) and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-redeemable</div> ordinary shares as these shares do not have any redemption features. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-redeemable</div> ordinary shares participate in the income or loss on marketable securities based on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-redeemable</div> shares’ proportionate interest. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">T</div>he following table reflects the calculation of basic and diluted net loss per ordinary share (in dollars, except per share amounts): </div></div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: "Times New Roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:76%;"> <tr style="font-size: 0px;"> <td style="width: 73%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class A ordinary Shares subject to possible redemption</div></div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Numerator: Earnings allocable to Class A ordinary shares subject to possible redemption</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Interest earned on marketable securities held in Trust Account</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,239</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">26,845</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unrealized loss on marketable securities held in Trust Account</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: interest available to be withdrawn for working capital</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(5,343</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">— </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income attributable</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1,896</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">26,845</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Denominator: Weighted Average Class A ordinary shares subject to possible redemption</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">8,162,790</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">8,174,309</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net income per share, Class A ordinary shares subject to possible redemption</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">— </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">— </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-style:italic;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Redeemable</div> Ordinary Shares</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Numerator: Net Loss minus Net Earnings</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net loss</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(3,584,072</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(3,817,036</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: Net income allocable to Class A ordinary shares subject to possible redemption</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,896</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(26,845</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Redeemable</div> Net Loss</div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(3,585,968</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(3,843,881</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Denominator: Weighted Average <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-redeemable</div> ordinary shares</div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Basic and diluted weighted average shares outstanding, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-redeemable</div> ordinary shares</div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3,771,210</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3,759,691</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Basic and diluted net loss per share, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-redeemable</div> ordinary shares</div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(0.95</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(1.02</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Concentration of Credit Risk </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts. </div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">F</div>air Value of Financial Instruments </div></div></div></div></div> <div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature. </div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">F</div>air Value Measurements </div></div></div></div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">F</div>air value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: </div></div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: "Times New Roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 9%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 3%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: top; font-size: 10pt;;text-align:left;"> <div style="text-align: left; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: "Times New Roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 9%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 3%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: top; font-size: 10pt;;text-align:left;"> <div style="text-align: left; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: "Times New Roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 9%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 3%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: top; font-size: 10pt;;text-align:left;"> <div style="text-align: left; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 9%; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. </div></div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Derivative Financial Instruments </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-valued</div> at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> based on whether or not <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">net-cash</div> settlement or conversion of the instrument could be required within 12 months of the balance sheet date. </div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Recent Accounting Standards </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">In August 2020, the FASB issued Accounting Standards Update (“ASU”) <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Debt — Debt with Conversion and Other Options</div></div> (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">470-20)</div> and <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Derivatives and Hedging — Contracts in Entity’s Own Equity</div></div> (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40)</div> (“ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06”)</div> to simplify accounting for certain financial instruments. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06</div> eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06</div> amends the diluted earnings per share guidance, including the requirement to use the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">if-converted</div> method for all instruments. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06</div> is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06</div> would have on its financial position, results of operations or cash flows.</div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>

<div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Basis of Presentation </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-Q</div> and Article 8 of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-X</div> of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K/A</div> for the year ended December 31, 2020 as filed with the SEC on May 14, 2021. The interim results for the three and six months ended June 30, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future periods. </div>

<div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Net Loss Per Ordinary Share </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net loss per share is computed by dividing net loss by the weighted-average number of ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture. The Company has not considered the effect of the warrants sold in the Initial Public Offering and private placement to purchase an aggregate of 3,211,334 shares in the calculation of diluted loss per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Company’s statements of operations includes a presentation of loss per share for ordinary shares subject to possible redemption in a manner similar to the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-class</div> method of loss per share. Net loss per ordinary share, basic and diluted, for Class A ordinary shares subject to possible redemption is calculated by dividing the proportionate share of income or loss on marketable securities held by the Trust Account by the weighted average number of Class A ordinary shares subject to possible redemption outstanding since original issuance. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Net loss per share, basic and diluted, for <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-redeemable</div> ordinary shares is calculated by dividing the net income (loss), adjusted for income or loss on marketable securities attributable to Class A ordinary shares subject to possible redemption, by the weighted average number of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-redeemable</div> ordinary shares outstanding for the period. </div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">N</div>on-redeemable</div> common stock includes Founder Shares (as defined in Note 5) and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-redeemable</div> ordinary shares as these shares do not have any redemption features. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-redeemable</div> ordinary shares participate in the income or loss on marketable securities based on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-redeemable</div> shares’ proportionate interest. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">T</div>he following table reflects the calculation of basic and diluted net loss per ordinary share (in dollars, except per share amounts): </div></div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: "Times New Roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:76%;"> <tr style="font-size: 0px;"> <td style="width: 73%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class A ordinary Shares subject to possible redemption</div></div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Numerator: Earnings allocable to Class A ordinary shares subject to possible redemption</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Interest earned on marketable securities held in Trust Account</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,239</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">26,845</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unrealized loss on marketable securities held in Trust Account</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: interest available to be withdrawn for working capital</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(5,343</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">— </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income attributable</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1,896</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">26,845</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Denominator: Weighted Average Class A ordinary shares subject to possible redemption</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">8,162,790</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">8,174,309</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net income per share, Class A ordinary shares subject to possible redemption</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">— </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">— </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-style:italic;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Redeemable</div> Ordinary Shares</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Numerator: Net Loss minus Net Earnings</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net loss</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(3,584,072</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(3,817,036</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: Net income allocable to Class A ordinary shares subject to possible redemption</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,896</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(26,845</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Redeemable</div> Net Loss</div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(3,585,968</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(3,843,881</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Denominator: Weighted Average <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-redeemable</div> ordinary shares</div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Basic and diluted weighted average shares outstanding, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-redeemable</div> ordinary shares</div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3,771,210</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3,759,691</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Basic and diluted net loss per share, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-redeemable</div> ordinary shares</div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(0.95</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(1.02</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table>

3211334

7239

26845

-5343 0

1896

26845

8162790

8174309

-3584072

-3817036

1896

26845

-3585968

-3843881

3771210

3759691

-0.95

-1.02

<div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Concentration of Credit Risk </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts. </div></div>

250000

<div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">F</div>air Value Measurements </div></div></div></div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">F</div>air value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: </div></div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: "Times New Roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 9%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 3%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: top; font-size: 10pt;;text-align:left;"> <div style="text-align: left; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: "Times New Roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 9%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 3%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: top; font-size: 10pt;;text-align:left;"> <div style="text-align: left; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: "Times New Roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 9%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 3%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: top; font-size: 10pt;;text-align:left;"> <div style="text-align: left; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 9%; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. </div></div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div>

<div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Recent Accounting Standards </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">In August 2020, the FASB issued Accounting Standards Update (“ASU”) <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Debt — Debt with Conversion and Other Options</div></div> (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">470-20)</div> and <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Derivatives and Hedging — Contracts in Entity’s Own Equity</div></div> (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40)</div> (“ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06”)</div> to simplify accounting for certain financial instruments. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06</div> eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06</div> amends the diluted earnings per share guidance, including the requirement to use the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">if-converted</div> method for all instruments. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06</div> is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06</div> would have on its financial position, results of operations or cash flows.</div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>

<div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NOTE 3. INITIAL PUBLIC OFFERING </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Pursuant to the Initial Public Offering, the Company sold 9,200,000 Units, inclusive of 1,200,000 Units sold to the underwriters on December 1, 2020 upon the underwriters’ election to fully exercise their over-allotment option, at a purchase price of $10.00 per Unit. Each Unit consists of one Class A ordinary share and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><span style="-sec-ix-hidden:hidden24409955">one-</span>third</div> of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at an exercise price of $11.50 per share, subject to adjustment (see Note 8). </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On December 1, 2020, the underwriters fully exercised their over-allotment option, resulting in an additional 1,200,000 Units issued for an aggregate amount of $12,000,000. In connection with the underwriters’ full exercise of their over-allotment option, the Company also consummated the sale of an additional 24,000 Private Placement Units at $10.00 per Private Placement Unit, generating total proceeds of $12,240,000. A total of $12,000,000 was deposited into the Trust Account, bringing the aggregate proceeds held in the Trust Account to $92,000,000. </div></div> 9200000 1200000

10.00

1 1

11.50

1200000 12000000 24000

10.00

12240000 12000000

92000000

<div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NOTE 4. PRIVATE PLACEMENT </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Simultaneously with the consummation of the Initial Public Offering, the Sponsor purchased an aggregate of 410,000 Private Placement Units at a price of $10.00 per Private Placement Unit, for an aggregate purchase price of $4,100,000. On December 1, 2020, as a result of the underwriters’ election to fully exercise their over-allotment option, the Sponsor purchased an additional 24,000 Private Placement Units, at a price of $10.00 per Private Placement Unit, or $240,000 in the aggregate (see Note 8). Each Private Placement Unit consists of one<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>Class A ordinary<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><span style="-sec-ix-hidden:hidden24409970">one-</span>third</div> of one redeemable warrant<div style="letter-spacing: 0px; top: 0px;;display:inline;">.</div> Each whole Private Placement Warrant is exercisable for one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 8). The proceeds from the sale of the Private Placement Units were added to the net proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Units held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Units and all underlying securities will expire worthless. </div> 410000

10.00

4100000 24000

10.00

240000 1

11.50

<div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NOTE 5. RELATED PARTY TRANSACTIONS </div></div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Founder Shares </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On September 4, 2020, the Sponsor paid $25,000 to cover certain offering and formation costs of the Company in consideration for 3,593,750 Class B ordinary shares. On October 8, 2020 and November 10, 2020, 718,750 and 575,000 Class B ordinary shares were contributed back to the Company for no consideration, respectively, resulting in there being 2,300,000 Class B ordinary shares (the “Founder Shares”) being issued and outstanding. The Founder Shares include an aggregate of up to 300,000 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment is not exercised in full or in part, so that the number of Founder Shares will collectively represent 20% of the Company’s issued and outstanding shares upon the completion of the Initial Public Offering (not including the Private Placement Shares). On December 1, 2020, the underwriters fully exercised their over-allotment option, therefore there are no Founder Shares subject to forfeiture. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination; and (B) subsequent to a Business Combination, (x) if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">share sub-divisions, share</div> capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">any 30-trading day</div> period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, amalgamation, share exchange, reorganization or other similar transaction that results in all of the Company’s shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property. </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Administrative Services Agreement </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company entered into an agreement, commencing on November 18, 2020 through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay the Sponsor a total of up to $55,000 per month for office space and administrative support services. For the period three and six months ended June 30, 2021, the Company incurred and paid $165,000 and $330,000, respectively, of such fees. </div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Related Party Loans </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s directors and officers may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into Private Placement Units of the post-Business Combination entity at a price of $10.00 per Private Placement Unit. The Private Placement Units would be identical to the Units. As of June 30, 2021 and December 31, 2020, the Company had no outstanding borrowings under the Working Capital Loans. </div></div>

25000

3593750

718750

575000

2300000

300000 0.20 12.00 20 30 P150D 55000

165000

330000

1500000 1500000 10.00 10.00

<div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">NOTE 6. COMMITMENTS</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> </div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Registration and Shareholder Rights </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Pursuant to a registration rights agreement entered into on November 18, 2020, the holders of the Founder Shares, Private Placement Units (including securities contained therein) and warrants that may be issued upon conversion of the Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Units and warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) will be entitled to registration rights. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. However, the registration and shareholder rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">lock-up</div> period. The registration rights agreement does not contain liquidating damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements.</div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Underwriting Agreement </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The underwriters are entitled to a deferred fee of $0.35 per Unit, or $3,220,000 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. </div></div>

0.35 3220000

<div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NOTE 7. S<div style="display:inline;">HARE</div>HOLDERS’ EQUITY </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Preference Shares</div></div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">—</div></div> The Company is authorized to issue 1,000,000 preference shares with a par value of $0.0001 per share, with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At June 30, 2021 and December 31, 2020, there were no preference shares issued or outstanding. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> A ordinary shares</div></div></div></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">—</div></div>The Company is authorized to issue 350,000,000 Class A ordinary shares, with a par value of $0.0001 per share. Holders of Class A ordinary shares are entitled to one vote for each share. At June 30, 2021 and December 31, 2020, there were 1,829,617 and 1,447,914 (excluding 7,804,383 and 8,186,086 shares subject to possible redemption) Class A ordinary shares issued and outstanding, respectively. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> B ordinary shares</div></div></div></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">—</div></div> The Company is authorized to issue 150,000,000 Class B ordinary shares, with a par value of $0.0001 per share. Holders of the Class B ordinary shares are entitled to one vote for each share. At June 30, 2021 and December 31, 2020, there were 2,300,000 Class B ordinary shares issued and outstanding. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Only holders of the Class B ordinary shares will have the right to vote on the election of directors prior to the Business Combination. Holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all other matters submitted to a vote of the Company’s shareholders except as otherwise required by law. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Class B ordinary shares will automatically convert into Class A ordinary shares on the first business day following the consummation of a Business Combination at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">as-converted</div> basis, 20% of the sum of (i) the total number of ordinary shares issued and outstanding (excluding the Private Placement Shares underlying the Private </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Placement Units) upon completion of the Initial Public Offering, plus (ii) the sum of the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of a Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in a Business Combination and any Private Placement Warrants issued to the Sponsor, members of the Company’s founding team or any of their affiliates upon conversion of Working Capital Loans. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than one to one.</div></div>

1000000

0.0001

350000000

0.0001

1 1

1829617

1447914

7804383

8186086

150000000

0.0001

1 1

2300000

<div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NOTE 8. WARRANT LIABILITY </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) one year from the closing of the Initial Public Offering. The Public Warrants will expire five years from the completion of a Business Combination or earlier upon redemption or liquidation. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating thereto is available, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption is available. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has agreed that as soon as practicable, but in no event later than 20 business days, after the closing of a Business Combination, it will use its commercially reasonable efforts to file with the SEC a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants, and the Company will use its commercially reasonable efforts to cause the same to become effective within 60 business days after the closing of a Business Combination, and to maintain the effectiveness of such registration statement and a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement; if the Class A ordinary shares are, at the time of any exercise of a warrant, not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th day after the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption, but will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Redemption of warrants when the price per Class</div></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> A ordinary share equals or exceeds $18.00</div></div>—Once the warrants become exercisable, the Company may redeem the outstanding Public Warrants (except with respect to the Private Placement Warrants): </div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: "Times New Roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">in whole and not in part; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: "Times New Roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">at a price of $0.01 per Public Warrant; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: "Times New Roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">upon not less than 30 days’ prior written notice of redemption to each warrant holder; and </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: "Times New Roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">sub-divisions,</div> share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-trading</div> day period ending on the third trading day prior to the date on which notice of the redemption is given to the warrant holders (the “Reference Value”). </div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Redemption of Warrants When the Price per Class</div></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> A Ordinary Share Equals or Exceeds $10.00</div></div>—Once the warrants become exercisable, the Company may redeem the outstanding warrants:</div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: "Times New Roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">in whole and not in part; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: "Times New Roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption; provided that during such 30 day period holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares, based on the redemption date and the fair market value of the Class A ordinary shares, that if the warrants are not exercised on a cashless basis or otherwise during such 30 day period, the Company shall redeem such warrants for $0.10 per share; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: "Times New Roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted for share subdivisions, share dividends, reorganizations, recapitalizations and the like) on the trading day before the Company sends the notice of redemption to the warrant holders; and </div></div> </td> </tr> </table> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: "Times New Roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">if the Reference Value is less than $18.00 per share (as adjusted for share splits, share dividends, reorganizations, recapitalizations and the like), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above. </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The exercise price and number of ordinary shares issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as described below, the Public Warrants will not be adjusted for issuances of ordinary shares at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of its Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00 and $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A ordinary shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and be <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-redeemable,</div> except as described above, so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. </div> P30D P30D P1Y

P5Y

P20D P60D 0.01 P30D 18.00 20 30 10.00 0.10 P30D 30 18.00 60 20 9.20 115 10.00 18.00 100 180 30

<div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NOTE 9. FAIR VALUE MEASUREMENTS </div></div></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;">The Company follows the guidance in ASC Topic 820, “Fair Value Measurements” for its financial assets and liabilities that are <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-measured</div> and reported at fair value at each reporting period, and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-financial</div> assets and liabilities that are <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-measured</div> and reported at fair value at least annually. </div></div> </div> </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: "Times New Roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="font-size: 0px;"> <td style="width: 3%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td style="width: 6%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td style="width: 89%;"/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top;">Level 1:</td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top;">Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.</td> </tr> <tr style="font-size: 1pt;"> <td style="height: 6pt;"> </td> <td colspan="2" style="height: 6pt;"> </td> <td colspan="2" style="height: 6pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top;">Level 2:</td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top;">Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.</td> </tr> <tr style="font-size: 1pt;"> <td style="height: 6pt;"> </td> <td colspan="2" style="height: 6pt;"> </td> <td colspan="2" style="height: 6pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top;">Level 3:</td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top;">Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.</td> </tr> </table> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at June 30, 2021 and December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: "Times New Roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:84%;"> <tr style="font-size: 0px;"> <td style="width: 67%; font-family: "Times New Roman";"/> <td style="width: 4%; vertical-align: bottom; font-family: "Times New Roman";"/> <td style="font-family: "Times New Roman";"/> <td style="font-family: "Times New Roman";"/> <td style="font-family: "Times New Roman";"/> <td style="width: 4%; vertical-align: bottom; font-family: "Times New Roman";"/> <td style="font-family: "Times New Roman";"/> <td style="font-family: "Times New Roman";"/> <td style="font-family: "Times New Roman";"/> <td style="width: 4%; vertical-align: bottom; font-family: "Times New Roman";"/> <td style="font-family: "Times New Roman";"/> <td style="font-family: "Times New Roman";"/> <td style="font-family: "Times New Roman";"/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 1pt;"> <div style="font-family: "Times New Roman"; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Description</div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30,<br/> 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets:</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Marketable securities held in Trust Account</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">1</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">92,029,147</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">91,997,501</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 6pt; font-family: "Times New Roman";"> </td> <td colspan="4" style="height: 6pt; font-family: "Times New Roman";"> </td> <td colspan="4" style="height: 6pt; font-family: "Times New Roman";"> </td> <td colspan="4" style="height: 6pt; font-family: "Times New Roman";"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrant liability – Public Warrants</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">1</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,753,334</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,250,667</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrant liability – Private Placement Warrants</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">3</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">384,814</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">153,347</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> </table> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">The Warrants were accounted for as liabilities in accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40</div> and are presented within warrant liabilities on our balance sheet. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the consolidated statements of operations. </div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">B</div>oth the Private Placement Warrants and the Public Warrants were initially valued using a binomial lattice model, which is considered to be a Level 3 fair value measurement. As of June 30, 2021, the Public Warrants were valued using the instrument’s publicly listed trading notice as of the balance sheet date, which is considered to be a Level 1 measurement due to the use of an observable market quote in an active market. The Private Warrants were valued using a binomial lattice model, which is considered to be a Level 3 fair value measurement. The binomial lattice model’s primary unobservable input utilized in determining the fair value of the Private Placement Warrants is the expected volatility of the common stock. The expected volatility as of the Initial Public Offering date was derived from observable public warrant pricing on comparable ‘blank-check’ companies without an identified target. The expected volatility as of subsequent valuation dates will be implied from the Company’s own public warrant pricing. A binomial lattice model methodology was also used in estimating the fair value of the Public Warrants for periods where no observable traded price was available, using the same expected volatility as was used in measuring the fair value of the Private Placement Warrants. For periods subsequent to the detachment of the Warrants from the Units, the close price of the Public Warrant price will be used as the fair value as of each relevant date. </div></div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents the changes in the fair value of warrant liabilities: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: "Times New Roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:84%;"> <tr style="font-size: 0px;"> <td style="width: 56%;"/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Private Placement</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Public</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrant Liabilities</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value as of January 1, 2021</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">153,347</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,250,667</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,404,014</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in valuation inputs or other assumptions</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(36,167</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(766,667</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(802,834</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value as of March 31, 2021</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">117,180</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,484,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,601,180</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in valuation inputs or other assumptions</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">267,634</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,269,334</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,536,968</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value as of June 30, 2021</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">384,814</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,753,334</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,138,148</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">There were no transfers in or out of Level 3 from other levels in the fair value hierarchy. </div></div>

92029147

91997501

4753334 3250667 384814 153347

<div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents the changes in the fair value of warrant liabilities: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: "Times New Roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:84%;"> <tr style="font-size: 0px;"> <td style="width: 56%;"/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Private Placement</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Public</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrant Liabilities</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value as of January 1, 2021</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">153,347</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,250,667</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,404,014</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in valuation inputs or other assumptions</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(36,167</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(766,667</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(802,834</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value as of March 31, 2021</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">117,180</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,484,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,601,180</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in valuation inputs or other assumptions</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">267,634</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,269,334</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,536,968</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value as of June 30, 2021</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">384,814</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,753,334</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,138,148</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: "Times New Roman";"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table>

153347

3250667

3404014

-36167

-766667

-802834

117180

2484000

2601180

267634

2269334

2536968

384814

4753334

5138148

<div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NOTE 10. SUBSEQUENT EVENTS </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements. </div></div>

XML 12 R1.htm IDEA: XBRL DOCUMENT

Cover Page - shares	6 Months Ended
Cover Page - shares	Jun. 30, 2021	Aug. 06, 2021
Cover Page
Document Type	10-Q
Document Period End Date	Jun. 30, 2021
Entity Registrant Name	Consonance-HFW Acquisition Corp.
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Entity Central Index Key	0001824893
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q2
Amendment Flag	false
Document Transition Report	false
Document Quarterly Report	true
Entity File Number	001-39635
Entity Incorporation, State or Country Code	E9
Entity Tax Identification Number	98-1556622
Entity Address, Address Line One	1 Palmer Square
Entity Address, Address Line Two	Suite 305
Entity Address, State or Province	NJ
Entity Address, City or Town	Princeton
Entity Address, Postal Zip Code	08540
City Area Code	609
Local Phone Number	921-2333
Class A ordinary
Cover Page
Title of 12(b) Security	Class A ordinary shares, par value $0.0001 per share
Trading Symbol	CHFW
Security Exchange Name	NYSE
Entity Common Stock, Shares Outstanding		9,634,000
Class B ordinary
Cover Page
Entity Common Stock, Shares Outstanding		2,300,000
Units, each consisting of one share of Class A ordinary shares, and one-third of a redeemable Warrant to acquire one Class A ordinary share
Cover Page
Title of 12(b) Security	units, each consisting of one Class A ordinary share and one-third of a warrant to acquire one Class A ordinary share
Trading Symbol	CHFW.U
Security Exchange Name	NYSE
Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
Cover Page
Title of 12(b) Security	Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
Trading Symbol	CHFW.W
Security Exchange Name	NYSE

XML 13 R2.htm IDEA: XBRL DOCUMENT

CONDENSED BALANCE SHEETS - USD ($)	Jun. 30, 2021	Dec. 31, 2020
Current assets
Cash	$ 390,673	$ 987,187
Prepaid expenses	526,805	790,341
Total Current Assets	917,478	1,777,528
Cash and marketable securities held in Trust Account	92,029,147	91,997,501
TOTAL ASSETS	92,946,625	93,775,029
Current liabilities
Accrued expenses	1,544,646	290,148
Total Current Liabilities	1,544,646	290,148
Warrant liability	5,138,148	3,404,014
Deferred underwriting fee payable	3,220,000	3,220,000
Total Liabilities	9,902,794	6,914,162
Commitments
Class A ordinary shares subject to possible redemption 7,804,383 and 8,186,086 shares at redemption value at June 30, 2021 and December 31, 2020	78,043,830	81,860,860
Stockholder's Equity
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding
Additional paid-in capital	10,938,952	7,121,960
Accumulated deficit	(5,939,364)	(2,122,328)
Total Stockholder's Equity	5,000,001	5,000,007
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	92,946,625	93,775,029
Class A ordinary
Stockholder's Equity
Common stock	183	145
Class B ordinary
Stockholder's Equity
Common stock	$ 230	$ 230

XML 14 R3.htm IDEA: XBRL DOCUMENT

CONDENSED BALANCE SHEETS (Parenthetical) - $ / shares	Jun. 30, 2021	Dec. 31, 2020
Temporary equity, shares outstanding	7,804,383	8,186,086
Preferred stock, par value, (per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Class A ordinary
Common shares, par value, (per share)	$ 0.0001	$ 0.0001
Common shares, shares authorized	350,000,000	350,000,000
Common shares, shares issued	1,829,617	1,447,914
Common shares, shares outstanding	1,829,617	1,447,914
Class B ordinary
Common shares, par value, (per share)	$ 0.0001	$ 0.0001
Common shares, shares authorized	150,000,000	150,000,000
Common shares, shares issued	2,300,000	2,300,000
Common shares, shares outstanding	2,300,000	2,300,000

XML 15 R4.htm IDEA: XBRL DOCUMENT

CONDENSED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended	6 Months Ended
CONDENSED STATEMENTS OF OPERATIONS - USD ($)	Jun. 30, 2021	Jun. 30, 2021
Operating and formation costs	$ 1,049,339	$ 2,114,548
Loss from operations	(1,049,339)	(2,114,548)
Other expense:
Interest earned on marketable securities held in Trust Account	8,534	31,646
Unrealized gain on marketable securities held in Trust Account	(6,299)	0
Changes in fair value of warrant liability	(2,536,968)	(1,734,134)
Other expense, net	(2,534,733)	(1,702,488)
Net loss	(3,584,072)	(3,817,036)
Class A ordinary shares subject to redemption
Other expense:
Interest earned on marketable securities held in Trust Account	$ 7,239	$ 26,845
Basic and diluted weighted average shares outstanding	8,162,790	8,174,309
Basic and diluted net income (Loss) per share	$ 0	$ 0
Non-redeemable ordinary shares
Other expense:
Net loss	$ (3,584,072)	$ (3,817,036)
Basic and diluted weighted average shares outstanding	3,771,210	3,759,691
Basic and diluted net income (Loss) per share	$ (0.95)	$ (1.02)

XML 16 R5.htm IDEA: XBRL DOCUMENT

CONDENSED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)	Total	Additional Paid-in Capital	Accumulated Deficit	Class A ordinary Common Stock	Class B ordinary Common Stock
Balance at the beginning at Dec. 31, 2020	$ 5,000,007	$ 7,121,960	$ (2,122,328)	$ 145	$ 230
Balance at the beginning (in shares) at Dec. 31, 2020				1,447,914	2,300,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Change in value of Class A ordinary shares subject to redemption	232,960	232,958		$ 2
Change in value of Class A ordinary shares subject to redemption (in shares)				23,296
Net loss	(232,964)		(232,964)
Balance at the end at Mar. 31, 2021	5,000,003	7,354,918	(2,355,292)	$ 147	$ 230
Balance at the end (in shares) at Mar. 31, 2021				1,471,210	2,300,000
Balance at the beginning at Dec. 31, 2020	5,000,007	7,121,960	(2,122,328)	$ 145	$ 230
Balance at the beginning (in shares) at Dec. 31, 2020				1,447,914	2,300,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(3,817,036)
Balance at the end at Jun. 30, 2021	5,000,001	10,938,952	(5,939,364)	$ 183	$ 230
Balance at the end (in shares) at Jun. 30, 2021				1,829,617	2,300,000
Balance at the beginning at Mar. 31, 2021	5,000,003	7,354,918	(2,355,292)	$ 147	$ 230
Balance at the beginning (in shares) at Mar. 31, 2021				1,471,210	2,300,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Change in value of Class A ordinary shares subject to redemption	3,584,070	3,584,034		$ 36
Change in value of Class A ordinary shares subject to redemption (in shares)				358,407
Net loss	(3,584,072)		(3,584,072)
Balance at the end at Jun. 30, 2021	$ 5,000,001	$ 10,938,952	$ (5,939,364)	$ 183	$ 230
Balance at the end (in shares) at Jun. 30, 2021				1,829,617	2,300,000

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794

+ Details

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References + Details

XML 17 R6.htm IDEA: XBRL DOCUMENT

CONDENSED STATEMENT OF CASH FLOWS - USD ($)	3 Months Ended	6 Months Ended
CONDENSED STATEMENT OF CASH FLOWS - USD ($)	Jun. 30, 2021	Jun. 30, 2021
Cash Flows from Operating Activities:
Net loss		$ (3,817,036)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account	$ (8,534)	(31,646)
Changes in fair value of warrant liability	2,536,968	1,734,134
Unrealized gain on marketable securities held in Trust Account	6,299	0
Changes in operating assets and liabilities:
Prepaid expenses and other current assets		263,536
Accrued expenses		1,254,498
Net cash used in operating activities		(596,514)
Net Change in Cash		(596,514)
Cash – Beginning of period		987,187
Cash – End of period	$ 390,673	390,673
Non-Cash investing and financing activities:
Change in value of Class A ordinary shares subject to possible redemption		$ (3,817,030)

XML 18 R7.htm IDEA: XBRL DOCUMENT

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	6 Months Ended
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	Jun. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Consonance-HFW Acquisition Corp. (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on August 21, 2020. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (“Business Combination”). The Company is not limited to a particular industry or geographic region for purposes of completing a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of June 30, 2021, the Company had not commenced any operations. All activity through June 30, 2021 relates to the Company’s formation, the initial public offering (“Initial Public Offering”), which is described below, and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The registration statement for the Company’s Initial Public Offering became effective on November 18, 2020. On November 23, 2020, the Company consummated the Initial Public Offering of 8,000,000 units (the “Units” and individually a “Unit” and, with respect to the Class A ordinary shares included in the Units sold, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $80,000,000 which is described in Note 3. Simultaneously with the consummation of the Initial Public Offering, the Company consummated the sale of 410,000 units (the “Private Placement Units” and individually a “Private Placement Unit”) at a price of $10.00 per Private Placement Unit in a private placement to Consonance Life Sciences (the “Sponsor”), generating gross proceeds of $4,100,000, which is described in Note 4. Following the consummation of the Initial Public Offering on November 23, 2020, an amount of $80,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Units was placed in a trust account (the “Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting certain conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below. On December 1, 2020, the underwriters fully exercised their over-allotment option, resulting in an additional 1,200,000 Units issued for an aggregate amount of $12,000,000. In connection with the underwriters’ full exercise of their over-allotment option, the Company also consummated the sale of an additional 24,000 Private Placement Units at $10.00 per Private Placement Unit, generating total proceeds of $12,240,000. A total of $12,000,000 was deposited into the Trust Account, bringing the aggregate proceeds held in the Trust Account to $92,000,000. Transaction costs amounted to $5,658,864, consisting of $1,840,000 of underwriting fees, $3,220,000 of deferred underwriting fees and $598,864 of other offering costs. T he Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward completing a Business Combination. The Company must complete its initial Business Combination with one or more target businesses that together have a fair market value equal to at least 80% of the net assets held in the Trust Account (excluding any deferred underwriting commissions held in the Trust Account and taxes payable on the interest earned on the Trust Account) at the time of the agreement to enter into a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act. On April 15, 2021, the Company has entered into a Business Combination agreement with Surrozen, Inc., see Note 10. Subsequent Events — Business Combination Agreement, PIPE Financing and Proxy Statement, however, There is no assurance that the Company will be able to successfully effect a Business Combination. The Company will provide its shareholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The shareholders will be entitled to redeem their shares for a pro rata portion of the amount held in the Trust Account (initially $10.00 per share), calculated as of two business days prior to the completion of a Business Combination, including any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations. There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. On June 24, 2021, the Company filed a Proxy Statement on Schedule 14A with the Securities and Exchange Commission (the “SEC”), see Note 10. Subsequent Events — Business Combination Agreement, PIPE Financing and Proxy Statement. B usiness Combination Agreement, PIPE Financing and Proxy Statement On April 15, 2021, the Company entered into a business combination agreement (the “Business Combination Agreement”) with Surrozen, Inc. (“Surrozen”), pursuant to which a wholly-owned subsidiary of the Company will merge with and into Surrozen, with Surrozen surviving as a wholly-owned subsidiary of the Company and the Company will redomicile as a Delaware corporation. In accordance with the terms and subject to the conditions of the Business Combination Agreement, each share and equity award (whether vested or unvested) of Surrozen outstanding as of closing will be exchanged for shares of the Company’s common stock or comparable equity awards that are settled or are exercisable for shares of the Company’s common stock, as applicable, based on an implied Surrozen equity value of $200,000,000 and a $10.00 per share value of the Company’s common stock. In connection with the foregoing and concurrently with the execution of the Business Combination Agreement, the Company entered into subscription agreements with certain investors (the “Subscription Agreement(s)” and such investors, the “PIPE Investors”), pursuant to which the PIPE Investors have agreed to subscribe for and purchase, and the Company has agreed to issue and sell to the PIPE Investors, an aggregate of 12,020,000 units, each consisting of one share of the Company’s common stock and one-third of one redeemable warrant for one share of the Company’s common stock (the “PIPE Warrants”), for a purchase price of $10.00 per unit (the “PIPE Units”), for aggregate gross proceeds of $120,200,000 (the “PIPE Financing”). Each whole PIPE Warrant entitles the holder thereof to purchase one share of the Company’s common stock at a price of $11.50 per share, subject to adjustment as described in the form of warrant agreement attached to the form of Subscription Agreement, and only whole PIPE Warrants will be exercisable. The PIPE Warrants have substantially the same provisions as the warrants issued in connection with the Company’s Initial Public Offering. The securities to be issued pursuant to the Subscription Agreements have not been registered under the Securities Act of 1933, as amended (the “Securities Act”) in reliance upon the exemption provided in Section 4(a)(2) of the Securities Act. On June 24, 2021, the Company filed a Proxy Statement on Schedule 14A with the Securities and Exchange Commission (the “SEC”), announcing an extraordinary general meeting of the Company submitting the Business Combination and its Condition Precedent Proposals (as defined in the Proxy Statement) for shareholder approval. R isks and Uncertainties M anagement continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position and/or effecting our Business Combination, the specific impact is not readily determinable as of the date of the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

XML 19 R8.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

6 Months Ended

Jun. 30, 2021

Accounting Policies [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

OTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

10-Q

and Article 8 of Regulation

S-X

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form

10-K/A

Emerging Growth Company

non-emerging

Use of Estimates

Cash and Cash Equivalents

Marketable Securities Held in Trust Account

At June 30, 2021 and December 31, 2020, substantially all of the assets held in the Trust Account were held in U.S. Treasury Bills.

Warrant Liability

This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional

paid-in

non-cash

gain or loss on the statements of operations.

Class A Ordinary Shares Subject to Possible Redemption

Income Taxes

more-likely-than-not

Net Loss Per Ordinary Share

The Company’s statements of operations includes a presentation of loss per share for ordinary shares subject to possible redemption in a manner similar to the

two-class

Net loss per share, basic and diluted, for

non-redeemable

ordinary shares outstanding for the period.

on-redeemable

common stock includes Founder Shares (as defined in Note 5) and

non-redeemable

ordinary shares as these shares do not have any redemption features.

Non-redeemable

ordinary shares participate in the income or loss on marketable securities based on

non-redeemable

shares’ proportionate interest.

he following table reflects the calculation of basic and diluted net loss per ordinary share (in dollars, except per share amounts):


	Three Months Ended June 30, 2021			Six Months Ended June 30, 2021
Class A ordinary Shares subject to possible redemption
Numerator: Earnings allocable to Class A ordinary shares subject to possible redemption
Interest earned on marketable securities held in Trust Account	$	7,239		$	26,845
Unrealized loss on marketable securities held in Trust Account
Less: interest available to be withdrawn for working capital		(5,343	)		—

Net income attributable	$	1,896		$	26,845

Denominator: Weighted Average Class A ordinary shares subject to possible redemption
Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption		8,162,790			8,174,309

Basic and diluted net income per share, Class A ordinary shares subject to possible redemption	$	—		$	—

Non-Redeemable Ordinary Shares
Numerator: Net Loss minus Net Earnings
Net loss	$	(3,584,072	)	$	(3,817,036	)
Less: Net income allocable to Class A ordinary shares subject to possible redemption		(1,896	)		(26,845	)

Non-Redeemable Net Loss	$	(3,585,968	)	$	(3,843,881	)

Denominator: Weighted Average Non-redeemable ordinary shares
Basic and diluted weighted average shares outstanding, Non-redeemable ordinary shares		3,771,210			3,759,691

Basic and diluted net loss per share, Non-redeemable ordinary shares	$	(0.95	)	$	(1.02	)

Concentration of Credit Risk

air Value of Financial Instruments

air Value Measurements

•

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

•

Derivative Financial Instruments

re-valued

non-current

based on whether or not

net-cash

settlement or conversion of the instrument could be required within 12 months of the balance sheet date.

Recent Accounting Standards

In August 2020, the FASB issued Accounting Standards Update (“ASU”)

2020-06,

Debt — Debt with Conversion and Other Options

(Subtopic

470-20)

and

Derivatives and Hedging — Contracts in Entity’s Own Equity

(Subtopic

815-40)

(“ASU

2020-06”)

to simplify accounting for certain financial instruments. ASU

2020-06

amends the diluted earnings per share guidance, including the requirement to use the

if-converted

method for all instruments. ASU

2020-06

would have on its financial position, results of operations or cash flows.

XML 20 R9.htm IDEA: XBRL DOCUMENT

INITIAL PUBLIC OFFERING	6 Months Ended
INITIAL PUBLIC OFFERING	Jun. 30, 2021
INITIAL PUBLIC OFFERING
INITIAL PUBLIC OFFERING	NOTE 3. INITIAL PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 9,200,000 Units, inclusive of 1,200,000 Units sold to the underwriters on December 1, 2020 upon the underwriters’ election to fully exercise their over-allotment option, at a purchase price of $10.00 per Unit. Each Unit consists of one Class A ordinary share and one-third of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at an exercise price of $11.50 per share, subject to adjustment (see Note 8). On December 1, 2020, the underwriters fully exercised their over-allotment option, resulting in an additional 1,200,000 Units issued for an aggregate amount of $12,000,000. In connection with the underwriters’ full exercise of their over-allotment option, the Company also consummated the sale of an additional 24,000 Private Placement Units at $10.00 per Private Placement Unit, generating total proceeds of $12,240,000. A total of $12,000,000 was deposited into the Trust Account, bringing the aggregate proceeds held in the Trust Account to $92,000,000.

XML 21 R10.htm IDEA: XBRL DOCUMENT

PRIVATE PLACEMENT	6 Months Ended
PRIVATE PLACEMENT	Jun. 30, 2021
PRIVATE PLACEMENT
PRIVATE PLACEMENT	NOTE 4. PRIVATE PLACEMENT Simultaneously with the consummation of the Initial Public Offering, the Sponsor purchased an aggregate of 410,000 Private Placement Units at a price of $10.00 per Private Placement Unit, for an aggregate purchase price of $4,100,000. On December 1, 2020, as a result of the underwriters’ election to fully exercise their over-allotment option, the Sponsor purchased an additional 24,000 Private Placement Units, at a price of $10.00 per Private Placement Unit, or $240,000 in the aggregate (see Note 8). Each Private Placement Unit consists of one Class A ordinary and one-third of one redeemable warrant . Each whole Private Placement Warrant is exercisable for one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 8). The proceeds from the sale of the Private Placement Units were added to the net proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Units held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Units and all underlying securities will expire worthless.

XML 22 R11.htm IDEA: XBRL DOCUMENT

RELATED PARTY TRANSACTIONS	6 Months Ended
RELATED PARTY TRANSACTIONS	Jun. 30, 2021
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 5. RELATED PARTY TRANSACTIONS Founder Shares On September 4, 2020, the Sponsor paid $25,000 to cover certain offering and formation costs of the Company in consideration for 3,593,750 Class B ordinary shares. On October 8, 2020 and November 10, 2020, 718,750 and 575,000 Class B ordinary shares were contributed back to the Company for no consideration, respectively, resulting in there being 2,300,000 Class B ordinary shares (the “Founder Shares”) being issued and outstanding. The Founder Shares include an aggregate of up to 300,000 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment is not exercised in full or in part, so that the number of Founder Shares will collectively represent 20% of the Company’s issued and outstanding shares upon the completion of the Initial Public Offering (not including the Private Placement Shares). On December 1, 2020, the underwriters fully exercised their over-allotment option, therefore there are no Founder Shares subject to forfeiture. The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination; and (B) subsequent to a Business Combination, (x) if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, amalgamation, share exchange, reorganization or other similar transaction that results in all of the Company’s shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property. Administrative Services Agreement The Company entered into an agreement, commencing on November 18, 2020 through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay the Sponsor a total of up to $55,000 per month for office space and administrative support services. For the period three and six months ended June 30, 2021, the Company incurred and paid $165,000 and $330,000, respectively, of such fees. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s directors and officers may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into Private Placement Units of the post-Business Combination entity at a price of $10.00 per Private Placement Unit. The Private Placement Units would be identical to the Units. As of June 30, 2021 and December 31, 2020, the Company had no outstanding borrowings under the Working Capital Loans.

XML 23 R12.htm IDEA: XBRL DOCUMENT

COMMITMENTS	6 Months Ended
COMMITMENTS	Jun. 30, 2021
COMMITMENTS
COMMITMENTS	NOTE 6. COMMITMENTS Registration and Shareholder Rights Pursuant to a registration rights agreement entered into on November 18, 2020, the holders of the Founder Shares, Private Placement Units (including securities contained therein) and warrants that may be issued upon conversion of the Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Units and warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) will be entitled to registration rights. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. However, the registration and shareholder rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period. The registration rights agreement does not contain liquidating damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters are entitled to a deferred fee of $0.35 per Unit, or $3,220,000 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

XML 24 R13.htm IDEA: XBRL DOCUMENT

SHAREHOLDERS' EQUITY	6 Months Ended
SHAREHOLDERS' EQUITY	Jun. 30, 2021
Stockholders' Equity Note [Abstract]
SHAREHOLDERS' EQUITY	NOTE 7. S HARE HOLDERS’ EQUITY Preference Shares — The Company is authorized to issue 1,000,000 preference shares with a par value of $0.0001 per share, with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At June 30, 2021 and December 31, 2020, there were no preference shares issued or outstanding. Class A ordinary shares — The Company is authorized to issue 350,000,000 Class A ordinary shares, with a par value of $0.0001 per share. Holders of Class A ordinary shares are entitled to one vote for each share. At June 30, 2021 and December 31, 2020, there were 1,829,617 and 1,447,914 (excluding 7,804,383 and 8,186,086 shares subject to possible redemption) Class A ordinary shares issued and outstanding, respectively. Class B ordinary shares — The Company is authorized to issue 150,000,000 Class B ordinary shares, with a par value of $0.0001 per share. Holders of the Class B ordinary shares are entitled to one vote for each share. At June 30, 2021 and December 31, 2020, there were 2,300,000 Class B ordinary shares issued and outstanding. Only holders of the Class B ordinary shares will have the right to vote on the election of directors prior to the Business Combination. Holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all other matters submitted to a vote of the Company’s shareholders except as otherwise required by law. The Class B ordinary shares will automatically convert into Class A ordinary shares on the first business day following the consummation of a Business Combination at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of (i) the total number of ordinary shares issued and outstanding (excluding the Private Placement Shares underlying the Private Placement Units) upon completion of the Initial Public Offering, plus (ii) the sum of the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of a Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in a Business Combination and any Private Placement Warrants issued to the Sponsor, members of the Company’s founding team or any of their affiliates upon conversion of Working Capital Loans. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than one to one.

XML 25 R14.htm IDEA: XBRL DOCUMENT

WARRANT LIABILITY

6 Months Ended

Jun. 30, 2021

Stockholders' Equity Note [Abstract]

WARRANT LIABILITY

NOTE 8. WARRANT LIABILITY

Redemption of warrants when the price per Class

A ordinary share equals or exceeds $18.00

—Once the warrants become exercisable, the Company may redeem the outstanding Public Warrants (except with respect to the Private Placement Warrants):

•

in whole and not in part;

•

at a price of $0.01 per Public Warrant;

•

upon not less than 30 days’ prior written notice of redemption to each warrant holder; and

•

if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share

sub-divisions,

share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a

30-trading

day period ending on the third trading day prior to the date on which notice of the redemption is given to the warrant holders (the “Reference Value”).

Redemption of Warrants When the Price per Class

A Ordinary Share Equals or Exceeds $10.00

—Once the warrants become exercisable, the Company may redeem the outstanding warrants:

•

in whole and not in part;

•

non-redeemable,

XML 26 R15.htm IDEA: XBRL DOCUMENT

FAIR VALUE MEASUREMENTS

6 Months Ended

Jun. 30, 2021

Fair Value Disclosures [Abstract]

FAIR VALUE MEASUREMENTS

NOTE 9. FAIR VALUE MEASUREMENTS

The Company follows the guidance in ASC Topic 820, “Fair Value Measurements” for its financial assets and liabilities that are

re-measured

and reported at fair value at each reporting period, and

non-financial

assets and liabilities that are

re-measured

and reported at fair value at least annually.


		Level 1:		Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

		Level 2:		Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.

		Level 3:		Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.


Description	Level		June 30, 2021		December 31, 2020
Assets:
Marketable securities held in Trust Account		1	$	92,029,147	$	91,997,501

Liabilities:
Warrant liability – Public Warrants		1	$	4,753,334	$	3,250,667
Warrant liability – Private Placement Warrants		3		384,814		153,347

The Warrants were accounted for as liabilities in accordance with ASC

815-40

The following table presents the changes in the fair value of warrant liabilities:


	Private Placement			Public			Warrant Liabilities
Fair value as of January 1, 2021	$	153,347		$	3,250,667		$	3,404,014
Change in valuation inputs or other assumptions		(36,167	)		(766,667	)		(802,834	)

Fair value as of March 31, 2021	$	117,180		$	2,484,000		$	2,601,180

Change in valuation inputs or other assumptions		267,634			2,269,334			2,536,968

Fair value as of June 30, 2021	$	384,814		$	4,753,334		$	5,138,148

There were no transfers in or out of Level 3 from other levels in the fair value hierarchy.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

XML 27 R16.htm IDEA: XBRL DOCUMENT

SUBSEQUENT EVENTS	6 Months Ended
SUBSEQUENT EVENTS	Jun. 30, 2021
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 10. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements.

XML 28 R17.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)

6 Months Ended

Jun. 30, 2021

Accounting Policies [Abstract]

Basis of Presentation

10-Q

and Article 8 of Regulation

S-X

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form

10-K/A

Emerging Growth Company

non-emerging

Use of Estimates

Cash and Cash Equivalents

Marketable Securities Held in Trust Account

At June 30, 2021 and December 31, 2020, substantially all of the assets held in the Trust Account were held in U.S. Treasury Bills.

Warrant Liability

This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional

paid-in

non-cash

gain or loss on the statements of operations.

Class A Ordinary Shares Subject to Possible Redemption

Income Taxes

more-likely-than-not

Net Loss Per Ordinary Share

The Company’s statements of operations includes a presentation of loss per share for ordinary shares subject to possible redemption in a manner similar to the

two-class

Net loss per share, basic and diluted, for

non-redeemable

ordinary shares outstanding for the period.

on-redeemable

common stock includes Founder Shares (as defined in Note 5) and

non-redeemable

ordinary shares as these shares do not have any redemption features.

Non-redeemable

ordinary shares participate in the income or loss on marketable securities based on

non-redeemable

shares’ proportionate interest.

he following table reflects the calculation of basic and diluted net loss per ordinary share (in dollars, except per share amounts):


	Three Months Ended June 30, 2021			Six Months Ended June 30, 2021
Class A ordinary Shares subject to possible redemption
Numerator: Earnings allocable to Class A ordinary shares subject to possible redemption
Interest earned on marketable securities held in Trust Account	$	7,239		$	26,845
Unrealized loss on marketable securities held in Trust Account
Less: interest available to be withdrawn for working capital		(5,343	)		—

Net income attributable	$	1,896		$	26,845

Denominator: Weighted Average Class A ordinary shares subject to possible redemption
Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption		8,162,790			8,174,309

Basic and diluted net income per share, Class A ordinary shares subject to possible redemption	$	—		$	—

Non-Redeemable Ordinary Shares
Numerator: Net Loss minus Net Earnings
Net loss	$	(3,584,072	)	$	(3,817,036	)
Less: Net income allocable to Class A ordinary shares subject to possible redemption		(1,896	)		(26,845	)

Non-Redeemable Net Loss	$	(3,585,968	)	$	(3,843,881	)

Denominator: Weighted Average Non-redeemable ordinary shares
Basic and diluted weighted average shares outstanding, Non-redeemable ordinary shares		3,771,210			3,759,691

Basic and diluted net loss per share, Non-redeemable ordinary shares	$	(0.95	)	$	(1.02	)

Concentration of Credit Risk

Fair Value of Financial Instruments

air Value of Financial Instruments

Fair Value Measurements

air Value Measurements

•

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

•

Derivative Financial Instruments

re-valued

non-current

based on whether or not

net-cash

settlement or conversion of the instrument could be required within 12 months of the balance sheet date.

Recent Accounting Standards

In August 2020, the FASB issued Accounting Standards Update (“ASU”)

2020-06,

Debt — Debt with Conversion and Other Options

(Subtopic

470-20)

and

Derivatives and Hedging — Contracts in Entity’s Own Equity

(Subtopic

815-40)

(“ASU

2020-06”)

to simplify accounting for certain financial instruments. ASU

2020-06

amends the diluted earnings per share guidance, including the requirement to use the

if-converted

method for all instruments. ASU

2020-06

would have on its financial position, results of operations or cash flows.

XML 29 R18.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

6 Months Ended

Jun. 30, 2021

Accounting Policies [Abstract]

Schedule of basic and diluted net income (loss) per ordinary share

he following table reflects the calculation of basic and diluted net loss per ordinary share (in dollars, except per share amounts):


	Three Months Ended June 30, 2021			Six Months Ended June 30, 2021
Class A ordinary Shares subject to possible redemption
Numerator: Earnings allocable to Class A ordinary shares subject to possible redemption
Interest earned on marketable securities held in Trust Account	$	7,239		$	26,845
Unrealized loss on marketable securities held in Trust Account
Less: interest available to be withdrawn for working capital		(5,343	)		—

Net income attributable	$	1,896		$	26,845

Denominator: Weighted Average Class A ordinary shares subject to possible redemption
Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption		8,162,790			8,174,309

Basic and diluted net income per share, Class A ordinary shares subject to possible redemption	$	—		$	—

Non-Redeemable Ordinary Shares
Numerator: Net Loss minus Net Earnings
Net loss	$	(3,584,072	)	$	(3,817,036	)
Less: Net income allocable to Class A ordinary shares subject to possible redemption		(1,896	)		(26,845	)

Non-Redeemable Net Loss	$	(3,585,968	)	$	(3,843,881	)

Denominator: Weighted Average Non-redeemable ordinary shares
Basic and diluted weighted average shares outstanding, Non-redeemable ordinary shares		3,771,210			3,759,691

Basic and diluted net loss per share, Non-redeemable ordinary shares	$	(0.95	)	$	(1.02	)

XML 30 R19.htm IDEA: XBRL DOCUMENT

FAIR VALUE MEASUREMENTS (Tables)

6 Months Ended

Jun. 30, 2021

Fair Value Disclosures [Abstract]

Schedule of company's assets that are measured at fair value on a recurring basis


Description	Level		June 30, 2021		December 31, 2020
Assets:
Marketable securities held in Trust Account		1	$	92,029,147	$	91,997,501

Liabilities:
Warrant liability – Public Warrants		1	$	4,753,334	$	3,250,667
Warrant liability – Private Placement Warrants		3		384,814		153,347

Summary of fair value of the warrant liabilities

The following table presents the changes in the fair value of warrant liabilities:


	Private Placement			Public			Warrant Liabilities
Fair value as of January 1, 2021	$	153,347		$	3,250,667		$	3,404,014
Change in valuation inputs or other assumptions		(36,167	)		(766,667	)		(802,834	)

Fair value as of March 31, 2021	$	117,180		$	2,484,000		$	2,601,180

Change in valuation inputs or other assumptions		267,634			2,269,334			2,536,968

Fair value as of June 30, 2021	$	384,814		$	4,753,334		$	5,138,148

XML 31 R20.htm IDEA: XBRL DOCUMENT

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details)				4 Months Ended	6 Months Ended
	Apr. 15, 2021 USD ($) $ / shares shares	Dec. 01, 2020 USD ($) $ / shares shares	Nov. 23, 2020 USD ($) $ / shares shares	Dec. 31, 2020 USD ($)	Jun. 30, 2021 USD ($) $ / shares
Subsidiary, Sale of Stock [Line Items]
Condition for future business combination number of businesses minimum				1
Proceeds from issuance of units		$ 12,240,000
Assets Held-in-trust		92,000,000
Additions to assets held in trust		$ 12,000,000
Transaction Costs					$ 5,658,864
Underwriting fees					1,840,000
Deferred underwriting fee payable				$ 3,220,000	3,220,000
Other offering costs					$ 598,864
Threshold minimum aggregate fair market value as a percentage of the assets held in the Trust Account					80.00%
Threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination					50.00%
Business Combination Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Business Acquisition equity interest issued or issuable value assigned	$ 200,000,000
Business Combination Agreement [Member] \| Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Business acquisition share price \| $ / shares	$ 10.00
PIPE Investors [Member] \| Subscription Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Stock issued during period shares new shares \| shares	12,020,000
Sale of stock price per share \| $ / shares	$ 10.00
PIPE Investors [Member] \| Subscription Agreement [Member] \| Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Warrant voting right per share \| shares	1
Class of warrant or right exercise price of warrants or rights \| $ / shares	$ 11.50
Pipe Warrant [Member] \| PIPE Investors [Member] \| Subscription Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Proceeds from issuance of warrants	$ 120,200,000
Initial Public Offering
Subsidiary, Sale of Stock [Line Items]
Sale of Units, net of underwriting discounts \| shares		9,200,000	8,000,000
Share price \| $ / shares			$ 10.00		$ 10.00
Proceeds from issuance of units			$ 80,000,000
Private Placement
Subsidiary, Sale of Stock [Line Items]
Sale of Units, net of underwriting discounts \| shares		24,000	410,000
Share price \| $ / shares		$ 10.00	$ 10.00
Proceeds from issuance of units		$ 240,000	$ 4,100,000
Over-allotment option
Subsidiary, Sale of Stock [Line Items]
Sale of Units, net of underwriting discounts \| shares		1,200,000
Proceeds from issuance of units		$ 12,000,000

XML 32 R21.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	Jun. 30, 2021	Dec. 31, 2020
Unrecognized tax benefits	$ 0	$ 0
Amounts accrued for the payment of interest and penalties	0	$ 0
Federal Depository Insurance Coverage	$ 250,000
Initial Public Offering and private placement
Number of warrants to purchase shares issued	3,211,334

XML 33 R22.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Basic and diluted net income (loss) per ordinary share (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2021
Net loss	$ (3,584,072)	$ (232,964)	$ (3,817,036)
Interest earned on marketable securities held in Trust Account	8,534		31,646
Class A ordinary Shares subject to possible redemption
Interest earned on marketable securities held in Trust Account	7,239		26,845
Less: interest available to be withdrawn for working capital	(5,343)		0
Net income (loss)	$ 1,896		$ 26,845
Basic and diluted weighted average shares outstanding	8,162,790		8,174,309
Basic and diluted net loss per share	$ 0		$ 0
Non-redeemable ordinary shares
Net loss	$ (3,584,072)		$ (3,817,036)
Less: Net income allocable to Class A ordinary shares subject to possible redemption	(1,896)		(26,845)
Net income (loss)	$ (3,585,968)		$ (3,843,881)
Basic and diluted weighted average shares outstanding	3,771,210		3,759,691
Basic and diluted net loss per share	$ (0.95)		$ (1.02)

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

+ Details

- Definition

Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1377-109256

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

+ Details

XML 34 R23.htm IDEA: XBRL DOCUMENT

INITIAL PUBLIC OFFERING (Details) - USD ($)	Dec. 01, 2020	Nov. 23, 2020	Jun. 30, 2021
Subsidiary, Sale of Stock [Line Items]
Proceeds from issuance of units	$ 12,240,000
Additions to assets held in trust	12,000,000
Assets Held-in-trust	$ 92,000,000
Initial Public Offering
Subsidiary, Sale of Stock [Line Items]
Sale of Units (in shares)	9,200,000	8,000,000
Share price		$ 10.00	$ 10.00
Proceeds from issuance of units		$ 80,000,000
Initial Public Offering \| Public Warrants
Subsidiary, Sale of Stock [Line Items]
Shares per unit		1
Warrants per unit		0.33
Shares per warrant		1
Exercise price of warrants		$ 11.50
Over-allotment option
Subsidiary, Sale of Stock [Line Items]
Sale of Units (in shares)	1,200,000
Proceeds from issuance of units	$ 12,000,000
Private Placement
Subsidiary, Sale of Stock [Line Items]
Sale of Units (in shares)	24,000	410,000
Share price	$ 10.00	$ 10.00
Shares per unit	1
Proceeds from issuance of units	$ 240,000	$ 4,100,000

XML 35 R24.htm IDEA: XBRL DOCUMENT

PRIVATE PLACEMENT (Details) - USD ($)	Dec. 01, 2020	Nov. 23, 2020	Dec. 31, 2020
Subsidiary, Sale of Stock [Line Items]
Proceeds from issuance of units	$ 12,240,000
Private Placement Warrants
Subsidiary, Sale of Stock [Line Items]
Exercise price of warrant			$ 11.50
Private Placement
Subsidiary, Sale of Stock [Line Items]
Sale of Units (in shares)	24,000	410,000
Share price	$ 10.00	$ 10.00
Proceeds from issuance of units	$ 240,000	$ 4,100,000
Shares per unit	1
Private Placement \| Private Placement Warrants
Subsidiary, Sale of Stock [Line Items]
Warrants per unit	0.33

XML 36 R25.htm IDEA: XBRL DOCUMENT

RELATED PARTY TRANSACTIONS - Founder Shares (Details)				6 Months Ended
RELATED PARTY TRANSACTIONS - Founder Shares (Details)	Nov. 10, 2020 USD ($) shares	Oct. 08, 2020 USD ($) shares	Sep. 04, 2020 USD ($) item $ / shares shares	Jun. 30, 2021 shares	Dec. 31, 2020 shares
Class B ordinary
Related Party Transaction [Line Items]
Common shares, shares issued (in shares)				2,300,000	2,300,000
Common shares, shares outstanding (in shares)				2,300,000	2,300,000
Class A ordinary
Related Party Transaction [Line Items]
Common shares, shares issued (in shares)				1,829,617	1,447,914
Common shares, shares outstanding (in shares)				1,829,617	1,447,914
Founder Shares \| Class B ordinary
Related Party Transaction [Line Items]
Stock repurchased during the period \| $	$ 0	$ 0
Stock repurchased during the period ( in shares)	575,000	718,750
Common shares, shares issued (in shares)			2,300,000
Common shares, shares outstanding (in shares)			2,300,000
Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders				20.00%
Founder Shares \| Sponsor
Related Party Transaction [Line Items]
Shares subject to forfeiture				300,000
Founder Shares \| Sponsor \| Class B ordinary
Related Party Transaction [Line Items]
Number of shares issued			3,593,750
Aggregate purchase price \| $			$ 25,000
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination \| item			20
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination \| item			30
Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences			150 days
Founder Shares \| Sponsor \| Class A ordinary
Related Party Transaction [Line Items]
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) \| $ / shares			$ 12.00

XML 37 R26.htm IDEA: XBRL DOCUMENT

RELATED PARTY TRANSACTIONS - Additional Information (Details) - USD ($)		3 Months Ended	6 Months Ended
	Nov. 18, 2020	Jun. 30, 2021	Jun. 30, 2021	Dec. 31, 2020
Administrative Services Agreement
Related Party Transaction [Line Items]
Expenses per month	$ 55,000
Expenses incurred and paid		$ 165,000	$ 330,000
Related Party Loans \| Working capital loans warrant
Related Party Transaction [Line Items]
Loan conversion agreement warrant		$ 1,500,000	$ 1,500,000	$ 1,500,000
Price of warrant		$ 10.00	$ 10.00	$ 10.00

XML 38 R27.htm IDEA: XBRL DOCUMENT

COMMITMENTS (Details) - USD ($)	Jun. 30, 2021	Dec. 31, 2020
COMMITMENTS
Deferred fee per unit	$ 0.35
Deferred underwriting fee payable	$ 3,220,000	$ 3,220,000

XML 39 R28.htm IDEA: XBRL DOCUMENT

SHAREHOLDERS' EQUITY - Preferred Stock Shares (Details) - $ / shares	Jun. 30, 2021	Dec. 31, 2020
Stockholders' Equity Note [Abstract]
Preferred shares, shares authorized	1,000,000	1,000,000
Preferred stock, par value, (per share)	$ 0.0001	$ 0.0001
Preferred shares, shares issued	0	0
Preferred shares, shares outstanding	0	0

XML 40 R29.htm IDEA: XBRL DOCUMENT

SHAREHOLDERS' EQUITY - Common Stock Shares (Details)	Jun. 30, 2021 item $ / shares shares	Dec. 31, 2020 item $ / shares shares
Class A ordinary
Class of Stock [Line Items]
Common shares, shares authorized (in shares)	350,000,000	350,000,000
Common shares, par value (in dollars per share) \| $ / shares	$ 0.0001	$ 0.0001
Common shares, votes per share \| item	1	1
Common shares, shares issued (in shares)	1,829,617	1,447,914
Common shares, shares outstanding (in shares)	1,829,617	1,447,914
Common stock subject to possible redemption, issued (in shares)	7,804,383	8,186,086
Class B ordinary
Class of Stock [Line Items]
Common shares, shares authorized (in shares)	150,000,000	150,000,000
Common shares, par value (in dollars per share) \| $ / shares	$ 0.0001	$ 0.0001
Common shares, votes per share \| item	1	1
Common shares, shares issued (in shares)	2,300,000	2,300,000
Common shares, shares outstanding (in shares)	2,300,000	2,300,000
Common stock subject to possible redemption, issued (in shares)	2,300,000

XML 41 R30.htm IDEA: XBRL DOCUMENT

WARRANT LIABILITY (Details)	6 Months Ended
WARRANT LIABILITY (Details)	Jun. 30, 2021 item d $ / shares
Class of Warrant or Right [Line Items]
Threshold number of business days before sending notice of redemption to warrant holders \| item	30
Trading period after business combination used to measure dilution of warrant \| d	20
Warrants
Class of Warrant or Right [Line Items]
Maximum period after business combination in which to file registration statement	20 days
Period of time within which registration statement is expected to become effective	60 days
Private Placement Warrants
Class of Warrant or Right [Line Items]
Restrictions on transfer period of time after business combination completion	30 days
Public Warrants
Class of Warrant or Right [Line Items]
Warrant exercise period condition one	30 days
Warrant exercise period condition two	1 year
Public Warrants expiration term	5 years
Warrant redemption condition minimum share price scenario two	$ 18.00
Share price trigger used to measure dilution of warrant	$ 9.20
Percentage of gross new proceeds to total equity proceeds used to measure dilution of warrant	60
Warrant exercise price adjustment multiple	115
Warrant redemption price adjustment multiple	100
Public Warrants \| Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00
Class of Warrant or Right [Line Items]
Warrant redemption condition minimum share price	$ 10.00
Warrant redemption condition minimum share price scenario two	18.00
Redemption price per public warrant (in dollars per share)	$ 0.01
Threshold trading days for redemption of public warrants \| item	20
Threshold consecutive trading days for redemption of public warrants \| item	30
Redemption period	30 days
Warrant redemption price adjustment multiple	180
Public Warrants \| Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00
Class of Warrant or Right [Line Items]
Warrant redemption condition minimum share price	$ 10.00
Warrant redemption condition minimum share price scenario two	18.00
Redemption price per public warrant (in dollars per share)	$ 0.10
Threshold trading days for redemption of public warrants \| item	30
Redemption period	30 days

XML 42 R31.htm IDEA: XBRL DOCUMENT

FAIR VALUE MEASUREMENTS (Details) - USD ($)	Jun. 30, 2021	Dec. 31, 2020
Assets:
Marketable securities held in Trust Account	$ 92,029,147	$ 91,997,501
Liabilities:
Warrant Liability	5,138,148	3,404,014
Level 1 \| Recurring
Assets:
Marketable securities held in Trust Account	92,029,147	91,997,501
Level 1 \| Recurring \| Public Warrants
Liabilities:
Warrant Liability	4,753,334	3,250,667
Level 3 \| Recurring \| Private Placement Warrants
Liabilities:
Warrant Liability	$ 384,814	$ 153,347

XML 43 R32.htm IDEA: XBRL DOCUMENT

FAIR VALUE MEASUREMENTS - Summary of fair value of the warrant liabilities (Details) - USD ($)	3 Months Ended
	Jun. 30, 2021	Mar. 31, 2021
Warrants Liabilities
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance at the beginning	$ 2,601,180	$ 3,404,014
Change in valuation inputs or other assumptions	2,536,968	(802,834)
Balance at the end	5,138,148	2,601,180
Private Placement Warrants
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance at the beginning	117,180	153,347
Change in valuation inputs or other assumptions	267,634	(36,167)
Balance at the end	384,814	117,180
Public Warrants
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance at the beginning	2,484,000	3,250,667
Change in valuation inputs or other assumptions	2,269,334	(766,667)
Balance at the end	$ 4,753,334	$ 2,484,000

XML 44 R33.htm IDEA: XBRL DOCUMENT

FAIR VALUE MEASUREMENTS - Additional Information (Details)	6 Months Ended
	Jun. 30, 2021 USD ($)
Warrants Liabilities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Transfers in or out of level 3	$ 0

EXCEL 45 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 46 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 47 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 48 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 98 233 1 false 31 0 false 8 false false R1.htm 1001 - Document - Cover Page Sheet http://Consonance.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1002 - Statement - CONDENSED BALANCE SHEETS Sheet http://Consonance.com/role/CondensedBalanceSheets CONDENSED BALANCE SHEETS Statements 2 false false R3.htm 1003 - Statement - CONDENSED BALANCE SHEETS (Parenthetical) Sheet http://Consonance.com/role/CondensedBalanceSheetsParenthetical CONDENSED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 1004 - Statement - CONDENSED STATEMENTS OF OPERATIONS Sheet http://Consonance.com/role/CondensedStatementsOfOperations CONDENSED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 1005 - Statement - CONDENSED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY Sheet http://Consonance.com/role/CondensedStatementOfChangesInShareholdersEquity CONDENSED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY Statements 5 false false R6.htm 1006 - Statement - CONDENSED STATEMENT OF CASH FLOWS Sheet http://Consonance.com/role/CondensedStatementOfCashFlows CONDENSED STATEMENT OF CASH FLOWS Statements 6 false false R7.htm 1007 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Sheet http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperations DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Notes 7 false false R8.htm 1008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://Consonance.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 1009 - Disclosure - INITIAL PUBLIC OFFERING Sheet http://Consonance.com/role/InitialPublicOffering INITIAL PUBLIC OFFERING Notes 9 false false R10.htm 1010 - Disclosure - PRIVATE PLACEMENT Sheet http://Consonance.com/role/PrivatePlacement PRIVATE PLACEMENT Notes 10 false false R11.htm 1011 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://Consonance.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 11 false false R12.htm 1012 - Disclosure - COMMITMENTS Sheet http://Consonance.com/role/Commitments COMMITMENTS Notes 12 false false R13.htm 1013 - Disclosure - SHAREHOLDERS' EQUITY Sheet http://Consonance.com/role/ShareholdersEquity SHAREHOLDERS' EQUITY Notes 13 false false R14.htm 1014 - Disclosure - WARRANT LIABILITY Sheet http://Consonance.com/role/WarrantLiability WARRANT LIABILITY Notes 14 false false R15.htm 1015 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://Consonance.com/role/FairValueMeasurements FAIR VALUE MEASUREMENTS Notes 15 false false R16.htm 1016 - Disclosure - SUBSEQUENT EVENTS Sheet http://Consonance.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 16 false false R17.htm 1017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 17 false false R18.htm 1018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://Consonance.com/role/SummaryOfSignificantAccountingPolicies 18 false false R19.htm 1019 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) Sheet http://Consonance.com/role/FairValueMeasurementsTables FAIR VALUE MEASUREMENTS (Tables) Tables http://Consonance.com/role/FairValueMeasurements 19 false false R20.htm 1020 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details) Sheet http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details) Details http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperations 20 false false R21.htm 1021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesTables 21 false false R22.htm 1022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Basic and diluted net income (loss) per ordinary share (Details) Sheet http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Basic and diluted net income (loss) per ordinary share (Details) Details 22 false false R23.htm 1023 - Disclosure - INITIAL PUBLIC OFFERING (Details) Sheet http://Consonance.com/role/InitialPublicOfferingDetails INITIAL PUBLIC OFFERING (Details) Details http://Consonance.com/role/InitialPublicOffering 23 false false R24.htm 1024 - Disclosure - PRIVATE PLACEMENT (Details) Sheet http://Consonance.com/role/PrivatePlacementDetails PRIVATE PLACEMENT (Details) Details http://Consonance.com/role/PrivatePlacement 24 false false R25.htm 1025 - Disclosure - RELATED PARTY TRANSACTIONS - Founder Shares (Details) Sheet http://Consonance.com/role/RelatedPartyTransactionsFounderSharesDetails RELATED PARTY TRANSACTIONS - Founder Shares (Details) Details 25 false false R26.htm 1026 - Disclosure - RELATED PARTY TRANSACTIONS - Additional Information (Details) Sheet http://Consonance.com/role/RelatedPartyTransactionsAdditionalInformationDetails RELATED PARTY TRANSACTIONS - Additional Information (Details) Details 26 false false R27.htm 1027 - Disclosure - COMMITMENTS (Details) Sheet http://Consonance.com/role/CommitmentsDetails COMMITMENTS (Details) Details http://Consonance.com/role/Commitments 27 false false R28.htm 1028 - Disclosure - SHAREHOLDERS' EQUITY - Preferred Stock Shares (Details) Sheet http://Consonance.com/role/ShareholdersEquityPreferredStockSharesDetails SHAREHOLDERS' EQUITY - Preferred Stock Shares (Details) Details 28 false false R29.htm 1029 - Disclosure - SHAREHOLDERS' EQUITY - Common Stock Shares (Details) Sheet http://Consonance.com/role/ShareholdersEquityCommonStockSharesDetails SHAREHOLDERS' EQUITY - Common Stock Shares (Details) Details 29 false false R30.htm 1030 - Disclosure - WARRANT LIABILITY (Details) Sheet http://Consonance.com/role/WarrantLiabilityDetails WARRANT LIABILITY (Details) Details http://Consonance.com/role/WarrantLiability 30 false false R31.htm 1031 - Disclosure - FAIR VALUE MEASUREMENTS (Details) Sheet http://Consonance.com/role/FairValueMeasurementsDetails FAIR VALUE MEASUREMENTS (Details) Details http://Consonance.com/role/FairValueMeasurementsTables 31 false false R32.htm 1032 - Disclosure - FAIR VALUE MEASUREMENTS - Summary of fair value of the warrant liabilities (Details) Sheet http://Consonance.com/role/FairValueMeasurementsSummaryOfFairValueOfTheWarrantLiabilitiesDetails FAIR VALUE MEASUREMENTS - Summary of fair value of the warrant liabilities (Details) Details 32 false false R33.htm 1033 - Disclosure - FAIR VALUE MEASUREMENTS - Additional Information (Details) Sheet http://Consonance.com/role/FairValueMeasurementsAdditionalInformationDetails FAIR VALUE MEASUREMENTS - Additional Information (Details) Details 33 false false All Reports Book All Reports d188183d10q.htm chfw-20210630.xsd chfw-20210630_cal.xml chfw-20210630_def.xml chfw-20210630_lab.xml chfw-20210630_pre.xml d188183dex311.htm d188183dex312.htm d188183dex321.htm d188183dex322.htm http://xbrl.sec.gov/dei/2020-01-31 http://fasb.org/srt/2020-01-31 http://fasb.org/us-gaap/2020-01-31 true true JSON 51 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d188183d10q.htm": { "axisCustom": 1, "axisStandard": 11, "contextCount": 98, "dts": { "calculationLink": { "local": [ "chfw-20210630_cal.xml" ] }, "definitionLink": { "local": [ "chfw-20210630_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "d188183d10q.htm" ] }, "labelLink": { "local": [ "chfw-20210630_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "chfw-20210630_pre.xml" ] }, "referenceLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml", "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml" ] }, "schema": { "local": [ "chfw-20210630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd", "https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd", "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 269, "entityCount": 1, "hidden": { "http://Consonance.com/20210630": 2, "http://xbrl.sec.gov/dei/2020-01-31": 7, "total": 9 }, "keyCustom": 52, "keyStandard": 181, "memberCustom": 18, "memberStandard": 13, "nsprefix": "chfw", "nsuri": "http://Consonance.com/20210630", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "1001 - Document - Cover Page", "role": "http://Consonance.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "chfw:PrivatePlacementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1010 - Disclosure - PRIVATE PLACEMENT", "role": "http://Consonance.com/role/PrivatePlacement", "shortName": "PRIVATE PLACEMENT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "chfw:PrivatePlacementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1011 - Disclosure - RELATED PARTY TRANSACTIONS", "role": "http://Consonance.com/role/RelatedPartyTransactions", "shortName": "RELATED PARTY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1012 - Disclosure - COMMITMENTS", "role": "http://Consonance.com/role/Commitments", "shortName": "COMMITMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1013 - Disclosure - SHAREHOLDERS' EQUITY", "role": "http://Consonance.com/role/ShareholdersEquity", "shortName": "SHAREHOLDERS' EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "chfw:WarrantsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1014 - Disclosure - WARRANT LIABILITY", "role": "http://Consonance.com/role/WarrantLiability", "shortName": "WARRANT LIABILITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "chfw:WarrantsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1015 - Disclosure - FAIR VALUE MEASUREMENTS", "role": "http://Consonance.com/role/FairValueMeasurements", "shortName": "FAIR VALUE MEASUREMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1016 - Disclosure - SUBSEQUENT EVENTS", "role": "http://Consonance.com/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "role": "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "role": "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1019 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)", "role": "http://Consonance.com/role/FairValueMeasurementsTables", "shortName": "FAIR VALUE MEASUREMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002 - Statement - CONDENSED BALANCE SHEETS", "role": "http://Consonance.com/role/CondensedBalanceSheets", "shortName": "CONDENSED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P08_21_2020To12_31_2020", "decimals": "0", "first": true, "lang": null, "name": "chfw:ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1020 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details)", "role": "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "shortName": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P08_21_2020To12_31_2020", "decimals": "0", "first": true, "lang": null, "name": "chfw:ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "us-gaap:UnrecognizedTaxBenefits", "div", "us-gaap:IncomeTaxPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:UnrecognizedTaxBenefits", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)", "role": "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:UnrecognizedTaxBenefits", "div", "us-gaap:IncomeTaxPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:UnrecognizedTaxBenefits", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P04_01_2021To06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Basic and diluted net income (loss) per ordinary share (Details)", "role": "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Basic and diluted net income (loss) per ordinary share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P04_01_2021To06_30_2021_ClassAOrdinarySharesSubjectForRedemptionMemberusgaapStatementClassOfStockAxis", "decimals": "0", "lang": null, "name": "chfw:InterestWorkingCapital", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P12_01_2020To12_01_2020", "decimals": "0", "first": true, "lang": null, "name": "chfw:UnitsIssuedDuringPeriodValueNewIssues", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1023 - Disclosure - INITIAL PUBLIC OFFERING (Details)", "role": "http://Consonance.com/role/InitialPublicOfferingDetails", "shortName": "INITIAL PUBLIC OFFERING (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "chfw:NumberOfSharesIssuedPerUnit", "div", "chfw:InitialPublicOfferingTextBlock", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P11_23_2020To11_23_2020_IPOMemberusgaapSubsidiarySaleOfStockAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis", "decimals": "INF", "lang": null, "name": "chfw:NumberOfSharesIssuedPerUnit", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P12_01_2020To12_01_2020", "decimals": "0", "first": true, "lang": null, "name": "chfw:UnitsIssuedDuringPeriodValueNewIssues", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1024 - Disclosure - PRIVATE PLACEMENT (Details)", "role": "http://Consonance.com/role/PrivatePlacementDetails", "shortName": "PRIVATE PLACEMENT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "chfw:PrivatePlacementTextBlock", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "PAsOn12_31_2020_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis", "decimals": "2", "lang": null, "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:CommonStockSharesOutstanding", "us-gaap:CommonStockSharesOutstanding", "us-gaap:CommonStockSharesIssued", "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "PAsOn06_30_2021_CommonClassBMemberusgaapStatementClassOfStockAxis", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesIssued", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1025 - Disclosure - RELATED PARTY TRANSACTIONS - Founder Shares (Details)", "role": "http://Consonance.com/role/RelatedPartyTransactionsFounderSharesDetails", "shortName": "RELATED PARTY TRANSACTIONS - Founder Shares (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P11_10_2020To11_10_2020_CommonClassBMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis", "decimals": "0", "lang": null, "name": "us-gaap:StockRepurchasedDuringPeriodValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P11_18_2020To11_18_2020_AdministrativeSupportAgreementMemberusgaapRelatedPartyTransactionAxis", "decimals": "0", "first": true, "lang": null, "name": "chfw:RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1026 - Disclosure - RELATED PARTY TRANSACTIONS - Additional Information (Details)", "role": "http://Consonance.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "shortName": "RELATED PARTY TRANSACTIONS - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P11_18_2020To11_18_2020_AdministrativeSupportAgreementMemberusgaapRelatedPartyTransactionAxis", "decimals": "0", "first": true, "lang": null, "name": "chfw:RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "2", "first": true, "lang": null, "name": "chfw:DeferredFeePerUnit", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1027 - Disclosure - COMMITMENTS (Details)", "role": "http://Consonance.com/role/CommitmentsDetails", "shortName": "COMMITMENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "2", "first": true, "lang": null, "name": "chfw:DeferredFeePerUnit", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockSharesAuthorized", "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1028 - Disclosure - SHAREHOLDERS' EQUITY - Preferred Stock Shares (Details)", "role": "http://Consonance.com/role/ShareholdersEquityPreferredStockSharesDetails", "shortName": "SHAREHOLDERS' EQUITY - Preferred Stock Shares (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R29": { "firstAnchor": { "ancestors": [ "us-gaap:CommonStockSharesAuthorized", "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "PAsOn06_30_2021_CommonClassAMemberusgaapStatementClassOfStockAxis", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1029 - Disclosure - SHAREHOLDERS' EQUITY - Common Stock Shares (Details)", "role": "http://Consonance.com/role/ShareholdersEquityCommonStockSharesDetails", "shortName": "SHAREHOLDERS' EQUITY - Common Stock Shares (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "chfw:CommonStockNumberOfVotesPerShare", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "PAsOn06_30_2021_CommonClassAMemberusgaapStatementClassOfStockAxis", "decimals": "INF", "lang": null, "name": "chfw:CommonStockNumberOfVotesPerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_item", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:TemporaryEquitySharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003 - Statement - CONDENSED BALANCE SHEETS (Parenthetical)", "role": "http://Consonance.com/role/CondensedBalanceSheetsParenthetical", "shortName": "CONDENSED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:TemporaryEquitySharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": "INF", "first": true, "lang": null, "name": "chfw:ThresholdNumberOfBusinessDaysBeforeSendingNoticeOfRedemptionToWarrantHolders", "reportCount": 1, "unique": true, "unitRef": "Unit_item", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1030 - Disclosure - WARRANT LIABILITY (Details)", "role": "http://Consonance.com/role/WarrantLiabilityDetails", "shortName": "WARRANT LIABILITY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": "INF", "first": true, "lang": null, "name": "chfw:ThresholdNumberOfBusinessDaysBeforeSendingNoticeOfRedemptionToWarrantHolders", "reportCount": 1, "unique": true, "unitRef": "Unit_item", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AssetsHeldInTrustNoncurrent", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1031 - Disclosure - FAIR VALUE MEASUREMENTS (Details)", "role": "http://Consonance.com/role/FairValueMeasurementsDetails", "shortName": "FAIR VALUE MEASUREMENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "PAsOn06_30_2021_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis", "decimals": "0", "lang": null, "name": "us-gaap:AssetsHeldInTrustNoncurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "PAsOn03_31_2021_WarrantsLiabilitiesMemberusgaapDerivativeInstrumentRiskAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1032 - Disclosure - FAIR VALUE MEASUREMENTS - Summary of fair value of the warrant liabilities (Details)", "role": "http://Consonance.com/role/FairValueMeasurementsSummaryOfFairValueOfTheWarrantLiabilitiesDetails", "shortName": "FAIR VALUE MEASUREMENTS - Summary of fair value of the warrant liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "PAsOn12_31_2020_WarrantsLiabilitiesMemberusgaapDerivativeInstrumentRiskAxis", "decimals": "0", "lang": null, "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P01_01_2021To06_30_2021_WarrantsLiabilitiesMemberusgaapDerivativeInstrumentRiskAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1033 - Disclosure - FAIR VALUE MEASUREMENTS - Additional Information (Details)", "role": "http://Consonance.com/role/FairValueMeasurementsAdditionalInformationDetails", "shortName": "FAIR VALUE MEASUREMENTS - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P01_01_2021To06_30_2021_WarrantsLiabilitiesMemberusgaapDerivativeInstrumentRiskAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P04_01_2021To06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingCostsAndExpenses", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004 - Statement - CONDENSED STATEMENTS OF OPERATIONS", "role": "http://Consonance.com/role/CondensedStatementsOfOperations", "shortName": "CONDENSED STATEMENTS OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P04_01_2021To06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingCostsAndExpenses", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "PAsOn12_31_2020", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005 - Statement - CONDENSED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY", "role": "http://Consonance.com/role/CondensedStatementOfChangesInShareholdersEquity", "shortName": "CONDENSED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P01_01_2021To03_31_2021", "decimals": "0", "lang": null, "name": "chfw:StockIssuedDuringPeriodValueChangeInValueOfClassAOrdinarySharesSubjectToRedemption", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006 - Statement - CONDENSED STATEMENT OF CASH FLOWS", "role": "http://Consonance.com/role/CondensedStatementOfCashFlows", "shortName": "CONDENSED STATEMENT OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1007 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS", "role": "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperations", "shortName": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "role": "http://Consonance.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "chfw:InitialPublicOfferingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1009 - Disclosure - INITIAL PUBLIC OFFERING", "role": "http://Consonance.com/role/InitialPublicOffering", "shortName": "INITIAL PUBLIC OFFERING", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d188183d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "chfw:InitialPublicOfferingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 31, "tag": { "chfw_AdditionsToAssetsHeldInTrust": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of significant additions in the period in assets held in trust (current, noncurrent, or unclassified).", "label": "Additions To Assets Held In Trust", "terseLabel": "Additions to assets held in trust" } } }, "localname": "AdditionsToAssetsHeldInTrust", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://Consonance.com/role/InitialPublicOfferingDetails" ], "xbrltype": "monetaryItemType" }, "chfw_AdministrativeSupportAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Administrative Support Agreement.", "label": "Administrative Support Agreement [Member]", "terseLabel": "Administrative Services Agreement" } } }, "localname": "AdministrativeSupportAgreementMember", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "chfw_AssetsHeldInTrustAccountPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of accounting policy for assets held in trust.", "label": "Assets Held In Trust Account, Policy [Policy Text Block]", "terseLabel": "Marketable Securities Held in Trust Account" } } }, "localname": "AssetsHeldInTrustAccountPolicyPolicyTextBlock", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "chfw_BusinessCombinationAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Combination Agreement Member", "label": "Business Combination Agreement [Member]" } } }, "localname": "BusinessCombinationAgreementMember", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails" ], "xbrltype": "domainItemType" }, "chfw_ChangeInValueOfCommonStockSubjectToPossibleRedemption": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of change in value of common stock subject to possible redemption, classified as non-cash investing and financing activity.", "label": "Change In Value Of Common Stock Subject To Possible Redemption", "terseLabel": "Change in value of Class A ordinary shares subject to possible redemption" } } }, "localname": "ChangeInValueOfCommonStockSubjectToPossibleRedemption", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "chfw_ClassAOrdinarySharesSubjectForRedemptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "definitionGuidance": "Class A ordinary Shares subject to possible redemption", "documentation": "Represents about Class A ordinary shares subject for redemption.", "label": "Class A Ordinary Shares Subject For Redemption [Member]", "verboseLabel": "Class A ordinary shares subject to redemption" } } }, "localname": "ClassAOrdinarySharesSubjectForRedemptionMember", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/CondensedStatementsOfOperations", "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails" ], "xbrltype": "domainItemType" }, "chfw_ClassOfWarrantOrRightPriceOfWarrantsOrRights": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Price of Warrants or Rights", "terseLabel": "Price of warrant" } } }, "localname": "ClassOfWarrantOrRightPriceOfWarrantsOrRights", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "chfw_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold number of specified consecutive trading days for stock price trigger considered for redemption of warrants.", "label": "Class Of Warrant Or Right, Redemption Of Warrants Or Rights, , Threshold Consecutive Trading Days", "terseLabel": "Threshold consecutive trading days for redemption of public warrants" } } }, "localname": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/WarrantLiabilityDetails" ], "xbrltype": "integerItemType" }, "chfw_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold number of specified trading days for stock price trigger considered for redemption of warrants.", "label": "Class Of Warrant Or Right, Redemption Of Warrants Or Rights, , Threshold Trading Days", "terseLabel": "Threshold trading days for redemption of public warrants" } } }, "localname": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/WarrantLiabilityDetails" ], "xbrltype": "integerItemType" }, "chfw_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redemption price per share or per unit of warrants or rights outstanding.", "label": "Class Of Warrant Or Right, Redemption Price Of Warrants Or Rights", "terseLabel": "Redemption price per public warrant (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/WarrantLiabilityDetails" ], "xbrltype": "perShareItemType" }, "chfw_CommonStockNumberOfVotesPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of votes that each common share is entitled.", "label": "Common Stock, Number Of Votes Per Share", "terseLabel": "Common shares, votes per share" } } }, "localname": "CommonStockNumberOfVotesPerShare", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/ShareholdersEquityCommonStockSharesDetails" ], "xbrltype": "integerItemType" }, "chfw_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The minimum number of businesses which the reporting entity must acquire with the net proceeds of the offering.", "label": "Condition for future business combination number of businesses minimum" } } }, "localname": "ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails" ], "xbrltype": "integerItemType" }, "chfw_DeferredFeePerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the deferred fee per unit.", "label": "Deferred Fee Per Unit", "terseLabel": "Deferred fee per unit" } } }, "localname": "DeferredFeePerUnit", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/CommitmentsDetails" ], "xbrltype": "perShareItemType" }, "chfw_DeferredOfferingCostsNoncurrent": { "auth_ref": [], "calculation": { "http://Consonance.com/role/CondensedBalanceSheets": { "order": 10.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of balance sheet date of underwriting fees payable or deferred, classified as noncurrent.", "label": "Deferred underwriting fee payable", "terseLabel": "Deferred underwriting fee payable" } } }, "localname": "DeferredOfferingCostsNoncurrent", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/CommitmentsDetails", "http://Consonance.com/role/CondensedBalanceSheets", "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails" ], "xbrltype": "monetaryItemType" }, "chfw_EmergingGrowthCompanyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the accounting policy on Emerging Growth Company.", "label": "Emerging Growth Company [Policy Text Block]", "terseLabel": "Emerging Growth Company" } } }, "localname": "EmergingGrowthCompanyPolicyTextBlock", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "chfw_FounderSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents the information pertaining to founder shares.", "label": "Founder Shares [Member]", "terseLabel": "Founder Shares" } } }, "localname": "FounderSharesMember", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "domainItemType" }, "chfw_InitialPublicOfferingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "INITIAL PUBLIC OFFERING" } } }, "localname": "InitialPublicOfferingAbstract", "nsuri": "http://Consonance.com/20210630", "xbrltype": "stringItemType" }, "chfw_InitialPublicOfferingAndPrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information about Initial Public Offering and private placement.", "label": "Initial Public Offering And Private Placement [Member]", "terseLabel": "Initial Public Offering and private placement" } } }, "localname": "InitialPublicOfferingAndPrivatePlacementMember", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "chfw_InitialPublicOfferingTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure on information about initial public offering.", "label": "Initial Public Offering [Text Block]", "terseLabel": "INITIAL PUBLIC OFFERING" } } }, "localname": "InitialPublicOfferingTextBlock", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/InitialPublicOffering" ], "xbrltype": "textBlockItemType" }, "chfw_InterestWorkingCapital": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest working capital.", "label": "Interest Working Capital", "terseLabel": "Less: interest available to be withdrawn for working capital" } } }, "localname": "InterestWorkingCapital", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails" ], "xbrltype": "monetaryItemType" }, "chfw_InvestorAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investor Axis", "label": "Investor [Axis]" } } }, "localname": "InvestorAxis", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails" ], "xbrltype": "stringItemType" }, "chfw_InvestorDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investor Domain", "label": "Investor [Domain]" } } }, "localname": "InvestorDomain", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails" ], "xbrltype": "domainItemType" }, "chfw_MaximumLoansConvertibleIntoWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The maximum amount which a potential loan could have repaid through issuance of warrants.", "label": "maximum Loans Convertible Into Warrants", "terseLabel": "Loan conversion agreement warrant" } } }, "localname": "MaximumLoansConvertibleIntoWarrants", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "chfw_MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The period of time after completion of a business combination in which the reporting entity is required to file a registration statement with the SEC.", "label": "Maximum Period After Business Combination In Which To File Registration Statement", "terseLabel": "Maximum period after business combination in which to file registration statement" } } }, "localname": "MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/WarrantLiabilityDetails" ], "xbrltype": "durationItemType" }, "chfw_NumberOfSharesIssuedPerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of shares in a unit.", "label": "Number of Shares Issued Per Unit", "terseLabel": "Shares per unit" } } }, "localname": "NumberOfSharesIssuedPerUnit", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/InitialPublicOfferingDetails", "http://Consonance.com/role/PrivatePlacementDetails" ], "xbrltype": "sharesItemType" }, "chfw_NumberOfSharesSubjectToForfeiture": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares owned by the founders subject to forfeiture if the underwriter overallotment option is not exercised in the proposed public offering.", "label": "Number Of Shares Subject To Forfeiture", "terseLabel": "Shares subject to forfeiture" } } }, "localname": "NumberOfSharesSubjectToForfeiture", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "sharesItemType" }, "chfw_NumberOfWarrantsIssuedPerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of warrants in a unit.", "label": "Number of Warrants Issued Per Unit", "terseLabel": "Warrants per unit" } } }, "localname": "NumberOfWarrantsIssuedPerUnit", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/InitialPublicOfferingDetails", "http://Consonance.com/role/PrivatePlacementDetails" ], "xbrltype": "sharesItemType" }, "chfw_PercentageOfGrossNewProceedsToTotalEquityProceedsUsedToMeasureDilutionOfWarrant": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The ratio of gross proceeds from a future offering to total equity proceeds which is used to measure whether dilution of the warrant has occurred. If aggregate gross proceeds from a new offering exceeds a specified percentage of total equity proceeds, the warrant exercise price will be adjusted.", "label": "Percentage Of Gross New Proceeds To Total Equity Proceeds Used To Measure Dilution Of Warrant", "terseLabel": "Percentage of gross new proceeds to total equity proceeds used to measure dilution of warrant" } } }, "localname": "PercentageOfGrossNewProceedsToTotalEquityProceedsUsedToMeasureDilutionOfWarrant", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/WarrantLiabilityDetails" ], "xbrltype": "pureItemType" }, "chfw_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The expected ownership percentage by the founders after completion of the proposed public offering.", "label": "Percentage Of Issued And Outstanding Shares After The Initial Public Offering Collectively Held By Initial Stockholders", "terseLabel": "Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders" } } }, "localname": "PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "percentItemType" }, "chfw_PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The period of time after filing within which the registration statement filed with the SEC is expected to become effective.", "label": "Period Of Time Within Which Registration Statement Is Expected To Become Effective", "terseLabel": "Period of time within which registration statement is expected to become effective" } } }, "localname": "PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/WarrantLiabilityDetails" ], "xbrltype": "durationItemType" }, "chfw_PipeInvestorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "PIPE Investors Member", "label": "PIPE Investors [Member]" } } }, "localname": "PipeInvestorsMember", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails" ], "xbrltype": "domainItemType" }, "chfw_PipeWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pipe warrant [Member].", "label": "Pipe Warrant [Member]" } } }, "localname": "PipeWarrantMember", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails" ], "xbrltype": "domainItemType" }, "chfw_PrivatePlacementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "PRIVATE PLACEMENT" } } }, "localname": "PrivatePlacementAbstract", "nsuri": "http://Consonance.com/20210630", "xbrltype": "stringItemType" }, "chfw_PrivatePlacementTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure on information about private placement.", "label": "Private Placement [Text Block]", "terseLabel": "PRIVATE PLACEMENT" } } }, "localname": "PrivatePlacementTextBlock", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/PrivatePlacement" ], "xbrltype": "textBlockItemType" }, "chfw_PrivatePlacementWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents a redeemable warrant (Private Placement Warrant) that entitles the holder to purchase shares of common stock if the underwriter's option is exercised in full.", "label": "Private Placement Warrants [Member]", "terseLabel": "Private Placement Warrants" } } }, "localname": "PrivatePlacementWarrantsMember", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/FairValueMeasurementsDetails", "http://Consonance.com/role/FairValueMeasurementsSummaryOfFairValueOfTheWarrantLiabilitiesDetails", "http://Consonance.com/role/PrivatePlacementDetails", "http://Consonance.com/role/WarrantLiabilityDetails" ], "xbrltype": "domainItemType" }, "chfw_PublicWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents a redeemable warrant (Public Warrant) that entitles the holder to purchase shares of common stock subject to adjustment.", "label": "Public Warrants [Member]", "terseLabel": "Public Warrants" } } }, "localname": "PublicWarrantsMember", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/FairValueMeasurementsDetails", "http://Consonance.com/role/FairValueMeasurementsSummaryOfFairValueOfTheWarrantLiabilitiesDetails", "http://Consonance.com/role/InitialPublicOfferingDetails", "http://Consonance.com/role/WarrantLiabilityDetails" ], "xbrltype": "domainItemType" }, "chfw_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for the scenario, where redemption of warrants when the price per share of class a common stock equals or exceeds $10.00.", "label": "Redemption Of Warrants When Price Per Share Of Class Common Stock Equals Or Exceeds10.00 [Member]", "terseLabel": "Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00" } } }, "localname": "RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/WarrantLiabilityDetails" ], "xbrltype": "domainItemType" }, "chfw_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for the scenario, where redemption of warrants when the price per share of class a common stock equals or exceeds $18.00.", "label": "Redemption Of Warrants When Price Per Share Of Class Common Stock Equals Or Exceeds18.00 [Member]", "terseLabel": "Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00" } } }, "localname": "RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/WarrantLiabilityDetails" ], "xbrltype": "domainItemType" }, "chfw_RedemptionPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redemption period.", "label": "Redemption Period", "terseLabel": "Redemption period" } } }, "localname": "RedemptionPeriod", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/WarrantLiabilityDetails" ], "xbrltype": "durationItemType" }, "chfw_RelatedPartyLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for related party loans.", "label": "Related Party Loans [Member]", "terseLabel": "Related Party Loans" } } }, "localname": "RelatedPartyLoansMember", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "chfw_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The contractual monthly amount to be paid for support services.", "label": "Related Party Transaction, Expenses from Transactions with Related Party Per Month", "terseLabel": "Expenses per month" } } }, "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "chfw_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The period of time after completion of a business combination during which the shares or warrant may not be transferred.", "label": "Restrictions On Transfer Period Of Time After Business Combination Completion", "terseLabel": "Restrictions on transfer period of time after business combination completion" } } }, "localname": "RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/WarrantLiabilityDetails" ], "xbrltype": "durationItemType" }, "chfw_SaleOfStockOtherOfferingCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of other offering costs incurred.", "label": "Sale of Stock, Other Offering Costs", "terseLabel": "Other offering costs" } } }, "localname": "SaleOfStockOtherOfferingCosts", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails" ], "xbrltype": "monetaryItemType" }, "chfw_SaleOfStockUnderwritingFees": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of offering fees incurred and paid for underwriters.", "label": "Sale of Stock, Underwriting fees", "terseLabel": "Underwriting fees" } } }, "localname": "SaleOfStockUnderwritingFees", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails" ], "xbrltype": "monetaryItemType" }, "chfw_SharePricetriggerUsedToMeasureDilutionOfWarrant": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The cutoff price used to measure whether dilution of the warrant has occurred. Shares issued below this price will cause the exercise price of the warrant to be adjusted.", "label": "Share PriceTrigger Used To Measure Dilution Of Warrant", "terseLabel": "Share price trigger used to measure dilution of warrant" } } }, "localname": "SharePricetriggerUsedToMeasureDilutionOfWarrant", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/WarrantLiabilityDetails" ], "xbrltype": "perShareItemType" }, "chfw_SponsorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for sponsor.", "label": "Sponsor [Member]", "terseLabel": "Sponsor" } } }, "localname": "SponsorMember", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "domainItemType" }, "chfw_StockIssuedDuringPeriodSharesChangeInValueOfClassAOrdinarySharesSubjectToRedemption": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during period value change in value of class a ordinary shares subject to redemption.", "label": "Stock Issued During Period Shares Change In Value Of Class A Ordinary Shares Subject To Redemption", "terseLabel": "Change in value of Class A ordinary shares subject to redemption (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesChangeInValueOfClassAOrdinarySharesSubjectToRedemption", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/CondensedStatementOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "chfw_StockIssuedDuringPeriodValueChangeInValueOfClassAOrdinarySharesSubjectToRedemption": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock issued during period value change in value of class a ordinary shares subject to redemption.", "label": "Stock Issued During Period Value Change In Value Of Class A Ordinary Shares Subject To Redemption", "terseLabel": "Change in value of Class A ordinary shares subject to redemption" } } }, "localname": "StockIssuedDuringPeriodValueChangeInValueOfClassAOrdinarySharesSubjectToRedemption", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/CondensedStatementOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "chfw_SubscriptionAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Subscription Agreement Member", "label": "Subscription Agreement [Member]" } } }, "localname": "SubscriptionAgreementMember", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails" ], "xbrltype": "domainItemType" }, "chfw_TemporaryEquityPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of accounting policy for temporary equity.", "label": "Temporary Equity, Policy [Policy Text Block]", "terseLabel": "Class A Ordinary Shares Subject to Possible Redemption" } } }, "localname": "TemporaryEquityPolicyPolicyTextBlock", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "chfw_ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the threshold minimum aggregate fair market value as a percentage of the assets held in the Trust Account.", "label": "Threshold Minimum Aggregate Fair Market Value As Percentage Of Assets Held In Trust Account", "terseLabel": "Threshold minimum aggregate fair market value as a percentage of the assets held in the Trust Account" } } }, "localname": "ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails" ], "xbrltype": "percentItemType" }, "chfw_ThresholdNumberOfBusinessDaysBeforeSendingNoticeOfRedemptionToWarrantHolders": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold number of business days before sending notice of redemption to warrant holders.", "label": "Threshold Number of Business Days Before Sending Notice of Redemption to Warrant Holders", "terseLabel": "Threshold number of business days before sending notice of redemption to warrant holders" } } }, "localname": "ThresholdNumberOfBusinessDaysBeforeSendingNoticeOfRedemptionToWarrantHolders", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/WarrantLiabilityDetails" ], "xbrltype": "integerItemType" }, "chfw_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination.", "label": "Threshold Percentage Of Outstanding Voting Securities Of Target To Be Acquired By Post Transaction Company To Complete Business Combination", "terseLabel": "Threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination" } } }, "localname": "ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails" ], "xbrltype": "percentItemType" }, "chfw_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The period of time after a business combination which must elapse before consideration of the share price condition for transfer of shares.", "label": "Threshold Period After Business Combination In Which Specified Trading Days Within Any Specified Trading Day Period Commences", "terseLabel": "Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences" } } }, "localname": "ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "durationItemType" }, "chfw_TradingPeriodAfterBusinessCombinationUsedToMeasureDilutionOfWarrant": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of trading days after a business combination during which the share price is compared to the specified dilution trigger share price in order to determine whether the warrant exercise price should be adjusted.", "label": "Trading Period After Business Combination Used To Measure Dilution of Warrant", "terseLabel": "Trading period after business combination used to measure dilution of warrant" } } }, "localname": "TradingPeriodAfterBusinessCombinationUsedToMeasureDilutionOfWarrant", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/WarrantLiabilityDetails" ], "xbrltype": "integerItemType" }, "chfw_TransactionCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of transaction costs incurred.", "label": "Transaction Costs", "terseLabel": "Transaction Costs" } } }, "localname": "TransactionCosts", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails" ], "xbrltype": "monetaryItemType" }, "chfw_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The share price threshold that must be achieved in order to waive the restriction on transfer of shares during a restricted period after a business combination.", "label": "Transfer, Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination, Stock Price Trigger", "terseLabel": "Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share)" } } }, "localname": "TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "perShareItemType" }, "chfw_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "When determining the condition for transfer of shares without restriction after a business combination, the number of consecutive trading days used to observe the share price.", "label": "Transfer, Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination, Threshold Consecutive Trading Days", "terseLabel": "Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination" } } }, "localname": "TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "integerItemType" }, "chfw_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "When determining the condition for transfer of shares without restriction after a business combination, the number of days in which the share price must exceed the specified amount.", "label": "Transfer, Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination, Threshold Trading Days", "terseLabel": "Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination" } } }, "localname": "TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "integerItemType" }, "chfw_UnitsEachConsistingOfOneShareOfClassOrdinarySharesAndOneThirdOfRedeemableWarrantToAcquireOneClassOrdinaryShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information pertaining to Unit each consisting of one class common stock.", "label": "Units Each Consisting Of One Share Of Class Ordinary Shares And One Third Of Redeemable Warrant To Acquire One Class Ordinary Share [Member]", "terseLabel": "Units, each consisting of one share of Class A ordinary shares, and one-third of a redeemable Warrant to acquire one Class A ordinary share" } } }, "localname": "UnitsEachConsistingOfOneShareOfClassOrdinarySharesAndOneThirdOfRedeemableWarrantToAcquireOneClassOrdinaryShareMember", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "chfw_UnitsIssuedDuringPeriodSharesNewIssues": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of new units issued during the period.", "label": "Units Issued During Period, Shares, New Issues", "terseLabel": "Sale of Units, net of underwriting discounts", "verboseLabel": "Sale of Units (in shares)" } } }, "localname": "UnitsIssuedDuringPeriodSharesNewIssues", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://Consonance.com/role/InitialPublicOfferingDetails", "http://Consonance.com/role/PrivatePlacementDetails" ], "xbrltype": "sharesItemType" }, "chfw_UnitsIssuedDuringPeriodValueNewIssues": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new unit issued during the period.", "label": "Units Issued During Period, Value, New Issues", "verboseLabel": "Proceeds from issuance of units" } } }, "localname": "UnitsIssuedDuringPeriodValueNewIssues", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://Consonance.com/role/InitialPublicOfferingDetails", "http://Consonance.com/role/PrivatePlacementDetails" ], "xbrltype": "monetaryItemType" }, "chfw_WarrantExercisePeriodConditionOne": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The period of time after completion of a business combination before a warrant may be exercised.", "label": "Warrant Exercise Period Condition One", "terseLabel": "Warrant exercise period condition one" } } }, "localname": "WarrantExercisePeriodConditionOne", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/WarrantLiabilityDetails" ], "xbrltype": "durationItemType" }, "chfw_WarrantExercisePeriodConditionTwo": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The alternate period of time after completion of an initial public offering before a warrant may be exercised.", "label": "Warrant Exercise Period Condition Two", "terseLabel": "Warrant exercise period condition two" } } }, "localname": "WarrantExercisePeriodConditionTwo", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/WarrantLiabilityDetails" ], "xbrltype": "durationItemType" }, "chfw_WarrantExercisePriceAdjustmentMultiple": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "In the event of dilution of the warrant, the multiple to be applied to the higher of the market price or the price of newly issued shares in order to obtain the adjusted exercise price.", "label": "Warrant Exercise Price Adjustment Multiple", "terseLabel": "Warrant exercise price adjustment multiple" } } }, "localname": "WarrantExercisePriceAdjustmentMultiple", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/WarrantLiabilityDetails" ], "xbrltype": "pureItemType" }, "chfw_WarrantLiability": { "auth_ref": [], "calculation": { "http://Consonance.com/role/CondensedBalanceSheets": { "order": 9.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Warrant liability.", "label": "Warrant liability", "terseLabel": "Warrant Liability" } } }, "localname": "WarrantLiability", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/CondensedBalanceSheets", "http://Consonance.com/role/FairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "chfw_WarrantLiabilityPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "warrant liability[Policy text block].", "label": "Warrant Liability [Policy Text Block]", "terseLabel": "Warrant Liability" } } }, "localname": "WarrantLiabilityPolicyTextBlock", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "chfw_WarrantRedemptionConditionMinimumSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The minimum trading price for the reporting entity's stock which must be achieved as a condition for redemption of the warrant.", "label": "Warrant Redemption Condition Minimum Share Price", "terseLabel": "Warrant redemption condition minimum share price" } } }, "localname": "WarrantRedemptionConditionMinimumSharePrice", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/WarrantLiabilityDetails" ], "xbrltype": "perShareItemType" }, "chfw_WarrantRedemptionConditionMinimumSharePriceScenarioTwo": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The minimum trading price for the reporting entity's stock which must be achieved as a condition for redemption of the warrant under another scenario.", "label": "Warrant Redemption Condition Minimum Share Price Scenario Two", "terseLabel": "Warrant redemption condition minimum share price scenario two" } } }, "localname": "WarrantRedemptionConditionMinimumSharePriceScenarioTwo", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/WarrantLiabilityDetails" ], "xbrltype": "perShareItemType" }, "chfw_WarrantRedemptionPriceAdjustmentMultiple": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "In the event of dilution of the warrant, the multiple to be applied to the higher of the market price or the price of newly issued shares in order to obtain the adjusted redemption price.", "label": "Warrant Redemption Price Adjustment Multiple", "terseLabel": "Warrant redemption price adjustment multiple" } } }, "localname": "WarrantRedemptionPriceAdjustmentMultiple", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/WarrantLiabilityDetails" ], "xbrltype": "pureItemType" }, "chfw_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf1150Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price.", "label": "Warrants Each Whole Warrant Exercisable For One Class Ordinary Share At Exercise Price Of 1150 [Member]", "terseLabel": "Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50" } } }, "localname": "WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf1150Member", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "chfw_WarrantsLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants Liabilities Member.", "label": "Warrants Liabilities [Member]", "terseLabel": "Warrants Liabilities" } } }, "localname": "WarrantsLiabilitiesMember", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/FairValueMeasurementsAdditionalInformationDetails", "http://Consonance.com/role/FairValueMeasurementsSummaryOfFairValueOfTheWarrantLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "chfw_WarrantsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants [Text Block].", "label": "Warrants [Text Block]", "terseLabel": "WARRANT LIABILITY" } } }, "localname": "WarrantsTextBlock", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/WarrantLiability" ], "xbrltype": "textBlockItemType" }, "chfw_WorkingCapitalLoansWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Working capital loans warrant.", "label": "Working Capital Loans Warrant [Member]", "terseLabel": "Working capital loans warrant" } } }, "localname": "WorkingCapitalLoansWarrantMember", "nsuri": "http://Consonance.com/20210630", "presentation": [ "http://Consonance.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Consonance.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Consonance.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Consonance.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Consonance.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Consonance.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]", "terseLabel": "Cover Page" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Consonance.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Consonance.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Consonance.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r231" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Consonance.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r232" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Consonance.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Consonance.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Consonance.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Consonance.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Consonance.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Consonance.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Consonance.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r233" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Consonance.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Consonance.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Consonance.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r233" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Consonance.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r235" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Consonance.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Consonance.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r233" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Consonance.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Consonance.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r234" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Consonance.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r233" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Consonance.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r233" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Consonance.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r233" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Consonance.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r233" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Consonance.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Consonance.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r229" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Consonance.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r230" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Consonance.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Consonance.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r130" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]", "terseLabel": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://Consonance.com/role/WarrantLiabilityDetails" ], "xbrltype": "domainItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r105", "r130", "r194" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://Consonance.com/role/WarrantLiabilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r19" ], "calculation": { "http://Consonance.com/role/CondensedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r12", "r135" ], "calculation": { "http://Consonance.com/role/CondensedBalanceSheets": { "order": 14.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r48", "r49", "r50", "r132", "r133", "r134" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedStatementOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]" } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r44", "r88", "r90", "r94", "r97", "r150", "r154", "r177", "r212", "r218" ], "calculation": { "http://Consonance.com/role/CondensedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "TOTAL ASSETS" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r4", "r6", "r24", "r44", "r97", "r150", "r154", "r177" ], "calculation": { "http://Consonance.com/role/CondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Fair Value Disclosure [Abstract]", "terseLabel": "Assets:" } } }, "localname": "AssetsFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsHeldInTrust": { "auth_ref": [ "r46" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total amount of cash and securities held by third party trustees pursuant to terms of debt instruments or other agreements as of the date of each statement of financial position presented, which can be used by the trustee only to pay the noncurrent portion of specified obligations.", "label": "Assets Held-in-trust", "terseLabel": "Assets Held-in-trust" } } }, "localname": "AssetsHeldInTrust", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://Consonance.com/role/InitialPublicOfferingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsHeldInTrustNoncurrent": { "auth_ref": [ "r46" ], "calculation": { "http://Consonance.com/role/CondensedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.", "label": "Assets Held-in-trust, Noncurrent", "terseLabel": "Cash and marketable securities held in Trust Account", "verboseLabel": "Marketable securities held in Trust Account" } } }, "localname": "AssetsHeldInTrustNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedBalanceSheets", "http://Consonance.com/role/FairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r47" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.", "label": "Basis of Presentation and Significant Accounting Policies [Text Block]", "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned": { "auth_ref": [ "r147" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.", "label": "Business Acquisition, Equity Interest Issued or Issuable, Value Assigned", "terseLabel": "Business Acquisition equity interest issued or issuable value assigned" } } }, "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.", "label": "Business Acquisition, Share Price", "terseLabel": "Business acquisition share price" } } }, "localname": "BusinessAcquisitionSharePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r2", "r17", "r38" ], "calculation": { "http://Consonance.com/role/CondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r7", "r39", "r41" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r33", "r38", "r40" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash \u2013 End of period", "periodStartLabel": "Cash \u2013 Beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r33", "r178" ], "calculation": { "http://Consonance.com/role/CondensedStatementOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net Change in Cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFDICInsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.", "label": "Cash, FDIC Insured Amount", "terseLabel": "Federal Depository Insurance Coverage" } } }, "localname": "CashFDICInsuredAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]", "terseLabel": "Non-Cash investing and financing activities:" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r42", "r44", "r62", "r63", "r64", "r68", "r72", "r76", "r77", "r78", "r97", "r177" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedBalanceSheets", "http://Consonance.com/role/CondensedBalanceSheetsParenthetical", "http://Consonance.com/role/CondensedStatementOfChangesInShareholdersEquity", "http://Consonance.com/role/CondensedStatementsOfOperations", "http://Consonance.com/role/CoverPage", "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://Consonance.com/role/RelatedPartyTransactionsFounderSharesDetails", "http://Consonance.com/role/ShareholdersEquityCommonStockSharesDetails", "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails", "http://Consonance.com/role/WarrantLiabilityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/ShareholdersEquityCommonStockSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r119", "r131" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://Consonance.com/role/FairValueMeasurementsAdditionalInformationDetails", "http://Consonance.com/role/FairValueMeasurementsDetails", "http://Consonance.com/role/FairValueMeasurementsSummaryOfFairValueOfTheWarrantLiabilitiesDetails", "http://Consonance.com/role/InitialPublicOfferingDetails", "http://Consonance.com/role/PrivatePlacementDetails", "http://Consonance.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://Consonance.com/role/WarrantLiabilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class of Warrant or Right [Domain]", "terseLabel": "Class of Warrant or Right [Domain]" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://Consonance.com/role/FairValueMeasurementsAdditionalInformationDetails", "http://Consonance.com/role/FairValueMeasurementsDetails", "http://Consonance.com/role/FairValueMeasurementsSummaryOfFairValueOfTheWarrantLiabilitiesDetails", "http://Consonance.com/role/InitialPublicOfferingDetails", "http://Consonance.com/role/PrivatePlacementDetails", "http://Consonance.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://Consonance.com/role/WarrantLiabilityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r112" ], "lang": { "en-us": { "role": { "definitionGuidance": "Class of warrant or right exercise price of warrants or rights", "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Exercise price of warrants", "verboseLabel": "Exercise price of warrant" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://Consonance.com/role/InitialPublicOfferingDetails", "http://Consonance.com/role/PrivatePlacementDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Warrant or Right [Line Items]" } } }, "localname": "ClassOfWarrantOrRightLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/WarrantLiabilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.", "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right", "terseLabel": "Shares per warrant", "verboseLabel": "Warrant voting right per share" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://Consonance.com/role/InitialPublicOfferingDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r112" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "verboseLabel": "Number of warrants to purchase shares issued" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightTable": { "auth_ref": [ "r119", "r131" ], "lang": { "en-us": { "role": { "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Class of Warrant or Right [Table]" } } }, "localname": "ClassOfWarrantOrRightTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/WarrantLiabilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r21", "r104", "r214", "r221" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "COMMITMENTS" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r101", "r102", "r103", "r106" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "COMMITMENTS" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/Commitments" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing ownership interest in a corporation.", "label": "Common Class A [Member]", "terseLabel": "Class A ordinary" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedBalanceSheets", "http://Consonance.com/role/CondensedBalanceSheetsParenthetical", "http://Consonance.com/role/CondensedStatementOfChangesInShareholdersEquity", "http://Consonance.com/role/CoverPage", "http://Consonance.com/role/RelatedPartyTransactionsFounderSharesDetails", "http://Consonance.com/role/ShareholdersEquityCommonStockSharesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonClassBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.", "label": "Common Class B [Member]", "terseLabel": "Class B ordinary" } } }, "localname": "CommonClassBMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedBalanceSheets", "http://Consonance.com/role/CondensedBalanceSheetsParenthetical", "http://Consonance.com/role/CondensedStatementOfChangesInShareholdersEquity", "http://Consonance.com/role/CoverPage", "http://Consonance.com/role/RelatedPartyTransactionsFounderSharesDetails", "http://Consonance.com/role/ShareholdersEquityCommonStockSharesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r48", "r49" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedStatementOfChangesInShareholdersEquity", "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common shares, par value, (per share)", "verboseLabel": "Common shares, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedBalanceSheetsParenthetical", "http://Consonance.com/role/ShareholdersEquityCommonStockSharesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common shares, shares authorized", "verboseLabel": "Common shares, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedBalanceSheetsParenthetical", "http://Consonance.com/role/ShareholdersEquityCommonStockSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common shares, shares issued", "verboseLabel": "Common shares, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedBalanceSheetsParenthetical", "http://Consonance.com/role/RelatedPartyTransactionsFounderSharesDetails", "http://Consonance.com/role/ShareholdersEquityCommonStockSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r11", "r111" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common shares, shares outstanding", "verboseLabel": "Common shares, shares outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedBalanceSheetsParenthetical", "http://Consonance.com/role/RelatedPartyTransactionsFounderSharesDetails", "http://Consonance.com/role/ShareholdersEquityCommonStockSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r11" ], "calculation": { "http://Consonance.com/role/CondensedBalanceSheets": { "order": 13.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r81", "r217" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Concentration of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/FairValueMeasurementsAdditionalInformationDetails", "http://Consonance.com/role/FairValueMeasurementsSummaryOfFairValueOfTheWarrantLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r160", "r161", "r162", "r163" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/FairValueMeasurementsAdditionalInformationDetails", "http://Consonance.com/role/FairValueMeasurementsSummaryOfFairValueOfTheWarrantLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativesReportingOfDerivativeActivity": { "auth_ref": [ "r41", "r159" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for derivatives entered into for trading purposes and those entered into for purposes other than trading including where and when derivative financial instruments and derivative commodity instruments and their related gains or losses are reported in the entity's statements of financial position, cash flows, and results of operations.", "label": "Derivatives, Reporting of Derivative Activity [Policy Text Block]", "terseLabel": "Derivative Financial Instruments" } } }, "localname": "DerivativesReportingOfDerivativeActivity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [ "r71" ], "lang": { "en-us": { "role": { "definitionGuidance": "Basic and diluted net income (Loss) per share", "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Basic and Diluted", "verboseLabel": "Basic and diluted net loss per share" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedStatementsOfOperations", "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r41", "r73", "r74" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Net Loss Per Ordinary Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r48", "r49", "r50", "r52", "r57", "r59", "r75", "r98", "r111", "r118", "r132", "r133", "r134", "r145", "r146", "r179", "r180", "r181", "r182", "r183", "r184", "r223", "r224", "r225" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedStatementOfChangesInShareholdersEquity", "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAdjustmentOfWarrants": { "auth_ref": [ "r36", "r107" ], "calculation": { "http://Consonance.com/role/CondensedStatementOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://Consonance.com/role/CondensedStatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.", "label": "Fair Value Adjustment of Warrants", "negatedLabel": "Changes in fair value of warrant liability", "verboseLabel": "Changes in fair value of warrant liability" } } }, "localname": "FairValueAdjustmentOfWarrants", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedStatementOfCashFlows", "http://Consonance.com/role/CondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r164", "r165", "r166", "r173" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r164", "r165" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of company's assets that are measured at fair value on a recurring basis" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r121", "r122", "r123", "r124", "r125", "r126", "r127", "r129", "r165", "r196", "r197", "r198" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r164", "r165", "r167", "r168", "r174" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r171" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "FAIR VALUE MEASUREMENTS" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r121", "r122", "r127", "r129", "r165", "r196" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level 1" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r121", "r122", "r123", "r124", "r125", "r126", "r127", "r129", "r165", "r198" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level 3" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsQuantitativeInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Measurement Inputs and Valuation Techniques [Abstract]" } } }, "localname": "FairValueInputsQuantitativeInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/FairValueMeasurementsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r169", "r173" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/FairValueMeasurementsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurement, Policy [Policy Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transfers of financial instrument classified as a liability into (out of) level 3 of the fair value hierarchy.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net", "terseLabel": "Transfers in or out of level 3" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/FairValueMeasurementsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r121", "r122", "r123", "r124", "r125", "r126", "r127", "r129", "r196", "r197", "r198" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r171", "r174" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "terseLabel": "Recurring" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss": { "auth_ref": [ "r170" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) recognized in income for derivative asset (liability) after deduction of derivative liability (asset), measured at fair value using unobservable input (level 3) and still held.", "label": "Fair Value, Net Derivative Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss)", "terseLabel": "Change in valuation inputs or other assumptions" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/FairValueMeasurementsSummaryOfFairValueOfTheWarrantLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/FairValueMeasurementsSummaryOfFairValueOfTheWarrantLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r169", "r172" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/FairValueMeasurementsSummaryOfFairValueOfTheWarrantLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock": { "auth_ref": [ "r169", "r172" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Summary of fair value of the warrant liabilities" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs": { "auth_ref": [ "r164", "r172" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs", "periodEndLabel": "Balance at the end", "periodStartLabel": "Balance at the beginning" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/FairValueMeasurementsSummaryOfFairValueOfTheWarrantLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r41", "r175", "r176" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO [Member]", "terseLabel": "Initial Public Offering" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://Consonance.com/role/InitialPublicOfferingDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r27", "r41", "r137", "r138", "r141", "r142", "r143", "r144", "r228" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r35" ], "calculation": { "http://Consonance.com/role/CondensedStatementOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "terseLabel": "Accrued expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r35" ], "calculation": { "http://Consonance.com/role/CondensedStatementOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedStatementOfChangesInShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r29", "r87" ], "calculation": { "http://Consonance.com/role/CondensedStatementOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://Consonance.com/role/CondensedStatementsOfOperations": { "order": 6.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 }, "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "negatedLabel": "Interest earned on marketable securities held in Trust Account", "terseLabel": "Interest earned on marketable securities held in Trust Account" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedStatementOfCashFlows", "http://Consonance.com/role/CondensedStatementsOfOperations", "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r18", "r44", "r91", "r97", "r151", "r154", "r155", "r177" ], "calculation": { "http://Consonance.com/role/CondensedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r16", "r44", "r97", "r177", "r213", "r220" ], "calculation": { "http://Consonance.com/role/CondensedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r20", "r44", "r97", "r151", "r154", "r155", "r177" ], "calculation": { "http://Consonance.com/role/CondensedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Fair Value Disclosure [Abstract]", "terseLabel": "Liabilities:" } } }, "localname": "LiabilitiesFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r33", "r34", "r37" ], "calculation": { "http://Consonance.com/role/CondensedStatementOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash Flows from Operating Activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r0", "r25", "r26", "r28", "r37", "r44", "r51", "r53", "r54", "r55", "r56", "r58", "r59", "r65", "r88", "r89", "r92", "r93", "r95", "r97", "r177", "r215", "r222" ], "calculation": { "http://Consonance.com/role/CondensedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net loss", "totalLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedStatementOfChangesInShareholdersEquity", "http://Consonance.com/role/CondensedStatementsOfOperations", "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r53", "r54", "r55", "r56", "r60", "r61", "r67", "r72", "r88", "r89", "r92", "r93", "r95" ], "calculation": { "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "totalLabel": "Net income (loss)" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Standards" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r30" ], "calculation": { "http://Consonance.com/role/CondensedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Other expense, net" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other expense:" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_NonredeemablePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares that are not redeemable before liquidation of the entity. Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Nonredeemable Preferred Stock [Member]", "terseLabel": "Non-redeemable ordinary shares" } } }, "localname": "NonredeemablePreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedStatementsOfOperations", "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingCostsAndExpenses": { "auth_ref": [], "calculation": { "http://Consonance.com/role/CondensedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.", "label": "Operating Costs and Expenses", "terseLabel": "Operating and formation costs" } } }, "localname": "OperatingCostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r88", "r89", "r92", "r93", "r95" ], "calculation": { "http://Consonance.com/role/CondensedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r1", "r158" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperations" ], "xbrltype": "textBlockItemType" }, "us-gaap_OverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.", "label": "Over-Allotment Option [Member]", "terseLabel": "Over-allotment option" } } }, "localname": "OverAllotmentOptionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://Consonance.com/role/InitialPublicOfferingDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value, (per share)", "verboseLabel": "Preferred stock, par value, (per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedBalanceSheetsParenthetical", "http://Consonance.com/role/ShareholdersEquityPreferredStockSharesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized", "verboseLabel": "Preferred shares, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedBalanceSheetsParenthetical", "http://Consonance.com/role/ShareholdersEquityPreferredStockSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued", "verboseLabel": "Preferred shares, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedBalanceSheetsParenthetical", "http://Consonance.com/role/ShareholdersEquityPreferredStockSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding", "verboseLabel": "Preferred shares, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedBalanceSheetsParenthetical", "http://Consonance.com/role/ShareholdersEquityPreferredStockSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r10" ], "calculation": { "http://Consonance.com/role/CondensedBalanceSheets": { "order": 12.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r3", "r5", "r99", "r100" ], "calculation": { "http://Consonance.com/role/CondensedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Expense, Current", "terseLabel": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.", "label": "Private Placement [Member]", "terseLabel": "Private Placement" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://Consonance.com/role/InitialPublicOfferingDetails", "http://Consonance.com/role/PrivatePlacementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "auth_ref": [ "r31" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).", "label": "Proceeds from Issuance of Warrants", "verboseLabel": "Proceeds from issuance of warrants" } } }, "localname": "ProceedsFromIssuanceOfWarrants", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r0", "r25", "r26", "r32", "r44", "r51", "r58", "r59", "r88", "r89", "r92", "r93", "r95", "r97", "r149", "r152", "r153", "r156", "r157", "r177", "r216" ], "calculation": { "http://Consonance.com/role/CondensedStatementOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r128", "r187", "r188" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]", "terseLabel": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r128", "r187", "r188", "r190" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://Consonance.com/role/RelatedPartyTransactionsFounderSharesDetails", "http://Consonance.com/role/WarrantLiabilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r128" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]", "terseLabel": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://Consonance.com/role/RelatedPartyTransactionsFounderSharesDetails", "http://Consonance.com/role/WarrantLiabilityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": { "auth_ref": [ "r187" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.", "label": "Related Party Transaction, Expenses from Transactions with Related Party", "verboseLabel": "Expenses incurred and paid" } } }, "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://Consonance.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r128", "r187", "r190", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r211" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r185", "r186", "r188", "r191", "r192" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r13", "r118", "r135", "r219", "r226", "r227" ], "calculation": { "http://Consonance.com/role/CondensedBalanceSheets": { "order": 15.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r48", "r49", "r50", "r52", "r57", "r59", "r98", "r132", "r133", "r134", "r145", "r146", "r223", "r225" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedStatementOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]", "terseLabel": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://Consonance.com/role/InitialPublicOfferingDetails", "http://Consonance.com/role/PrivatePlacementDetails", "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of Stock, Price Per Share", "terseLabel": "Sale of stock price per share" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r72" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "verboseLabel": "Schedule of basic and diluted net income (loss) per ordinary share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r45", "r189", "r190" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://Consonance.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r22", "r42", "r76", "r77", "r108", "r109", "r110", "r112", "r113", "r114", "r115", "r116", "r117", "r118" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/ShareholdersEquityCommonStockSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "terseLabel": "Share price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://Consonance.com/role/InitialPublicOfferingDetails", "http://Consonance.com/role/PrivatePlacementDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r111" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Shares, Issued", "periodEndLabel": "Balance at the end (in shares)", "periodStartLabel": "Balance at the beginning (in shares)" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedStatementOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r9", "r10", "r11", "r42", "r44", "r62", "r63", "r64", "r68", "r72", "r76", "r77", "r78", "r97", "r111", "r177" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedBalanceSheets", "http://Consonance.com/role/CondensedBalanceSheetsParenthetical", "http://Consonance.com/role/CondensedStatementOfChangesInShareholdersEquity", "http://Consonance.com/role/CondensedStatementsOfOperations", "http://Consonance.com/role/CoverPage", "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://Consonance.com/role/RelatedPartyTransactionsFounderSharesDetails", "http://Consonance.com/role/ShareholdersEquityCommonStockSharesDetails", "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails", "http://Consonance.com/role/WarrantLiabilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r23", "r48", "r49", "r50", "r52", "r57", "r59", "r75", "r98", "r111", "r118", "r132", "r133", "r134", "r145", "r146", "r179", "r180", "r181", "r182", "r183", "r184", "r223", "r224", "r225" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedStatementOfChangesInShareholdersEquity", "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedBalanceSheets", "http://Consonance.com/role/CondensedBalanceSheetsParenthetical", "http://Consonance.com/role/CondensedStatementOfChangesInShareholdersEquity", "http://Consonance.com/role/CondensedStatementsOfOperations", "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails", "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r48", "r49", "r50", "r75", "r199" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedBalanceSheets", "http://Consonance.com/role/CondensedBalanceSheetsParenthetical", "http://Consonance.com/role/CondensedStatementOfChangesInShareholdersEquity", "http://Consonance.com/role/CondensedStatementsOfOperations", "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails", "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r10", "r11", "r111", "r118" ], "lang": { "en-us": { "role": { "definitionGuidance": "Stock issued during period shares new shares", "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "verboseLabel": "Number of shares issued" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://Consonance.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r10", "r11", "r111", "r118" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "verboseLabel": "Aggregate purchase price" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r10", "r11", "r111", "r118" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Shares", "verboseLabel": "Stock repurchased during the period ( in shares)" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r10", "r11", "r111", "r118" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Value", "verboseLabel": "Stock repurchased during the period" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r11", "r14", "r15", "r44", "r96", "r97", "r177" ], "calculation": { "http://Consonance.com/role/CondensedBalanceSheets": { "order": 11.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance at the end", "periodStartLabel": "Balance at the beginning", "totalLabel": "Total Stockholder's Equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedBalanceSheets", "http://Consonance.com/role/CondensedStatementOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Stockholder's Equity" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r43", "r118", "r120" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "SHAREHOLDERS' EQUITY" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/ShareholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r193", "r195" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Different names of stock transactions and the different attributes of each transaction.", "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]" } } }, "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://Consonance.com/role/InitialPublicOfferingDetails", "http://Consonance.com/role/PrivatePlacementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://Consonance.com/role/InitialPublicOfferingDetails", "http://Consonance.com/role/PrivatePlacementDetails", "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Subsidiary, Sale of Stock [Line Items]" } } }, "localname": "SubsidiarySaleOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://Consonance.com/role/InitialPublicOfferingDetails", "http://Consonance.com/role/PrivatePlacementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "auth_ref": [], "calculation": { "http://Consonance.com/role/CondensedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Carrying Amount, Attributable to Parent", "verboseLabel": "Class A ordinary shares subject to possible redemption 7,804,383 and 8,186,086 shares at redemption value at June 30, 2021 and December 31, 2020" } } }, "localname": "TemporaryEquityCarryingAmountAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquitySharesIssued": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Issued", "terseLabel": "Common stock subject to possible redemption, issued (in shares)" } } }, "localname": "TemporaryEquitySharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/ShareholdersEquityCommonStockSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquitySharesOutstanding": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Outstanding", "verboseLabel": "Temporary equity, shares outstanding" } } }, "localname": "TemporaryEquitySharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r148" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic": { "auth_ref": [ "r66", "r69", "r70" ], "calculation": { "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails": { "order": 3.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.", "label": "Undistributed Earnings (Loss) Allocated to Participating Securities, Basic", "negatedLabel": "Less: Net income allocable to Class A ordinary shares subject to possible redemption" } } }, "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrealizedGainLossOnInvestments": { "auth_ref": [ "r36" ], "calculation": { "http://Consonance.com/role/CondensedStatementOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://Consonance.com/role/CondensedStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "definitionGuidance": "Unrealized gain on marketable securities held in Trust Account", "documentation": "Amount of unrealized gain (loss) on investment.", "label": "Unrealized Gain (Loss) on Investments", "negatedLabel": "Unrealized gain on marketable securities held in Trust Account" } } }, "localname": "UnrealizedGainLossOnInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedStatementOfCashFlows", "http://Consonance.com/role/CondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r136", "r140" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "terseLabel": "Unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "auth_ref": [ "r139" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued", "verboseLabel": "Amounts accrued for the payment of interest and penalties" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r79", "r80", "r82", "r83", "r84", "r85", "r86" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Warrants" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/WarrantLiabilityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r168" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants and Rights Outstanding, Term", "terseLabel": "Public Warrants expiration term" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/WarrantLiabilityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).", "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted", "verboseLabel": "Basic and diluted weighted average shares outstanding" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Consonance.com/role/CondensedStatementsOfOperations", "http://Consonance.com/role/SummaryOfSignificantAccountingPoliciesBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 8 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r1": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r103": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r106": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(4)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r158": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579240-113959" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13279-108611" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r192": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r195": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.28,29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650" }, "r229": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r231": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r232": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r233": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r234": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r235": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(b))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r47": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6787-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1377-109256" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2626-109256" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "65", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2793-109256" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "66", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2814-109256" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316" } }, "version": "2.1" } ZIP 52 0001193125-21-239469-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-21-239469-xbrl.zip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

P6KSYH+Z5>Y6;3WP'%^)"G MM;M.(5*#S9L+EM]?'J):UH8E7S]'LPRC>T1/@'S-"CJ#O:&9+(]8_R:^ 5^P2KYX+!F=,;:EIRPX9AM]S^='6E%*\@ M\[<<32?9%Q3F)4:7<5*NS1_[:7J.U

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